<SEC-DOCUMENT>0001641172-25-021109.txt : 20250728
<SEC-HEADER>0001641172-25-021109.hdr.sgml : 20250728
<ACCEPTANCE-DATETIME>20250728082000
ACCESSION NUMBER:		0001641172-25-021109
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250728
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250728
DATE AS OF CHANGE:		20250728

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ProPhase Labs, Inc.
		CENTRAL INDEX KEY:			0000868278
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				232577138
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21617
		FILM NUMBER:		251153012

	BUSINESS ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530
		BUSINESS PHONE:		(215) 345-0919

	MAIL ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUIGLEY CORP
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:PRPH="http://prophaselabs.com/20250728">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_PRPH_prophaselabs.com_20250728 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20250728_20250728 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0000868278 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000004" name="dei:EntityCentralIndexKey">0000868278</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="prph-20250728.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-07-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-07-28</xbrli:startDate>
        <xbrli:endDate>2025-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_907_edei--DocumentType_c20250728__20250728_zT2TbDdNQXvk"><ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_906_edei--DocumentPeriodEndDate_c20250728__20250728_zeujpYUy54b5"><ix:nonNumeric contextRef="AsOf2025-07-28" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">July 28, 2025</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_905_edei--EntityRegistrantName_c20250728__20250728_zwlE6RYe0Lac"><ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000011" name="dei:EntityRegistrantName">PROPHASE
LABS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Company as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20250728__20250728_zFyJeDMVtmR7"><ix:nonNumeric contextRef="AsOf2025-07-28" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityFileNumber_c20250728__20250728_zjsqj0lL7LY4"><ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000013" name="dei:EntityFileNumber">000-21617</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20250728__20250728_z0ChGZuyNZd8"><ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000014" name="dei:EntityTaxIdentificationNumber">23-2577138</ix:nonNumeric></span>
    </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 66%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_90F_edei--EntityAddressAddressLine1_c20250728__20250728_zRuY3heqHY81" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000015" name="dei:EntityAddressAddressLine1">626
                                            RXR Plaza</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                            <span id="xdx_905_edei--EntityAddressAddressLine2_c20250728__20250728_zKRJ7t7BGt41"><ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000016" name="dei:EntityAddressAddressLine2">6<sup>th</sup>
                                            Floor</ix:nonNumeric></span></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntityAddressCityOrTown_c20250728__20250728_zH0nDu0dBnal"><ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000017" name="dei:EntityAddressCityOrTown">Uniondale</ix:nonNumeric></span>,
    <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20250728__20250728_zC0DsGPNyaB"><ix:nonNumeric contextRef="AsOf2025-07-28" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressPostalZipCode_c20250728__20250728_zYCEOMteYGyc"><ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000019" name="dei:EntityAddressPostalZipCode">11556</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_903_edei--CityAreaCode_c20250728__20250728_ze40DbqdHRs"><ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000020" name="dei:CityAreaCode">(215)</ix:nonNumeric></span> <span id="xdx_905_edei--LocalPhoneNumber_c20250728__20250728_zTJvusokSQU8"><ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000021" name="dei:LocalPhoneNumber">345-0919</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any
of the following provisions (<i>see</i> General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--WrittenCommunications_c20250728__20250728_zZQoA7V5hgh"><ix:nonNumeric contextRef="AsOf2025-07-28" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--SolicitingMaterial_c20250728__20250728_zudD0pAI2rn9"><ix:nonNumeric contextRef="AsOf2025-07-28" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementTenderOffer_c20250728__20250728_zIMrumQeidVc"><ix:nonNumeric contextRef="AsOf2025-07-28" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20250728__20250728_z0wXiRU2xYc7"><ix:nonNumeric contextRef="AsOf2025-07-28" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
Registered Pursuant to Section 12(b) of the Exchange Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Each Class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Each Exchange on Which Registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--Security12bTitle_c20250728__20250728_z0sUbRN0dAz8"><ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, par value $0.0005</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20250728__20250728_zMXjs3zHmIY6"><ix:nonNumeric contextRef="AsOf2025-07-28" id="Fact000027" name="dei:TradingSymbol">PRPH</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--SecurityExchangeName_c20250728__20250728_zDJ2vBqD5VF3"><ix:nonNumeric contextRef="AsOf2025-07-28" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_904_edei--EntityEmergingGrowthCompany_c20250728__20250728_zCRMcDc4E6I"><ix:nonNumeric contextRef="AsOf2025-07-28" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
July 22, 2025, ProPhase Labs, Inc. (the &#8220;Company&#8221;) entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;),
Convertible Notes (the &#8220;Notes&#8221;), Warrants (the &#8220;Warrants&#8221;), Security Agreement, Registration Rights Agreement,
and Transfer  Agent Reservation Letter with two investors (the &#8220;Investors&#8221;) for a private placement of senior secured
convertible notes and warrants. To protect the interests of the Company and its shareholders, the Company reserved the right to prepay
the loan at any time without penalty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All material terms of the transaction are set forth in the exhibits filed herewith, and this summary is qualified in its
entirety by reference to those exhibits. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement with the two Investors is for the sale and issuance of an aggregate principal cash investment amount of $3,000,000
of 20% Original Issue Discount Senior Secured Convertible Notes and common stock purchase warrants to acquire up to 5,250,000 shares
of common stock. After the OID, the two Notes have a combined principal face amount of $3,750,000. After repayment of certain
obligations from the flow of funds, net proceeds to the Company were $2,251,343.20 from the lead investor and $500,000 from the second
investor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net proceeds are for working capital, general corporate purposes, debt repayment, and as otherwise described in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notes mature on July 22, 2026, bear interest at 10% per annum on the original principal face amount and provide for other customary
terms and covenants. The Notes are not convertible for four months after execution and may be prepaid at any time without penalty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants are exercisable at an exercise price of $0.50 per share (subject to adjustment) and expire five years from their date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Note conversion waiting period of four months, the Notes permit holders to convert outstanding principal and accrued interest
into shares of common stock at a conversion price that is the lower of 80% of the trailing ten-day volume weighted average price (VWAP)
or a fixed maximum price, but with a set floor price and certain caps on conversion to prevent excessive dilution. Unlike so-called &#8220;death
spiral&#8221; or toxic convertible structures, the conversion price cannot fall indefinitely, large block conversions are limited, and
investors do not have unrestricted rights to convert at deepening discounts regardless of market price - meaning the structure
is designed to protect long-term shareholder value and avoid downward price spirals, subject to continued listing on the Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
transaction involves the potential issuance of shares of common stock upon conversion of the Notes or exercise of the Warrants, subject
to Nasdaq and charter limitations, including a 19.99% cap pending stockholder approval. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties agreed to reserve 1.0 million shares now, and upon shareholder approval of the amendment of the certificate of incorporation
to authorize additional shares, the Transfer Agent
will increase the reserve to 226,310,704 shares. Any failure by the Company to get the additional shares authorized would be resolved
in a cash settlement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
stockholder approval of the</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> issuance of shares in
excess of 19.99% of the outstanding common stock, issuances will not exceed this threshold.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the agreements, the</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Company has until November 22,
2025 to authorize, register, and reserve the additional shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement, Notes, Warrants, and Security Agreement executed on July 22, 2025 provide for the potential issuance of a substantial
number of new shares upon conversion of the notes and exercise of the warrants, which may dilute existing shareholders and increase the
supply of shares available for resale. In addition, the Security Agreement grants investors a first priority security interest in substantially
all Company assets, meaning that in the event of a default under the Notes, secured creditors would have rights superior to those of
existing shareholders (see &#8220;Purchase Agreement Section 4,&#8221; &#8220;Note Conversion Provisions,&#8221; &#8220;Warrant Exercise
Provisions,&#8221; and &#8220;Security Agreement Section 2&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Security Agreement (executed July 22, 2025) grants the investors a first priority lien on substantially all of the Company&#8217;s
and certain subsidiary&#8217;s assets as collateral, the agreement also includes protective provisions for the Company. Specifically,
the Secured Parties may not take enforcement action or foreclose on collateral unless and until there has been an Event of Default, and
then only after prescribed notice periods and opportunity to cure. Additionally, all sales or dispositions of collateral must be commercially
reasonable and compliant with applicable law, and the agreement preserves the Company&#8217;s ability to continue using its assets in
the ordinary course of business until an uncured default occurs. These provisions ensure that, absent a default, the Company retains
full control over its assets and operations. The subsidiaries and Covid receivables that are the basis for the Company&#8217;s previously
disclosed Crown Medical Collections initiative are carved out.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
Ted Karkus, CEO, and an additional investor, who had collectively previously invested $1.0 million, agreed to subordinate their prior
secured loans to this offering and contractually accepted restrictions on payments to them while the Notes are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the loan were reviewed and approved by the Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
securities have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold absent registration
or an applicable exemption from registration requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All
material terms of the transaction are set forth in the exhibits filed herewith, and this summary is qualified in its entirety by reference
to those exhibits, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">which are attached hereto as Exhibit
10.1 through Exhibit 10.6 and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information provided in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02 Unregistered Sales of Equity Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 1.01 above is incorporated by reference into this Item 3.02.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sale and issuance of the Notes and Warrants described above, and the shares of common stock issuable upon conversion or exercise thereof,
have not been registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and were made in reliance upon
the exemptions from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D thereunder. Each Investor
has represented in its representations and warranties in the Purchase Agreement that it is an accredited investor as defined in Rule
501(a) of Regulation D.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>Item 8.01 &#8211; Other Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company has established a record
date of August 1, 2025 for a special meeting of stockholders to be held on Friday, August 29, 2025, at 4:00 p.m. Eastern Time, at 273
Merrick Road, Lynbrook, NY 11563. The meeting will start promptly at 4:00 p.m., Eastern Time. The Company intends to file a preliminary
proxy statement with the SEC in due course. Additional information regarding the proposals will be included in the proxy materials when
filed with the SEC. This communication does not constitute a solicitation of any vote or approval and is being provided for informational
purposes only in accordance with SEC rules. No proxies are being solicited at this time, and stockholders are not being requested to
take any action until they have received definitive proxy materials that will be filed with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="width: 0.1in">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Securities Purchase Agreement, dated as of July 22, 2025 (portions redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K)</a></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Form of 20% OID Senior Secured Convertible Note (portions redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K)</a></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-3.htm">Form of Common Stock Purchase Warrant (portions redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K)</a></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-4.htm">Registration Rights Agreement, dated July 22, 2025 (portions redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K)</a></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-5.htm">Security Agreement, dated July 22, 2025 (portions redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K)</a></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-6.htm">Transfer Agent Reservation Letter, dated July 22, 2025 (portions redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K)</a></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ProPhase
    Labs, Inc.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Ted Karkus</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board and Chief Executive Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
July 28, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OUwNC3xMLCILkYhelxxjSXdkdrP6pP6yVYmGC8PMvWdGiJnY0kY1yHBZlzmcsO0aaRFKrJFRX9El0t0+AddLvCljWWo7jj8wJcegY5Z+KN1+TPbKYJVAsJpHTjEEcbKIoTgIb/BT0rWqUFslG5C6goKpY4VW8nu6cJIv0tS+x09nZKNIJxD6wWR/IArCCI7Uyyfx3UCep8KbjeWJLdOjc6nsZVEPJGQNtu6dmei/vC/QJkpk -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<B>Agreement</B>&rdquo;) is dated as of July 22, 2025 and is by and between ProPhase Labs,
Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and each purchaser identified on the <B><U>Annex A</U></B> hereto (each,
including its successors and assigns, an &ldquo;<B>Investor</B>&rdquo; or &ldquo;<B>Holder</B>&rdquo;) and collectively, the &ldquo;<B>Investors</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>the Investors wish to purchase from the Company, and the Company wishes to issue and sell to the Investors: (i) 20% OID Senior Secured
Convertible Notes in the form of <B><U>Appendix A</U></B> hereto (each, a &ldquo;<B>Note</B>&rdquo; and collectively, the &ldquo;<B>Notes</B>&rdquo;);
and (ii) Warrants to Purchase Common Stock in the form of <B><U>Appendix B</U></B> hereto (each, a &ldquo;<B>Warrant</B>&rdquo; and collectively,
the &ldquo;<B>Warrants</B>&rdquo;); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company and Investors are executing and delivering this Agreement in reliance upon an exemption from securities registration requirements
of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), afforded by the provisions of Section 4(a)(2) and/or
Rule 506(b) of Regulation D promulgated thereunder by the U.S. Securities and Exchange Commission;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the
receipt and adequacy of which are hereby acknowledged, the Company and each Investor agree as follows:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ARTICLE
I<BR>
</U>DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.01. <U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise
defined herein have the meanings given to such terms in the Notes, and (b) the following terms have the meanings set forth in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>$</U>&rdquo;
means United States Dollars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Asset
Sale</U>&rdquo; means any sale, lease, license, assign, transfer, spin-off, split-off, closing, conveyance or other disposition of any
assets or rights of the Company or any Subsidiary owned or hereafter acquired whether in a single transaction or a series of related
transactions other than any (i) sale, leases, license, assignment, transfer, conveyance or other dispositions of such assets or rights
by the Company and its Subsidiaries in the ordinary course of business consistent with its past practice and (ii) sales of inventory
and product in the ordinary course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board</U>&rdquo;
means the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except Saturday, Sunday, any day which is a federal legal holiday in the United States or any day on which
banking institutions in the State of New York are authorized or required by law or other governmental action to close. If the last or
appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then
such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of Securities pursuant to Section 2.01.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means for any Securities, the Business Day when all of the Transaction Documents for such Securities shall have been
executed and delivered by the applicable parties thereto, and conditions precedent to the applicable Investors&rsquo; obligations to
pay the Subscription Amount and the Company&rsquo;s obligations to deliver such Securities shall have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0005 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalent</U>&rdquo; means any convertible security or warrant, option or other right to subscribe for or purchase any additional
shares of Common Stock or any other Common Stock Equivalent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; has the meaning provided in the Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; has the meaning provided in the Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Convertibility
Date</U>&rdquo; has the meaning provided in the Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the disclosure schedule or schedules or other writings delivered by the Company to the Investors prior to
the date hereof and identified by the Company as such.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means: (i) the issuance by the Company of Securities and (upon conversion or exercise thereof) Underlying Shares,
(ii) the issuance by the Company of Common Stock upon the exercise of an outstanding stock option or warrant or the conversion of a security
outstanding on the date hereof as disclosed in SEC Reports, or (iii) the issuance by the Company of any Common Stock or standard options
to purchase Common Stock to directors, officers, employees or consultants of the Company or its Subsidiaries in their capacity as such
pursuant to an employee benefit plan which has been approved by the Board prior to or subsequent to the date hereof pursuant to which
Common Stock and standard options to purchase Common Stock may be issued to any employee, officer, director or consultant for services
provided to the Company or its subsidiaries in their capacity as such.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exercise
Price</U>&rdquo; has the meaning provided in the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FINRA</U>&rdquo;
means the Financial Industry Regulatory Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
means: (A) any liabilities and other obligations of the Company and its Subsidiaries for borrowed money, amounts owed or funds advanced;
(B) all obligations of the Company and its Subsidiaries evidenced by bonds, debentures, notes or other similar instruments or debt securities
(including any seller notes relating to prior acquisitions); (C) all obligations in respect of letters of credit, whether or not drawn,
and bankers&rsquo; acceptances issued for the account of the Company and its Subsidiaries, (D) all obligations arising from deferred
compensation arrangements of the Company and its Subsidiaries or any joint or common employer together with the Company or any of its
Subsidiaries; (E) all obligations of any person or entity secured by a lien on any assets or rights of the Company and its Subsidiaries;
(F) all capital lease obligations of the Company and its Subsidiaries having a present value (on an aggregate basis for all capital leases);
(G) any deferred rent of the Company and its Subsidiaries; (H) any taxes payable, or tax withholding obligations, the payment of which
is due or past due by the Company and its Subsidiaries; (I) any deferred purchase price for property or services (including with respect
to any earnout or similar payments) with respect to which any Company and its Subsidiaries is liable, contingently or otherwise, as obligor
or otherwise; (J) any accrued or declared and unpaid dividends or distributions on the Company&rsquo;s or any Subsidiary&rsquo;s equity
capital; (K) any amounts due from the Company due to change in control or similar provisions; (L) payments or other amounts due from
the Company for any loans, payment deferrals, customer credits, or other Liabilities of the Companies relating to or arising under or
from: (1) the Coronavirus Aid, Relief, and Economic Security Act, including with respect to any loans or other amounts advanced or provided
to any Company thereunder; or (2) the COVID-19 global pandemic, the economic effect thereof, or from any of the precautionary or emergency
measures, recommendations or orders taken or issued by any person in response to the COVID-19 global pandemic; (M) all other Liabilities
of the Company (other than the long-term portion of any capital lease obligations) classified as non-current liabilities in accordance
with generally accepted accounting principles; (N) all accrued interest, prepayment premiums or penalties, indemnities, and fees and
expenses related to any of the foregoing (including any prepayment premiums payable as a result of the consummation of the transactions
contemplated by this Agreement); and (O) all guaranties, endorsements and other contingent obligations of the Company in respect of any
of the foregoing liabilities or obligations of any other person, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.01(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lead
Investor</U>&rdquo; means REDACTED.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.01(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
shall mean a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction or adverse claim
of a third party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning ascribed to such term in Section 3.01(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Money
Laundering Laws</U>&rdquo; has the meaning ascribed to such term in Section 3.01(hh).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>OID</U>&rdquo;
means 20%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Principal Amount</U>&rdquo; means, with respect to any Investor&rsquo;s Note(s), the amount obtained by <I>dividing</I>: (i) the Subscription
Amount for such Note(s) under this Agreement <I>by</I> (ii) 100% <I>less</I> the OID.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Permitted
Additional Debt</U>&rdquo; means (i) at any time, up to $3,000,000 of post-Closing senior secured Indebtedness (including convertible
Indebtedness), <I>provided</I> that such Indebtedness shall not (x) constitute a VRT Transaction or (y) require the payment or prepayment
of any principal amount prior to the &ldquo;Scheduled Maturity Date&rdquo; identified in the Notes; (ii) from and after the Convertibility
Date, additional Notes (&ldquo;<B>Additional Notes</B>&rdquo;) with additional Warrants (&ldquo;<B>Additional Warrants</B>&rdquo;) issued
under this Agreement (subject to the final sentence of this paragraph, in an aggregate Original Principal Amount (with respect to such
Additional Notes) not to exceed $3,000,000 <I>less</I> the amount of Indebtedness described in the foregoing clause (i) then outstanding;
and (iii) at any time, such additional Indebtedness as shall be approved by the holders of a majority in Original Principal Amount of
the Notes then outstanding (including the Lead Investor, if then a holder of any Notes). All Additional Notes shall be substantially
in the same form as the Notes issued on the initial Closing Date hereunder except that the &ldquo;Scheduled Maturity Date&rdquo; identified
therein shall be one year from the Closing Date for such Additional Notes; and all Additional Warrants shall be substantially in the
form of the Warrants issued on such initial Closing Date except that the &ldquo;Termination Date&rdquo; identified therein shall be five
year from the Closing Date for such Additional Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Permitted
ATM</U>&rdquo; means any &ldquo;at-the-market&rdquo; offering whereby the Company or any Subsidiary sells equity securities at a future
determined price (other than standard and customary &ldquo;preemptive&rdquo; or &ldquo;participation&rdquo; rights).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Permitted
Indebtedness</U>&rdquo; has the meaning ascribed to such term in Section 3.01(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Permitted
Liens</U>&rdquo; has the meaning ascribed to such term in Section 3.01(o).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prior
$1,000,000 Debt</U>&rdquo; means the senior secured Indebtedness owed to the Chief Executive Officer of the Company and a private investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prior
$1,000,000 Debt Payment Restrictions</U>&rdquo; has the meaning that no principal payments will be made on the Prior $1,000,000 Debt
<I>unless</I> such payment is made on a proportional basis (based on outstanding principal amounts (after giving effect to OID) with
substantially simultaneous payments or prepayments of Notes (&ldquo;<B>Repayment Restrictions</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Notes</U>&rdquo;
means the 20% OID Senior Secured Convertible Notes in the form of <B><U>Appendix A</U></B> attached hereto issued by the Company to the
Investors hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or un-incorporated association, joint-venture, limited liability
company, joint-stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Rights Agreement</U>&rdquo; means the Registration Rights Agreement, dated as of the date hereof, in the form of <B><U>Appendix C</U></B>
attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.01(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Reserve Amount</U>&rdquo; means: (A) prior to the Stockholder Approval Date (as defined in Section 4.03), 1,000,000 shares; and (B) from
and after the Stockholder Approval Date 400% of the maximum number of Underlying Shares issuable upon conversion or exercise of the Securities
then outstanding, as applicable, as of each applicable date of determination (without taking into account any limitations on such conversions
or exercises as set forth in the Securities).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to
time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC</U>&rdquo;
means the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; has the meaning ascribed to such term in 3.01(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Notes and the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Security
Agreement</U>&rdquo; means the Security Agreement, dated as of the date hereof, in the form of <B><U>Appendix D</U></B> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>State
Securities Laws</U>&rdquo; means the securities (or &ldquo;blue sky&rdquo;) rules, regulations, or other similar laws of a particular
state.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Investor, the aggregate amount to be paid for Securities purchased hereunder as specified below such
Investor&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United States
Dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsequent
Financing</U>&rdquo; means any securities issuance (other than in an Exempt Issuance or pursuant to any Transaction Document), incurrence
of Indebtedness or any other loan or debt or equity financing agreement or arrangement of or for the Company or any Subsidiary that is
consummated after the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any direct or indirect subsidiary of the Company as set forth on Section 3.01(a) and shall, where applicable, include any direct
or indirect subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>TA
Reservation Letters</U>&rdquo; means the letters with respect to the reservation of the Required Reserve Amount of Underlying Shares
in the form of <B><U>Appendix E</U></B> attached hereto executed by the Company, Lead Investor, and the transfer agent of the Common
Stock, the first letter to be delivered by the Company to the Transfer Agent to reserve 1,000,000 shares within one (1) business day
of Closing, and the second letter to increase the total reserve to four hundred percent (400%) of the maximum aggregate number of Underlying
Shares (Notes and Warrants) based on $3.75MM (after OID) be delivered by the Company to the Transfer Agent within one (1) business day
of Stockholder Approval. Lead Investor agrees upon request to provide written instructions to the Transfer Agent that Underlying Shares
may be taken out of reserve and shall no longer be subject to the terms of the TA Reservation Letters within two (2) Business Days of
full repayment or conversion of the Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Notes, the Warrants, the Registration Rights Agreement, the Security Agreement, the TA
Reservation Letter and all appendices, exhibits and schedules hereto and thereto and any other documents or agreements executed in connection
with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means the Warrants to Purchase Common Stock in the form of <B><U>Appendix B</U></B> attached hereto issued by the Company to the Investors
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of or otherwise pursuant to the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Underlying
Shares</U>&rdquo; means the Conversion Shares and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VRT
Transaction</U>&rdquo; means any (i) transaction in which the Company or any Subsidiary issues or sells any convertible securities either
(A) at a conversion, exercise or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations
for the Common Stock at any time after the initial issuance of such convertible securities, or (B) with a conversion, exercise or exchange
price that is subject to being reset at some future date after the initial issuance of such convertible securities or upon the occurrence
of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or
(ii) the entry into any agreement (including, without limitation, an equity line of credit but excluding a Permitted ATM) whereby the
Company or any Subsidiary may sell securities at a future determined price (other than standard and customary &ldquo;preemptive&rdquo;
or &ldquo;participation&rdquo; rights).</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ARTICLE
II<BR>
</U>PURCHASE AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.01 <U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with
the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Investors, severally and not
jointly, agree to purchase Securities. At the Closing, the Investors shall deliver, via wire transfer, immediately available funds equal
to the Investors&rsquo; aggregate Subscription Amounts to the Company and the Company shall issue and deliver to each Investor its Securities.
The Company and each Investor shall deliver the other items set forth in Section 2.02 deliverable at the Closing. Upon satisfaction of
the conditions set forth in Sections 2.02 and 2.03, the Closing shall occur at the offices of the Company&rsquo;s counsel, or such other
location as the parties shall mutually agree or may be closed remotely by electronic delivery of documents. The Closing Date for any
Securities shall be the date indicated on the applicable Investor&rsquo;s signature page attached hereto as <B><U>Annex A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.02 <U>Closing Deliverables</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>By Each Investor</U>. On or prior to the Closing Date, each Investor shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 127.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
  Agreement duly executed by such Investor;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  Registration Rights Agreement duly executed by such Investor;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  Security Agreement duly executed by such Investor, and</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 127.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
  Investor&rsquo;s Subscription Amount by wire transfer to the Company pursuant to the wiring instructions set forth in Section 2.03(c);
  <I>provided</I> that the Lead Investor shall (a) for the account of the Company, directly pay REDACTED to the Lead Investor&rsquo;s
  counsel as provided in Section 5.02 on the Closing Date and directly pay REDACTED to REDACTED as provided in Section 4.02 and (b) deduct
  such amount from its Subscription Amount otherwise payable to the Company hereunder.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>By the Company</U>. On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Investor:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
  Agreement, duly executed by an authorized officer of behalf of the Company;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
  Note registered in the name of each relevant Investor duly executed by an authorized officer on behalf of the Company and having an
  Original Principal Amount equal to the amount obtained by <I>dividin</I>g: (a) such Investor&rsquo;s Subscription Amount by (b) 100%
  <I>minus</I> the OID;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
  Warrant registered in the name of each relevant Investor duly executed by an authorized officer on behalf of the Company and being
  initially exercisable for a number of shares of Common Stock (subject to adjustment as provided therein) equal to the amount obtaining
  by <I>dividing</I>: (a) seventy percent (70%) of the Original Principal Amount of such Investor&rsquo;s Note(s) by (b) fifty cents
  ($0.50);</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  Registration Rights Agreement duly executed by an authorized officer on behalf of the Company;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  Security Agreement duly executed by an authorized officer on behalf of the Company and each of its Subsidiaries Nebula Genomics, Inc.,
  ProPhase BioPharma, Inc., and TK Supplements, Inc.;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  TA Reservation Letter executed and delivered by an authorized offer on behalf of the Company and the transfer agent of the Common Stock;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  Company confirms that the holders of the Prior $1,000,000 Debt have agreed in writing to: (A) the Prior $1,000,000 Debt Repayment Restrictions
  and (B) the full subordination of the Prior $1,000,000 Debt to the Notes;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
  officer&rsquo;s certificate of the Company certifying the Company&rsquo;s and each of its Subsidiaries party to the Security Agreement:
  (A) certified certificate of incorporation; (B) good standing certificate in the jurisdiction of its incorporation, subject to a tax
  payment plan in the case of the Company; (C) bylaws; and (D) resolutions of the Board approving and authorizing the execution, delivery
  and performance of the Transaction Documents and the transactions contemplated thereby.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.03 <U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  accuracy in all material respects on the Closing Date of each Investor&rsquo;s representations and warranties contained herein;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
  obligations, covenants and agreements of each Investor required to be performed at or prior to the Closing Date shall have been performed;
  and</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 127.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  delivery by each Investor of the items set forth in Section 2.02(a) of this Agreement.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Investors hereunder in connection with the Closing are subject to the following conditions being met
(it being understood that the Company may waive any of the conditions for any Closing hereafter):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
  Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
  as of a specific date therein in which case they shall be accurate as of such date);</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
  obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;
  and</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  delivery by the Company of the items set forth in Section 2.02(b) of this Agreement; and</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 127.45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
  shall have been no Material Adverse Effect with respect to the Company since the date hereof.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The wiring instructions for the Company are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 113.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 2.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
Name: REDACTED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 2.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
Address: REDACTED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 2.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABA
No.: REDACTED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 2.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
No.: REDACTED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 2.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SWIFT/BIC
code: REDACTED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 2.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acct.
Name: REDACTED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 2.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference:
[Investor Name]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ARTICLE
III</U><BR>
REPRESENTATIONS AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.01 <U>Representations and Warranties of the Company</U>. The Company hereby represents and warrants to each Investor that, except as
set forth in the SEC Reports and/or Disclosure Schedules, the following representations are true and complete as of the date of the date
hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. The Company does not have any direct or indirect subsidiaries other than as set forth in the SEC Reports.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company is an entity duly incorporated, validly existing and in good standing under the laws
of the State of Delaware, subject to owing a tax balance that has been disclosed and is on a payment plan, with the requisite power and
authority to own and use its properties and assets and to carry on its business as currently conducted. The Company is not in violation
or default of any of the provisions of its articles of incorporation or bylaws, each, as amended and in effect. A complete and correct
copy of the Company&rsquo;s certificate or articles of incorporation and bylaws, each as amended and in effect on the date of this Agreement
and as they will be in effect on the Closing Date, is attached to the officer&rsquo;s certificate referenced in Section 2.02(b)(ix).
There are no other organizational or charter documents of the Company. Each of the Company and its Subsidiaries is duly qualified to
conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business
conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing,
as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Document; (ii) a material adverse effect on the results of operations, assets, business, prospects
or condition (financial or otherwise) of the Company or any of its material assets or lines of business, individually; or (iii) a material
adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations under any Transaction
Document (any of (i), (ii) or (iii), a &ldquo;<B>Material Adverse Effect</B>&rdquo;) and no Proceeding has been instituted in any such
jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification; <I>provided,
however</I>, that &ldquo;Material Adverse Effect&rdquo; shall not include any event, occurrence, fact, condition or change, directly
or indirectly, arising out of or attributable to: (i) general economic or political conditions, (ii) conditions generally affecting the
industry in which the Company or any Subsidiary operates, (iii) any changes in financial or securities markets in general, (iv) acts
of war (whether or not declared), armed hostilities or terrorism, or the escalation or worsening thereof, (v) any pandemic, epidemics
or human health crises (including COVID-19), (vi) any changes in applicable laws or accounting rules, (vii) the announcement, pendency
or completion of the transactions contemplated by the Transaction Documents, or (viii) any action required or permitted by the Transaction
Documents or any action taken (or omitted to be taken) with the written consent of or at the written request of the Investors holding
a majority in Original Principal Amount of the Notes then outstanding (including the Lead Investor, if then a holder of any Notes).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by each of the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution
and delivery of each of the Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and
thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company,
the Board or the Company&rsquo;s stockholders (except as provided in Section 4.03) in connection therewith other than in connection with
the Required Approvals. Each Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by
the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of
the Company enforceable against the Company in accordance with its terms, except: (i) as limited by general equitable principles and
applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo;
rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies; and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of the Transaction Documents to which it is a party, the
issuance and sale of the Securities, the issuance of the Underlying Shares in accordance with the provisions of the Transaction Documents,
and the consummation by the Company of the other transactions contemplated hereby and thereby do not and will not: (i) conflict with
or violate any provision of the Company&rsquo;s certificate of incorporation, bylaws or other organizational or charter documents; (ii)
conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in
the creation of any Lien upon any of the properties or assets of the Company (other than pursuant to the Security Agreement), or give
to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any
agreement, credit facility, debt or other instrument (evidencing a Company debt or otherwise) or other understanding to which the Company
is a party or by which any property or asset of the Company is bound or affected; or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company is subject (including federal and State Securities Laws and regulations), or by which any
property or asset of the Company is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or
reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) such consents,
waivers, or authorizations as have been obtained before the Closing; and (ii) the filing of Form D with the Commission and such filings
as are required to be made under applicable State Securities Laws (collectively, the &ldquo;<B>Required Approvals</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities</U>. The Securities are duly authorized and, when issued and/or paid for in accordance with the terms of
this Agreement, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens other than restrictions on
transfer provided for in the Transaction Documents. The Underlying Shares, when issued in accordance with the terms of the terms of the
Securities, will be validly issued, fully paid and nonassessable, free and clear of all Liens other than restrictions on transfer provided
for herein or therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company is as set forth in the most recent SEC Reports. Since the date of the most recently
filed SEC Report, other than as disclosed in Form D, filed on July 7, 2025, the Company has not issued any Common Stock, Common Stock
Equivalents or other equity interests (other than Exempt Issuances) or (without duplication) pursuant to the conversion and/or exercise
of Common Stock Equivalents outstanding as of the date of the most recently filed SEC Report. Except in instances where valid waivers
have been obtained, no Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate
in the transactions contemplated by the Transaction Documents. Except as set forth in the SEC Reports, there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any Common Stock or
the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
is or may become bound to issue additional Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance
and sale of the Securities and Underlying Shares will not obligate the Company or any Subsidiary to issue Common Stock or other securities
to any Person (other than holders of Securities) and will not result in a right of any holder of Company securities to adjust the exercise,
conversion, exchange or reset price under any of such securities. All of the outstanding shares of capital stock of the Company are duly
authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws,
and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.
Except for the Required Approvals, as provided in Section 4.03, and waivers that have heretofore been obtained, no further approval or
authorization of any stockholder, the Board or others is required for the issuance and sale of the Securities and Underlying Shares.
There are no stockholder agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock
to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein
as the &ldquo;<B>SEC Reports</B>&rdquo;). As of their respective dates, the SEC Reports complied in all material respects with the requirements
of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of
a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the
SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect
thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted
accounting principles applied on a consistent basis during the periods involved (&ldquo;<B>GAAP</B>&rdquo;), except as may be otherwise
specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes
required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries
as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited
statements, to normal year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Undisclosed Liabilities</U>. Each of the Company and its Subsidiaries has no material liability, Indebtedness, obligation, expense,
claim, deficiency or guaranty of any type, whether accrued, absolute, contingent, matured, unmatured or otherwise, required to be reflected
in financial statements in accordance with GAAP, which individually or in the aggregate: (A) has not been reflected in the latest balance
sheet included in the financial statements referenced hereinabove; or (B) has not arisen: (i) in the ordinary course of business, consistent
with past practices, since the date of the latest balance sheet included in such financial statements in an amount that does not exceed
$25,000 in any one case or $50,000 in the aggregate, (ii) pursuant to or in connection with this Agreement or other Transaction Document,
or (c) are executory performance obligations to be performed after the date hereof in the ordinary course of business pursuant to agreement(s)
entered into in the ordinary course of business, consistent with past practices. Each of the Company and its Subsidiaries is not in default
with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Material Changes</U>. Since the date of the latest financial statements included in the SEC Reports: (A) there has been no event,
occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect; (B) neither the Company
nor any of its Subsidiaries has incurred any Indebtedness or other liabilities (contingent or otherwise) other than (i) trade payables
and accrued expenses incurred in the ordinary course of business consistent with past practice, (ii) liabilities not required to be reflected
in the Company&rsquo;s financial statements pursuant to GAAP, and (iii) Permitted Additional Debt (collectively, &ldquo;<B>Permitted
Indebtedness</B>&rdquo;); (C) the Company has not altered their method of accounting; (D) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock except; and (E) the Company and its Subsidiaries have not issued any equity securities except in favor of
an officer, director or consultant pursuant to an existing Company equity incentive plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Litigation</U>. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of
the Company, threatened against or affecting the Company or any of its Subsidiaries, or any of their respective properties or assets,
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<B>Action</B>&rdquo;) which: (A) adversely affects or challenges the legality, validity or enforceability of
any of the Transaction Documents; or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a
Material Adverse Effect. None of the Company, any of its Subsidiaries or any director or officer thereof, is or has been the subject
of any Action involving: (x) a claim of violation of or liability under the Securities Act, the Exchange Act, FINRA rules or any State
Securities Laws; (y) breach of fiduciary duty; or (z) fraud (statutory or common law), embezzlement, misappropriation or conversion of
property or rights, or any other crime involving deceit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company or any of its Subsidiaries which could reasonably be expected to result in a Material Adverse Effect. None of the employees
of the Company or any of its Subsidiaries is a member of a union that relates to such employee&rsquo;s relationship with the Company
or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement. The
Company believes that its relationships with its employees are good. No executive officer, to the knowledge of the Company, is, or is
now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information
agreement or non- competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party,
and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. To the best of the Company&rsquo;s knowledge, the Company and each of its Subsidiaries
is in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices,
terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Compliance</U>. Except as disclosed set forth in the SEC Reports, each of the Company and its Subsidiaries (i) is neither in default
under nor in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result
in a default by the Company under), nor has the Company received notice of a claim that it is in default under or that it is in violation
of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its
properties is bound (whether or not such default or violation has been waived); (ii) is not in violation of any order of any court, arbitrator
or governmental body; and (iii) is not and has not been in material violation of any statute, law, rule or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws applicable to its business and all such laws that
affect the environment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct its business, except where the failure to possess such permits
could not reasonably be expected to result in a Material Adverse Effect (&ldquo;Material Permits&rdquo;), and the Company has not received
any notice of proceedings relating to the revocation or modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and its Subsidiaries have good and marketable title in fee simple to all real property and good and
marketable title in all personal property owned by it that, in each case, is material to the business of the Company and its Subsidiaries,
in each case free and clear of all Liens, except for the Liens that the Company is aware of and has disclosed on Schedule 3.01(o) (collectively,
&ldquo;<B>Permitted Liens</B>&rdquo;): (i) Permitted Liens (as such term is defined in the Security Agreement); and (ii) Liens disclosed
in the SEC Reports that do not materially and adversely interfere with the use made and proposed to be made of such property by the Company
and its Subsidiaries. Any real property and facilities held under lease by the Company or a Subsidiary is held by it under valid, subsisting
and enforceable leases with which the Company or such Subsidiary (as applicable) are in compliance. For any known or unknown UCC financing
statement(s) that currently exist naming the Company as &ldquo;Debtor&rdquo;, the Company cannot increase its Indebtedness to the party
named as the &ldquo;Secured Party in such UCC financing statement(s). The existence of any unknown UCC is not an Event of Default; provided
that RDM files a UCC-3 Amendment, Assignment, Continuation, or Termination of a Financing Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Patents and Trademarks</U>. (i) The Company and/or a Subsidiary thereof has, or has rights to use, all patents, patent applications,
trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual
property rights and similar rights as necessary or material for use in connection with its business and which the failure to so have
could reasonably be expected to have a Material Adverse Effect (collectively, the &ldquo;<B>Intellectual Property Rights</B>&rdquo;);
(ii) the Company has not received a notice (written or otherwise) that any of the Intellectual Property Rights violates or infringes
upon the intellectual property rights of any other Person; (iii) all Intellectual Property Rights are enforceable by the Company and/or
a Subsidiary thereof, and there is no existing infringement by any other Person of any of the Intellectual Property Rights, except where
the failure to be so enforceable or for such infringements as would not, individually or in the aggregate, reasonably be expected to
have a Material Adverse Effect; and (iv) the Company has taken reasonable security measures to protect the secrecy, confidentiality and
value of all of such Intellectual Property Rights, except where failure to do so could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Transactions with Officers, Directors and Employees</U>. None of the officers or directors of the Company or any of its Subsidiaries
and, to the knowledge of the Company, none of the employees of the Company or any of its Subsidiaries, is presently a party to any transaction
with the Company (other than for services as employees, officers and directors), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring
payments to or from, any such officer, director or employee or, to the knowledge of the Company, any entity in which any such officer,
director or employee has a substantial interest or is an officer, director, trustee, member or partner, in each case other than for:
(x) payment of salary or fees for services rendered; (y) reimbursement for expenses incurred on behalf of the Company; and (z) other
employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Intentionally Omitted</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Private Placement</U>. Assuming the accuracy of the Investors&rsquo; representations and warranties set forth in Section 3.02, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Investors as contemplated
hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities
will not be or be an Affiliate of, an &lsquo;investment company&rsquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not be an &ldquo;investment company&rdquo; subject to registration
under such Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Registration Rights</U>. Other than pursuant to the Transaction Documents, no Person has any right to demand the Company to file a
registration statement under the Securities Act covering the sale of any securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Disclosure</U>. Except with respect to: (i) the material terms and conditions of the transactions contemplated by the Transaction
Documents; and (ii) information given to the Investors, if any, which the Company hereby confirms will not constitute material non-public
information, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Investors or <U>their</U>
respective agents or counsel with any information that it believes constitutes or might constitute material, nonpublic information. The
Company understands and confirms that the Investors will rely on the foregoing representation in effecting transactions in securities
of the Company. All disclosure furnished by or on behalf of the Company to the Investors regarding the Company, its business and the
transactions contemplated hereby, is true and correct and does not contain any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>No Integrated Offering</U>. Assuming the accuracy of the Investors&rsquo; representations and warranties set forth in Section 3.02,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of the Securities Act which would require the registration of any such
securities under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder: (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature; (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, and projected capital requirements and capital availability thereof; and (iii) the current
cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking
into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts
are required to be paid. The Company will not, after the Closing Date, incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). Except as disclosed in the SEC Reports,
the Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation
under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries have filed all federal, state and foreign income and franchise tax returns
and have paid or accrued all taxes shown as due thereon, and the Company has no knowledge of a tax deficiency which has been asserted
or threatened against the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>No General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
or Underlying Shares by any form of general solicitation or general advertising. The Company has offered the Securities and Underlying
Shares for sale only to the Investors and certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Insurance</U>. The Company and its Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as management of the Company reasonably believes to be prudent and customary in the businesses in which
the Company and its Subsidiaries are engaged. The Company has never been refused any insurance coverage sought or applied for, and the
Company has no reason to believe that it will not be able to renew all existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Acknowledgment Regarding Investors&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Investors
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Investor is acting as a financial adviser or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Investor or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Investors&rsquo; purchase of the Securities. The Company further represents to each Investor that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>No Disqualification Events</U>. With respect to Securities to be offered and sold hereunder in reliance on Rule 506(b) under the Securities
Act (&ldquo;Regulation D Securities&rdquo;), none of the Company, any of its predecessors, any affiliated issuer, any director, executive
officer, other officer of the Company participating in the offering hereunder, any beneficial owner of twenty percent (20%) or more of
the Company&rsquo;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is
defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;Issuer
Covered Person&rdquo; and, together, &ldquo;Issuer Covered Persons&rdquo;) is subject to any of the &lsquo;Bad Actor&rsquo; disqualifications
described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &ldquo;Disqualification Event&rdquo;), except for a Disqualification
Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is
subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e),
and has furnished to the Investors a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Other Covered Persons</U>. The Company is not aware of any person (other than any Issuer Covered Person) that has been or will be
paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Regulation D Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Notice of Disqualification Events</U>. The Company will notify the Investors in writing, prior to the Closing Date of: (i) any Disqualification
Event relating to any Issuer Covered Person; and (ii) any event that would, with the passage of time, become a Disqualification Event
relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Foreign Corrupt Practices</U>. Neither the Company, any of its Subsidiaries nor, to the knowledge of the Company, no agent or other
person acting on behalf of the Company or any of its Subsidiaries, has: (i) directly or indirectly, used any funds for unlawful contributions,
gifts, entertainment or other unlawful expenses related to foreign or domestic political activity; (ii) made any unlawful payment to
foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds;
(iii) failed to disclose fully any contribution made by the Company (or made by any person acting on its behalf of which the Company
is aware) which is in violation of law; or (iv) violated in any material respect any provision of the Foreign Corrupt Practices Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Office of Foreign Assets Control</U>. Neither the Company, any of its Subsidiaries nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or Affiliate of the Company or any of its Subsidiaries, is currently subject to any U.S. sanctions administered
by the Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;OFAC&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon an Investor&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Affiliates is subject to the Bank Holding Company Act of 1956, as
amended (&ldquo;BHCA&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (&ldquo;Federal Reserve&rdquo;).
Neither the Company nor any of its Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding
shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject
to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Affiliates exercises a controlling influence
over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<B>Money Laundering Laws</B>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any of its Subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 77.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Representations</U>. The representations and warranties of the Company contained in this Agreement, and the certificate(s) furnished
or to be furnished to the Investors at the Closing, when taken as a whole, do not contain any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements contained herein or therein not misleading in light of the circumstances
under which they were made. The Company acknowledges and agrees that the representations contained in Section 3.02 shall not modify,
amend or affect such Investor&rsquo;s right to rely on the Company&rsquo;s representations and warranties contained in this section 3.01
or elsewhere in this Agreement or any representations and warranties contained in any other Transaction Document, or any other document
or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.02 <U>Representations and Warranties of the Investors</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Investor, for itself and for no other Investor, hereby represents and warrants as of the date hereof and as of the Closing Date to the
Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Authority; Organization</U>. Such Investor has full power and authority (and, if such Investor is an individual, the capacity) to
enter into this Agreement and to perform all obligations required to be performed by it hereunder. If an entity, such Investor is an
entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with full right,
corporate or partnership power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Investor of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate or
similar action on the part of such Investor. Each Transaction Document to which it is a party has been duly executed by such Investor,
and when delivered by such Investor in accordance with the terms hereof, will constitute the valid and legally binding obligation of
such Investor, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable
bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights
generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies,
and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Own Account</U>. Such Investor understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered
under the Securities Act or any applicable State Securities Law and is acquiring the Securities as principal for its own account and
not with a view to or for distributing or reselling such Securities, any Underlying Shares or any part thereof in violation of the Securities
Act or any applicable State Securities Law, has no present intention of distributing any of the Securities or Underlying Shares in violation
of the Securities Act or any applicable State Securities Law and has no direct or indirect arrangement or understandings with any other
persons to distribute or regarding the distribution of the same in violation of the Securities Act or any applicable State Securities
Law (it being understood that this representation and warranty not limiting such Investor&rsquo;s right to sell the Securities and Underlying
Shares in compliance with applicable federal and State Securities Laws). Such Investor is acquiring the Securities hereunder in the ordinary
course of its business for its own account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Non-Transferrable</U>. Such Investor agrees: (i) that the Investor will not sell, assign, pledge, give, transfer or otherwise dispose
of the Securities or Underlying Shares or any interest therein, or make any offer or attempt to do any of the foregoing, except pursuant
to a registration of the Securities under the Securities Act and all applicable State Securities Laws, or in a transaction which is exempt
from the registration provisions of the Securities Act and all applicable State Securities Laws, (ii) that the certificates representing
the Securities and Underlying Shares will bear a legend making reference to the foregoing restrictions, and (iii) that the Company and
its Affiliates shall not be required to give effect to any purported transfer of Securities or Underlying Shares except upon compliance
with the foregoing restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Investor Status</U>. Such Investor is an &ldquo;accredited investor&rdquo; as defined in Rule 501(a) under Regulation D of the Securities
Act. The undersigned agrees to furnish any additional information requested by the Company or any of its Affiliates to assure compliance
with applicable U.S. federal and state securities laws in connection with the purchase and sale of the Securities. Any information that
has been furnished or that will be furnished by the undersigned to evidence its status as an accredited investor is accurate and complete,
and does not contain any misrepresentation or material omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Experience of Such Investor</U>. Such Investor, either alone or together with its representatives, has such knowledge, sophistication,
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Investor is able to bear the economic risk of an
investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>No Trading Market</U>. Such Investor acknowledges that there is currently no trading market for the Securities and that none is expected
to develop.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>General Solicitation</U>. Such Investor undersigned acknowledges that neither the Company nor any other person offered to sell the
Securities to it by means of any form of general solicitation or advertising, including, but not limited to: (i) any advertisement, article,
notice, or other communication published in any newspaper, magazine or similar media or broadcast over television or radio, or (ii) any
seminar or meeting whose attendees were invited by any general solicitation or general advertising.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Confidentiality</U>. Other than to other Persons party to this Agreement and its advisors who have agreed to keep information confidential
or have a fiduciary obligation to keep such information confidential, such Investor has maintained the confidentiality of all disclosures
made to it in connection with the transaction (including the existence and terms of this transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Foreign Investor</U>. If such Investor is not a United States person, such Investor represents that it has satisfied itself as to
the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Securities or any use of this
Agreement, including: (i) the legal requirements within its jurisdiction for the purchase of the Securities, (ii) any foreign exchange
restrictions applicable to such purchase, (iii) any governmental or other consents that may need to be obtained, and (iv) the income
tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale or transfer of the Securities.
The Investor further represents that its payment for, and its continued beneficial ownership of the Securities, will not violate any
applicable securities or other laws of its jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Information from Company</U>. Such Investor and its investment managers, if any, have been afforded the opportunity to obtain any
information necessary to verify the accuracy of any representations or information presented by the Company in this Agreement and have
had all inquiries to the Company answered, and have been furnished all requested materials, relating to the Company and the Offering
and sale of the Securities and anything set forth in the Transaction Documents. Neither the Investor nor the Investor&rsquo;s investment
managers, if any, have been furnished any offering literature by the Company or any of its Affiliates, associates, or agents other than
the Transaction Documents, and the agreements referenced therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Short Sale Limitation</U>. Each Investor covenants and agrees that, for so long as such Investor holds any Notes, Warrants, or other
securities convertible into or exercisable for shares of Common Stock of the Company, neither such Investor nor any of its Affiliates
shall, at any time, maintain a net short position (whether through direct short sales, synthetic positions using derivatives, or otherwise)
in excess of 4.99% of the Company&rsquo;s aggregate outstanding shares of Common Stock, as calculated on a fully diluted basis. For the
purposes of this provision, &ldquo;net short position&rdquo; means the excess of the number of shares of Common Stock that such Investor
and its Affiliates have sold short over the number of shares they beneficially own and may convert or exercise, as determined in accordance
with Regulation SHO under the Exchange Act and the Listing Rules of the Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Speculative Nature of Investment; Risk Factors</U>. <B>SUCH INVESTOR UNDERSTANDS THAT AN INVESTMENT IN THE SECURITIES INVOLVES A HIGH
DEGREE OF RISK. </B>Such Investor acknowledges that: (i) any projections, forecasts or estimates as may have been provided to the Investor
are purely speculative and cannot be relied upon to indicate actual results that may be obtained through this investment; any such projections,
forecasts and estimates are based upon assumptions which are subject to change and which are beyond the control of the Company or its
management, (ii) the tax effects which may be expected by this investment are not susceptible to absolute prediction, and new developments
and rules of the Internal Revenue Service, audit adjustment, court decisions or legislative changes may have an adverse effect on one
or more of the tax consequences of this investment, and (iii) the Investor has been advised to consult with his own advisor regarding
legal matters and tax consequences involving this investment. The Investor represents that the Investor&rsquo;s investment objective
is speculative in that the Investor seeks the maximum total return through an investment in a broad spectrum of securities, which involves
a higher degree of risk than other investment styles and therefore the Investor&rsquo;s risk exposure is also speculative. The Securities
offered hereby are highly speculative and involve a high degree of risk and Investor should only purchase these securities if Investor
can afford to lose their entire investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Money Laundering</U>. If an entity, the operations of such Investor are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Money Laundering Laws, and no Action or Proceeding by or before any court
or governmental agency, authority or body or any arbitrator involving the Company with respect to the Money Laundering Laws is pending
or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in Section 3.02 shall not modify, amend or affect such Investor&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transaction contemplated hereby.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ARTICLE
IV</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.01 <U>Transfer Restrictions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Securities and Underlying Shares may only be disposed of in compliance with state and federal securities laws. In connection with
any transfer of Securities or Underlying Shares other than pursuant to an effective registration statement or Rule 144, the Company may
require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor to the effect that such transfer
does not require registration of such transferred Securities or Underlying Shares under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Investors agree to the imprinting, so long as is required by this Section 4.01, of a legend on any of the Securities and Underlying
Shares in the following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0.5in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NEITHER]
THIS SECURITY [NOR THE SECURITIES [INTO/FOR] WHICH THIS SECURITY IS [CONVERTIBLE/EXERCISABLE] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES
AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL
TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Upon the Investor&rsquo;s request in connection with a proposed sale of Underlying Shares pursuant to Rule 144 and if the Company reasonably
determines it is so required, upon receipt of customary documentation from Investor&rsquo;s broker (if the Underlying Shares are sold
in brokers transactions), the Company shall, at its own cost and effort, retain legal counsel to provide an opinion letter to the Company&rsquo;s
transfer agent opining that the Underlying Shares may be resold without registration under the Securities Act, pursuant to Rule 144,
promulgated thereunder, so long as the requirements of Rule 144 are met for any Underlying Shares to be resold thereunder. The Company
shall arrange for any such opinion letter to be provided not later than two (2) Business Days after the date of delivery to and receipt
by the Company of a written request by any Investor together with (if required in order to render the opinion) any broker&rsquo;s representation
letter of other customary documentation reasonably requested by the Company evidencing compliance with Rule 144 (the &ldquo;<B>Legend
Removal Date</B>&rdquo;), and such opinion letter may be a &ldquo;blanket&rdquo; opinion letter covering Underlying Shares held by more
than one Investor (if applicable to more than one Investor).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Each Investor, severally and not jointly with the other Investors, agrees that such Investor will sell Securities and Underlying Shares
only pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements,
or an exemption therefrom, and that if Securities or Underlying Shares are sold pursuant to a registration statement, they will be sold
in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates
representing Securities as set forth in this Section 4.01 is predicated upon the Company&rsquo;s reliance upon this understanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.02 <U>Use of Proceeds</U>. The Company: (i) may use the proceeds from the sale of the Securities for working capital and general corporate
purposes, and (ii) shall use proceeds to pay off RDM to have RDM file a UCC-3 Amendment, Assignment, Continuation, or Termination of
a Financing Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.03 <U>Stockholder Approval</U>. From and after the date hereof the Company shall use its best efforts to either (x) if the Company
shall have obtained the prior written consent of the requisite stockholders (the &ldquo;<B>Stockholder Consent</B>&rdquo;) to obtain
the Stockholder Approval (as defined below), inform the stockholders of the Company of the receipt of the Stockholder Consent by preparing
and filing with the SEC an information statement with respect thereto distributed to the Company&rsquo;s Stockholders not less than twenty
(20) days prior to the Stockholder Approval Deadline (as hereinafter defined) or (y) provide each stockholder entitled to vote at a special
meeting of stockholders of the Company (which may also be at the annual meeting of stockholders) (the &ldquo;<B>Stockholder Meeting</B>&rdquo;),
which shall be promptly called and held not later than September 18, 2025 (the &ldquo;<B>Stockholder Approval Deadline</B>&rdquo;), a
proxy statement or information statement (as applicable). The proxy statement, if any, shall solicit each of the Company&rsquo;s stockholder&rsquo;s
affirmative vote at the Stockholder Meeting for approval of resolutions (&ldquo;<B>Stockholder Resolutions</B>&rdquo;) providing for
(i) the issuance of all of the Underlying Shares in excess of 19.99% of the number of the Company&rsquo;s issued and outstanding shares
of Common Stock at a price less than the minimum price required by the Company&rsquo;s current Trading Market, in compliance with the
rules and regulations of such Trading Market (without regard to any limitation on conversion or exercise thereof), and (ii) authorization
to increase the authorized Common Stock of the Company to ensure that the number of authorized shares is sufficient to meet the Required
Reserve Amount (such affirmative approval being referred to herein as the &ldquo;<B>Stockholder Approval</B>&rdquo;, and the date such
Stockholder Approval is obtained, the &ldquo;<B>Stockholder Approval Date</B>&rdquo;), and, in the case of a Stockholder Meeting, the
Company shall use its best efforts to solicit its stockholders&rsquo; approval of such resolutions and to cause the Board to recommend
to the stockholders that they approve such resolutions. The Company shall be obligated to seek to obtain the Stockholder Approval by
the Stockholder Approval Deadline. If the Stockholder Approval is not obtained on or prior to the Stockholder Approval Deadline: (i)
the Company shall cause an additional Stockholder Meeting to be held on or prior to the thirtieth (30<SUP>th</SUP>) calendar day following
the failure to obtain Stockholder Approval, and (ii) shall thereafter (if necessary) cause repeated and further additional Stockholder
Meetings to be held on successive 30-day intervals following the failure to obtain Stockholder Approval until Stockholder Approval is
obtained. Until Stockholder Approval is obtained, the Company shall not issue shares in excess of 19.99% of the Company&rsquo;s outstanding
Common Stock at a per share price less than the minimum price required by the Company&rsquo;s current principal Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.04 <U>Reservation of Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Within one (1) Business Day of Stockholder Approval, and so long as any of the Securities remain outstanding, the Company shall take
all action necessary to at all times have authorized, and reserved for the purpose of issuance, no less than the Required Reserve Amount
of shares of Common Stock; provided that at no time shall the number of shares of Common Stock reserved pursuant to this Section 4.04
be reduced other than proportionally in connection with any conversion, exercise and/or payment as applicable, of Securities. If at any
time after the Stockholder Approval Deadline the number of shares of Common Stock authorized and reserved for issuance is not sufficient
to meet the Required Reserve Amount, the Company will promptly take all corporate action necessary to authorize and reserve a sufficient
number of shares, including, without limitation, calling a special meeting of stockholders to authorize additional shares to meet the
Company&rsquo;s obligations pursuant to the Transaction Documents, in the case of an insufficient number of authorized shares, obtain
stockholder approval of an increase in such authorized number of shares, and voting the management shares of the Company in favor of
an increase in the authorized shares of the Company to ensure that the number of authorized shares is sufficient to meet the Required
Reserve Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Insufficient Authorized Shares</U>. Notwithstanding Section 4.04(a), and not in limitation thereof, if at any time after the Stockholder
Approval Deadline while any of the Securities remain outstanding the Company does not have a sufficient number of authorized and unreserved
shares of Common Stock to satisfy its obligation to reserve for issuance upon conversion or exercise of the Securities at least a number
of shares of Common Stock equal to the Required Reserve Amount (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company shall
immediately take all action necessary to increase the Company&rsquo;s authorized Common Stock to an amount sufficient to allow the Company
to reserve the Required Reserve Amount for the Notes then outstanding. Without limiting the generality of the foregoing sentence, as
soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than sixty (60) days after
the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its stockholders for the approval of an increase
in the number of authorized Common Stock. In connection with such meeting, the Company shall provide each stockholder with a proxy statement
and shall use its best efforts to solicit its stockholders&rsquo; approval of such increase in authorized Common Stock and to cause the
Board to recommend to the stockholders that they approve such proposal. <U>On or after November 18, 2025, </U>in the event that the Company
is prohibited from issuing shares of Common Stock pursuant to the terms of the Securities due to the failure by the Company to have sufficient
shares of Common Stock available out of the authorized but unissued shares of Common Stock (such unavailable number of shares of Common
Stock, the &ldquo;<B>Authorized Failure Shares</B>&rdquo;), in lieu of delivering such Authorized Failure Shares to the Holder, the Company
shall pay cash in exchange for the redemption of such portion of the Conversion Amount of Notes (as defined therein) converted and/or
Exercise Price of Warrants (as defined therein) exercised (as applicable) in such Authorized Failure Shares at a price equal to the product
of (1) 150% and (2) the sum of: (i) the product of (x) such number of Authorized Failure Shares and (y) the greatest Closing Sale Price
of the Common Stock on any Trading Day during the period commencing on the date the Holder delivers the applicable notice(s) of conversion
and/or exercise (as applicable) with respect to such Authorized Failure Shares to the Company and ending on the date of such issuance
and payment under this Section 4.04(b); and (ii) to the extent the Purchaser purchases (in an open market transaction or otherwise) shares
of Common Stock to deliver in satisfaction of a sale by the Purchaser of Authorized Failure Shares, any brokerage commissions and other
out-of-pocket expenses, if any, of the Holder incurred in connection therewith. Nothing contained in Section 4.04(a) or this Section
4.04(b) shall limit any obligations of the Company under any provision of the Transaction Documents. For purposes of the foregoing &ldquo;<B>Closing
Sale Price</B>&rdquo; means, for any security as of any date, the last closing trade price, for such security on the principal Trading
Market (or other market) therefor, as reported by Bloomberg, or, if such Trading Market (or other market) begins to operate on an extended
hours basis and does not designate the closing trade price then the last bid price or last trade price, respectively, of such security
prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or, if such principal Trading Market (or other market) is not the principal
securities exchange or trading market for such security, the last trade price of such security on the principal securities exchange or
trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last trade price
of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no
last trade price is reported for such security by Bloomberg, the average of the ask prices of any market makers for such security as
reported in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices). If the Sale Price
cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such
date shall be the fair market value as mutually determined by the Company and the Lead Investor. All such determinations shall be appropriately
adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions during such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.05 <U>Mandatory Paydown of Notes</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsequent Financing</U>. Upon the consummation by the Company or any of its Subsidiaries of any Subsequent Financing (other than
a Permitted ATM or other Permitted Additional Debt) while any Notes remain outstanding, the Lead Investor may require that the Company
shall utilize and apply one hundred percent (100%) of the net cash proceeds thereof to the payment or prepayment of the Premium Amount
of the Notes (as defined therein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Permitted ATM</U>. Upon the consummation by the Company or any of its Subsidiaries of any Permitted ATM while any Notes remain outstanding,
the Lead Investor may require that the Company shall utilize and apply up to twenty-five percent (25%) of the net cash proceeds thereof
to the payment or prepayment of the Premium Amount of the Notes (as defined therein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Asset Sales</U>. Upon the consummation by the Company or any of its Subsidiaries of any Asset Sale while any Notes remain outstanding,
the Lead Investor may require that the Company shall utilize and apply one hundred percent (100%) of the net cash proceeds thereof to
the payment or prepayment of the Payment Amount of the Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Pro Rata Payments</U>. All net cash proceeds required by the Lead Investor to be applied to the payment or prepayment of Notes shall
be offered and paid to all Investors holding Notes who wish to accept such payment or prepayment <I>pro rata</I> in proportion to the
respective Original Principal Amounts of their respective Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.06 <U>Most-Favored Nations</U>. So long as any obligations of the Company under the Transaction Documents are outstanding, upon any
issuance of (or announcement of intent to effect an issuance of) any security or amendment to (or the Company&rsquo;s announcement of
intent to effect an amendment to) any security that was originally issued before the date hereof by the Company or any Subsidiary, with
any term that the Lead Investor reasonably believes is more favorable to the purchaser(s) of such security than to the Investors under
the Transaction Documents, or with a term in favor of the purchaser(s) of such security that the Lead Investor reasonably believes was
not similarly provided to the Investors under the Transaction Documents, then: (i) the Company shall notify the Investors of such additional
or more favorable term within three (3) Business Days of the issuance and/or amendment (as applicable) of the respective security; and
(ii) such term, at each Investor&rsquo;s option, shall become a part of the Transaction Documents with such Investor(s) (regardless of
whether the Company complied with the notification provision of this Section 4.06). The types of terms contained in another security
that may be more favorable to the purchaser(s) of such security include, but are not limited to, terms addressing conversion price, discounts
and adjustments thereof, prepayment rate, conversion lookback periods, interest rates, original issue discounts, stock sale price, private
placement price per share, commitment shares, warrant coverage and warrant exercise price. If any Investor elects to have the term become
a part of the Transaction Documents with such Investor, then the Company shall immediately deliver acknowledgment of such adjustment
in form and substance reasonably satisfactory to such Investor (the &ldquo;<B>Acknowledgment</B>&rdquo;) within three (3) business days
of Company&rsquo;s receipt of request from Purchaser (the &ldquo;Adjustment Deadline&rdquo;), provided that Company&rsquo;s failure to
timely provide the Acknowledgement shall not affect the automatic amendments contemplated hereby. Notwithstanding the foregoing, if and
whenever on or after the date of this Agreement the Company grants, issues or sells (or enters into any agreement to grant, issue or
sell), or in accordance with this Section 4.06 is deemed to have granted, issued or sold, any shares of Common Stock (including the granting,
issuance or sale of shares of Common Stock owned or held by or for the account of the Company, issued or sold or deemed to have been
granted, issued or sold) for a consideration per share (the &ldquo;<B>New Issuance Price</B>&rdquo;) less than a price equal to the Conversion
Price and/or Exercise Price in effect immediately prior to such granting, issuance or sale or deemed granting, issuance or sale (such
Conversion Price then in effect is referred to herein as the &ldquo;<B>Applicable Price</B>&rdquo;) (the foregoing a &ldquo;<B>Dilutive
Issuance</B>&rdquo;), then, immediately after such Dilutive Issuance, the Conversion Price and/or Exercise Price (as applicable) then
in effect shall be reduced to an amount equal to the New Issuance Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.07. <U>Rollover Rights</U>. So long as any Note is outstanding, if the Company completes any single public offering or private placement
of its equity, equity-linked or debt securities (each, a &ldquo;<B>Future Transaction</B>&rdquo;), the each Investor may, in its sole
discretion, elect to apply as purchase consideration for such Future Transaction: (i) all, or any portion, of the then Premium Amount
of such Investor&rsquo;s Note(s), and (ii) any Warrants and other securities of the Company then held by such Investor, at their fair
value (the &ldquo;<B>Rollover Rights</B>&rdquo;). The Company shall give written notice to the Investors, but in no event less than fifteen
(15) days before the anticipated closing date of such Future Transaction. Each Investor may exercise its Rollover Rights by providing
the Company written notice of such exercise within five (5) Business Days before the closing of the Future Transaction. In the event
that any Investor exercises its Rollover Rights, then such elected portion with respect to (i) and (ii) above, shall automatically convert
into the corresponding securities issued in such Future Transaction under the terms of such Future Transaction, such that the Purchaser
will receive all securities (including, without limitation, any warrants) issuable under the Future Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 78pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.08. <U>Rights of First Refusal</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Additional Notes</U>. Investors holding outstanding Notes shall have a pro rata right of first refusal on the purchase of Additional
Notes, if any are or are to be issued, on the same terms, any Additional Notes that the Company proposes to issue. The Company shall
provide written notice by email to the email address in the Notice Provision, Section 5.04, to each Investor of the proposed issuance
of Additional Notes, which notice shall include all material terms of the proposed issuance. Each Investor shall have five (5) business
days from receipt of such notice to respond in writing to exercise its right to purchase all or a portion of such Additional Notes. Failure
of an Investor to respond within such five (5) business day period shall constitute a waiver of such Investor&rsquo;s right of first refusal
with respect to such issuance only. If the Investors, collectively, elect to purchase more than the total amount of Additional Notes
offered, then each participating Investor shall be allocated a pro rata portion of the Additional Notes based on the then outstanding
Original Principal Amount of Notes held by such Investor relative to the then outstanding Original Principal Amount of Notes held by
all participating Investors (or as otherwise mutually agreed among the participating Investors).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Equity Line of Credit</U>. In addition, the Lead Investor will have the right of first refusal on providing to the Company any equity
line of credit for the period commencing on the Closing Date and ending on the later of (i) the first anniversary of the Closing Date
(ii) the first date on which no Notes remain outstanding The Company shall provide written notice by email to the Lead Investor to the
email address in the Notice Provision, Section 5.04 of any proposed equity line of credit facility, which notice shall include all material
terms of the proposed facility. The Lead Investor shall have five (5) business days from receipt of such notice to respond in writing
to exercise its right to provide such equity line of credit. Failure of the Lead Investor to respond within such five (5) business day
period shall constitute a waiver of the Lead Investor&rsquo;s right of first refusal with respect to such equity line of credit facility only.
The Company shall not establish an equity line of credit with any third party on terms more favorable than those offered to the Lead
Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 78pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 78pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 78pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.09 <U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Underlying Shares may result in dilution of
the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges
that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the Underlying Shares pursuant
to the Securities, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless
of the effect of any such dilution or any claim the Company may have against any Investor and regardless of the dilutive effect that
such issuance may have on the ownership of the other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.10 <U>Registration Rights and Security Agreements</U>. The Company shall cause the Registration Rights Agreement and Security Agreement
to remain in full force and effect and the Company shall comply in all material respects with the terms thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.11 <U>Integration</U>. The Company shall not sell, offer for sale, or solicit offers to buy or otherwise negotiate in respect of any
security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities to the Investors
in a manner that would require the registration under the Securities Act of the sale of the Securities to the Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.12 <U>Publicity</U>. The Company and each Investor shall consult with each other in issuing any other press releases with respect to
the transactions contemplated hereby, and neither the Company nor any Investor shall issue any such press release nor otherwise make
any such public statement without the prior consent of the Company with respect to any press release of any Investor, or without the
prior consent of each Investor with respect to any press release of the Company mentioning such Investor, which consent shall not unreasonably
be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other
party with prior notice of such public statement or communication.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.13 <U>Indemnification of Investors</U>. The Company shall indemnify, reimburse and hold harmless the Investors and their respective
partners, members, stockholders, officers, directors, employees and agents (and any other persons with other titles that have similar
functions) (collectively, &ldquo;<B>Indemnitees</B>&rdquo;) from and against any and all losses, claims, liabilities, damages, penalties,
suits, costs and expenses, of any kind or nature, (including fees relating to the cost of investigating and defending any of the foregoing)
imposed on, incurred by or asserted against such Indemnitee in any way related to or arising from or alleged to arise from: (i) any breach
of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction
Documents and (ii) any action instituted against such Indemnitee in any capacity, or any of them or their respective Affiliates, by any
stockholder of the Company who is not an Affiliate of such Indemnitee, with respect to any of the transactions contemplated by the Transaction
Documents (unless such action is based upon a breach of such Indemnitee&rsquo;s representations, warranties or covenants under the Transaction
Documents or any agreements or understandings such Indemnitee may have with any such stockholder or any violations by such Indemnitee
of state or federal securities laws or any conduct by such Indemnitee which results from the gross negligence or willful misconduct of
the Indemnitee as determined by a final, non-appealable decision of a court of competent jurisdiction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.14 <U>Keystone ELOC</U>. As long as any Warrants remain outstanding, unless the holder(s) of a majority of the then outstanding Warrants
(including the Lead Investor, if it then holds any Warrants) shall have otherwise given their prior written consent, the Company shall
not, directly or indirectly, draw on or otherwise utilize its existing Equity Line of Credit with Keystone Capital Partners, LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.15. If the Company has now or in the future forms or has any Subsidiary not a party to the Security with $1.00 or more in assets, such
Subsidiary shall promptly provide notice thereof to the Lead Investor, execute and deliver to the Secured Parties the Security Agreement
and one or more UCC financing statements that shall be filed against such Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.16. <U>Participation in Subsequent Financings</U>. The Company shall permit Investors holding outstanding Notes to participate (on
a pro rata basis in proportion to the respective Original Principal Amount of Notes) in fifty percent (50%) of each Subsequent Financing
(other than a Future Transaction, as defined in Section 4.07), and the Company shall apply all or any part of the Payment Amount (or,
if an Event of Default shall have previously occurred under the Notes, the Premium Amount), as determined by each participating Investor,
that would otherwise be payable to such Investor under its Note(s) on a dollar-for-dollar basis against the purchase price of the securities
or Indebtedness to be purchased by investors in such Subsequent Placement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ARTICLE
V</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.01 <U>Termination</U>. This Agreement may be terminated by any Investor, as to such Investor&rsquo;s obligations hereunder only and
without any effect whatsoever on the obligations between the Company and the other Investors, by written notice to the other parties,
if the Closing has not been consummated for such Investor within five (5) Business Days of its execution of this Agreement; provided,
however, that such termination will not affect the right of any party to sue for any breach by the other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.02 <U>Fees and Expenses</U>. Except as provided in this Section 5.02, the Company and the Investors shall bear their own expenses incurred
in connection with its negotiation, preparation, execution, delivery and performance of the Transaction Documents, including, without
limitation, reasonable attorneys&rsquo; and consultants&rsquo; fees and expenses, transfer agent fees, fees for stock quotation services,
fees relating to any amendments or modifications of the Transaction Documents or any consents or waivers of provisions in the Transaction
Documents, fees for the preparation of opinions of counsel, escrow fees, and costs of restructuring the transactions contemplated by
the Transaction Documents. The Company shall bear (as provided in Section 2.02(a)(iv)) $50,000 for the fees and expenses of the Lead
Investor&rsquo;s counsel in connection with the negotiation, preparation, execution, delivery and performance of the Transaction Documents,
payable as a holdback of $50,000 out of the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.03 <U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with
respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.04 <U>Notices</U>. Any notice, request, instruction or other document to be given hereunder by any party to the others shall be in
writing and delivered personally or sent by registered or certified mail, postage prepaid, or by or email:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>if
to an Investor:</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the address set forth on such Investor&rsquo;s signature page hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>with
a copy (that shall not constitute notice) to:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REDACTED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>if
to the Company:</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Labs, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">626
RXR Plaza, 6th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uniondale,
New York 11556</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Ted Karkus, CEO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
karkus@prophaselabs.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>with
a copy (that shall not constitute notice) to</I>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REDACTED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
to such other persons or addresses as may be designated in writing by the party to receive such notice as provided above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.05 <U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented, or amended except in a written
instrument signed, in the case of an amendment, by the Company and the Investors holding at least a majority in Original Principal Amount
of the Notes then outstanding (including the Lead Investor, if then a holder of any Notes) or, in the case of a waiver, by the party
against whom enforcement of any such waived provision is sought. No waiver of any default with respect to any provision, condition or
requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver
of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder
in any manner impair the exercise of any such right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.06 <U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Investor (other than by merger). Any Investor may assign any or all of its rights under this Agreement to any Person to whom
such Investor assigns or transfers any Securities, provided that such transfer complies with all applicable federal and State Securities
Laws and that such transferee agrees in writing with the Company to be bound, with respect to the transferred Securities, by the provisions
of the Transaction Documents that apply to the &ldquo;Investors.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.07 <U>No Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.08 <U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the
principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense
of the transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates,
directors, officers, stockholders, employees or agents) shall be commenced exclusively by arbitration be administered by Mediation and
Civil Arbitration, Inc. d/b/a RapidRuling (www.rapidruling.com) in accordance with its Commercial Arbitration Rules effective at the
time a claim is made, and judgment on the award rendered by the arbitrator(s) may be entered in any court having jurisdiction thereof.
Arbitrators shall be appointed by RapidRuling. The place of arbitration shall be Wilmington, Delaware, and any hearing shall be held
via video or telephone conference. The parties hereto agree that no objection shall be taken to the decision, order or award of the tribunal
following any such hearing on the basis that the hearing was held by video or telephone conference. The parties hereto consent to electronic
service of process, with service to be made to the following email addresses the Company: karkus@prophaselabs.com, with a copy to REDACTED,
and Lead Investor: REDACTED. All such service of process may come from the opposing party&rsquo;s email listed here, efile@rapidruling.com.
The parties hereto shall list all said email addresses as &ldquo;safe senders&rdquo; (or other whitelist) and are responsible to check
their &ldquo;SPAM&rdquo; and &ldquo;junk&rdquo; type incoming messages on a daily basis. In any such arbitration award, the arbitrator
shall require the breaching party (if any), as finally determined by the arbitrator, to pay the non-breaching Party&rsquo;s costs and
expenses (including such nonbreaching party&rsquo;s reasonable attorneys&rsquo; fees, arbitration costs, court costs, and other expenses)
associated with enforcing the Agreement and collecting any judgment related thereto. In the event that any provision of this Agreement
is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent
that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may
prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.09 <U>No Broker-Dealer Acknowledgement</U>. Absent a final adjudication from a court of competent jurisdiction stating otherwise, so
long as any obligation of the Company under the Notes or any other Transaction Documents is outstanding, the Company shall not state,
claim, allege, or in any way assert to any person, institution or entity, that any Investor is currently, or ever has been, a broker-dealer
under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.10 <U>Opportunity to Consult with Counsel</U>. The Company and the Investors each represents and acknowledges that it has been provided
with the opportunity to discuss and review the terms of the Notes and the other Transaction Documents with its counsel before signing
it and that it is freely and voluntarily signing the Transaction Documents in exchange for the benefits provided herein. In light of
this, each of the Company and the Investors will not contest the validity of Transaction Documents and the transactions contemplated
therein. Each of the Company and the Investors further represents and acknowledges that it has been provided a reasonable period of time
within which to review the terms of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.11 <U>Non-Circumvention</U>. The Company covenants and agrees that it will not, by amendment of its certificate of formation, certificate
of incorporation, operating agreement, or bylaws (collectively the &ldquo;Corporate Governance Documents&rdquo;), or through any reorganization,
transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of the Notes or any other Transaction Document, and will at
all times in good faith carry out all the provisions thereof take all action as may be required to protect the rights of the Investors.
Without limiting the generality of the foregoing, the Company: (i) shall not increase the par value of the Underlying Shares above the
Conversion Price then in effect, (ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and non-assessable Common Stock upon the conversion of the Notes and exercise of the Warrants and (iii)
shall be prohibited from amending its Corporate Governance Documents in any way to reduce authorized shares or from reducing the share
reserve amount at the transfer agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.12 <U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.13 <U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by email delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature
page was an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.14 <U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.15 <U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) any of the other Transaction Documents, whenever any Investor exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Investor may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; provided, however, that in the case of a rescission of a conversion
of a Note, the Investor shall be required to return any shares of Common Stock subject to any such rescinded conversion or exercise notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.16 <U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.17 <U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Investors and the Company will be entitled to seek specific performance under the Transaction Documents. The parties agree
that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the
Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense
that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.18 <U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Investor pursuant to any Transaction
Document or an Investor enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person under any law
(including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent
of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force
and effect as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.19 <U>Independent Nature of Investors&rsquo; Obligations and Rights</U>. The obligations of each Investor under any Transaction Document
are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance
or non-performance of the obligations of any other Investor under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Investor pursuant thereto, shall be deemed to constitute the Investors as a partnership,
an association, a joint venture, or any other kind of entity, or create a presumption that the Investors are in any way acting in concert
or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Investor shall be
entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or
out of the other Transaction Documents, and it shall not be necessary for any other Investor to be joined as an additional party in any
proceeding for such purpose. Each Investor has been represented by its own separate legal counsel in their review and negotiation of
the Transaction Documents. The Company has elected to provide all Investors with the same terms and Transaction Documents for the convenience
of the Company and not because it was required or requested to do so by the Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.20 <U>Construction</U>. The parties agree that each of them and/or their respective counsel has reviewed and had an opportunity to
revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved
against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments hereto. In addition,
each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.21 <U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed
to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5.22 WAIVER OF JURY TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE
PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<B>SIGNATURE
PAGES FOLLOW</B>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPHASE
    LABS, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTORS:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Investors executing the Signature Page in the form attached hereto as <B><U>Annex A-1</U></B>
                                            or <B><U>Annex A-2</U></B> and delivering the same to the Company or its agents shall be
                                            deemed to have executed this Agreement and agreed to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex
A-1</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities
Purchase Agreement Investor Counterpart Signature Page</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.95pt; text-align: justify; text-indent: 39pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, desiring to: (i) enter into this Securities Purchase Agreement dated as of July 22, 2025 (the &ldquo;<B>Agreement</B>&rdquo;),
with the undersigned, ProPhase Labs, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), in or substantially in the form
furnished to the undersigned and (ii) purchase the Securities as set forth below, hereby agrees to purchase such Securities from the
Company as of the Closing and further agrees to join the Agreement as a party thereto, with all the rights and privileges appertaining
thereto, and to be bound in all respects by the terms and conditions thereof. The undersigned specifically acknowledges having read the
representations in this Agreement&rsquo;s section entitled &ldquo;Representations Warranties of the Investors&rdquo;, and hereby represents
that the statements contained therein are complete and accurate with respect to the undersigned as an Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTOR
    </B>(<I>if an individual</I>):</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTOR
    </B>(<I>if an entity</I>):</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REDACTED</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTOR
    </B>(<I>if investing jointly</I>)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
    Amount:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<B>2,500,000</B></FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SSN/EIN/ITIN:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex
A-2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities
Purchase Agreement Investor Counterpart Signature Page</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.95pt; text-align: justify; text-indent: 39pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, desiring to: (i) enter into this Securities Purchase Agreement dated as of July 22, 2025 (the &ldquo;<B>Agreement</B>&rdquo;),
with the undersigned, ProPhase Labs, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), in or substantially in the form
furnished to the undersigned and (ii) purchase the Securities as set forth below, hereby agrees to purchase such Securities from the
Company as of the Closing and further agrees to join the Agreement as a party thereto, with all the rights and privileges appertaining
thereto, and to be bound in all respects by the terms and conditions thereof. The undersigned specifically acknowledges having read the
representations in this Agreement&rsquo;s section entitled &ldquo;Representations Warranties of the Investors&rdquo;, and hereby represents
that the statements contained therein are complete and accurate with respect to the undersigned as an Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTOR
    </B>(<I>if an individual</I>):</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTOR
    </B>(<I>if an entity</I>):</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REDACTED</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTOR
    </B>(<I>if investing jointly</I>)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
    Amount:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<B>500,000</B></FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SSN/EIN/ITIN:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>APPENDIX
A</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Notes</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>APPENDIX
B</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Warrants</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>APPENDIX
C</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Registration Rights Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>APPENDIX
D</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Security Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>APPENDIX
E</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of TA Reservation Letter</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosure
Schedule 3.01(o)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(UCC
Liens)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York State</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">202407025945792
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 78%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/02/2024
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">202502115167553
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/11/2025
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">202409176295890
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/17/2024
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">202304285595783
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/28/2023
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">202305265748419</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/26/2023</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 50%">Original Issue Date: July 22, 2025</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 28%; text-align: left">Subscription Amount:</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">2,500,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Scheduled Maturity Date: July 22, 2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Original Issue Discount:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">625,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Original Interest Discount: 20%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Original Principal Amount:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,125,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPHASE
LABS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20%
OID SENIOR SECURED CONVERTIBLE NOTE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
20% OID SENIOR SECURED CONVERTIBLE NOTE is one of a series of duly authorized and validly issued senior secured promissory notes of ProPhase
Labs, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), designated as its 20% OID Senior Secured Convertible Notes (this
note, the &ldquo;<B>Note</B>&rdquo; and, collectively with the other notes of such series, the &ldquo;<B>Notes</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the Company promises to pay to <B>REDACTED,</B> or its registered assigns (the &ldquo;<B>Holder</B>&rdquo;), the principal
sum of $3,125,000 (the &ldquo;<B>Original Principal Amount</B>&rdquo;) on the earlier to occur the Scheduled Maturity Date set forth
hereinabove, or such earlier date as this Note is required or permitted to be repaid as provided hereunder or under the Purchase Agreement
(as defined below) (as the case may be, the &ldquo;<B>Maturity Date</B>&rdquo;). This Note is subject to the following additional provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1.</B> <U>Definitions</U>. For the purposes hereof, in addition to the terms defined elsewhere in this Note: (a) capitalized terms not
otherwise defined herein shall have the meanings set forth in the Purchase Agreement, and (b) the following terms shall have the following
meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Applicable
Rate</U>&rdquo; means ten percent (10%) prior to the occurrence of an Event of Default and twenty-four percent (24%) from and after the
occurrence of any Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion</U>&rdquo;
means a conversion of this Note pursuant to Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Amount</U>&rdquo; shall have the meaning set forth in Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Date</U>&rdquo; means the date on or after the Convertibility Date of any Conversion in accordance with the terms of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; means, as of any Conversion Date, the lower of: (A) the greater of (1) eighty percent (80%) of the VWAP of the Common
Stock for such Conversion Date and (2) the Floor Price, and (B) the Maximum Conversion Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; with respect to any Conversion, a number of shares of Common Stock equal to the number obtained (rounded up to the
nearest whole share) by <I>dividing</I> the Conversion Amount thereof <I>by</I> the Conversion Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Convertibility
Date</U>&rdquo; means the earlier to occur of: (i) the date that is four (4) months after the Original Issue Date, and (ii) the Maturity
Date; and (ii) such earlier date as may be approved in advance by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Default
Amount</U>&rdquo; means the product of: (A) the sum of (1) the outstanding Original Principal Amount of this Note, <I>plus</I> (2) all
accrued and unpaid interest (including compounded interest) thereon, if any, <I>plus</I> (3) all liquidated damages due under this Note,
the Purchase Agreement or any other Transaction Document, <I>plus</I> (4) all other costs and expenses due under or in respect of this
Note, if any, and (B)(1) 112% until the one-month anniversary of the relevant Event(s) of Default, (2) 124% from and after the two month
anniversary of the relevant Event(s) of Default, and (3) 136% from and after three- month anniversary of the relevant Event(s) of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event
of Default</U>&rdquo; shall have the meaning set forth in Section 7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Floor
Price</U>&rdquo; means the product of: (A)(i) prior to the Stockholder Approval Date, 50%, and (ii) on and after the Stockholder Approval
Date, 20%; and (B) the lesser of: (i) the last closing price of the Common Stock immediately preceding the date of this Agreement, and
(ii) the average closing price of the Common Stock on for the five Trading Days immediately preceding the date of this Agreement; <I>provided</I>
that from and after the occurrence of any Event of Default under Section 7(h) hereof the Floor Price shall be zero ($0).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Interest
Payment Date</U>&rdquo; means the 28<SUP>th</SUP> day of each calendar month from and after the Original Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Maximum
Conversion Price</U>&rdquo; means $1.25.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Note
Register</U>&rdquo; shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Issue Date</U>&rdquo; means the date of the first issuance of the Notes, regardless of any transfers of any Note and regardless of the
number of instruments which may be issued to evidence such Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Payment
Amount</U>&rdquo; means 100% of the sum of: (1) the outstanding Original Principal Amount of this Note, <I>plus</I> (2) all accrued and
unpaid simple interest thereon, if any, <I>plus</I> (3) all liquidated damages due under this Note, the Purchase Agreement or any other
Transaction Document, <I>plus</I> (4) all other costs and expenses due under or in respect of this Note, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Premium
Amount</U>&rdquo; means 110% of the sum of: (1) the outstanding Original Principal Amount of this Note, <I>plus</I> (2) all accrued and
unpaid interest(including compounded interest) thereon, if any, <I>plus</I> (3) all liquidated damages due under this Note, the Purchase
Agreement or any other Transaction Document, <I>plus</I> (4) all other costs and expenses due under or in respect of this Note, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchase
Agreement</U>&rdquo; means the Securities Purchase Agreement, dated as of July 16, 2025, by and among the Company and the original Holders,
as amended, modified, or supplemented from time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Share
Delivery Date</U>&rdquo; shall have the meaning set forth in Section 4(b)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means any day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed for trading or quoted on the date
in question: the NYSE, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, or the Nasdaq Global Select Market (or
any successors of any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any Conversion Date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
listed or quoted on a Trading Market, the lowest daily volume weighted average price of the Common Stock within the ten (10) Trading
Days immediately prior to such Conversion Date (or the nearest preceding date) on the Trading Market on which the Common Stock is then
listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City
time)) (or a similar organization or agency succeeding to its functions of reporting prices), (b) if the Common Stock is not then listed
or quoted for trading on a Trading Market, the lowest volume weighted average price of the Common Stock within the ten (10) Trading Days
immediately prior to such Conversion Date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is
not then listed or quoted for trading on a Trading Market, OTCQB or OTCQX and if prices for the Common Stock are then reported in the
&ldquo;Pink Sheets&rdquo; published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting
prices), the lowest bid price per share of the Common Stock so reported within the ten (10) Trading Days immediately prior to such Conversion
Date (or the nearest preceding date), or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall
be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.</B> <U>Payments; Interest, Etc.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Payment</U>.
The entire unpaid Payment Amount shall be due and payable on the Maturity Date; <I>provided</I> that if an Event of Default shall have
previously occurred (whether before or after the Maturity Date) then the Default Amount shall become immediately due and payable. The
Company hereby waives, any presentment, demand, protest or other notice of any kind, and the Holder may immediately and without expiration
of any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Interest</U>.
Interest shall accrue on the outstanding Payment Amount (or, if an Event of Default shall have previously occurred, the Default Amount)
at an annual rate equal to the Applicable Rate. Such interest shall be calculated on the basis of a 360-day year, consisting of twelve
30 calendar day periods, and shall accrue daily commencing on the issue of this Note until payment (or conversion) in full of the Payment
Amount (or, if an Event of Default shall have previously occurred, the Default Amount). Interest shall cease to accrue with respect to
any Notes converted hereunder, <I>provided </I>that the Company actually delivers the Conversion Shares within the time period required
hereunder. Payments of interest hereunder will be paid to the Person in whose name this Note is registered on the Note Register.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Voluntary
Prepayment</U>. <FONT STYLE="background-color: white">The Company may prepay this Note in full at any time after the Original Issue Date
in an amount equal to the Payment Amount (or, if an Event of Default shall have previously occurred, the Default Amount). Voluntary prepayment
shall not be offered to any holder of Notes unless voluntary prepayment is offered on a <I>pro rata</I> basis to all holders of Notes
on identical terms. The Company shall give at least five (5) days&rsquo; prior written notice to Holder of such proposed prepayment by
email to the Holder and Lead Investor (the latter at </FONT>REDACTED <FONT STYLE="background-color: white">and </FONT>REDACTED<FONT STYLE="background-color: white">),
and Holder may, by written Notice of Conversion to the Company delivered on or before 4:00 p.m. (New York City time) on the fifth day
(5th) after such notice of proposed prepayment by email to REDACTED, elect to convert up to $500,000 of the outstanding principal balance
of this Note into Conversion Shares hereunder.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Note
Register</U>. All payments and prepayments hereunder will be paid to the Person in whose name this Note is registered on the records
of the Company regarding registration and transfers of this Note (the &ldquo;<B>Note Register</B>&rdquo;). Upon the payment in full of
the Payment Amount (or, if an Event of Default shall have previously occurred, the Default Amount) in accordance with the terms of this
Note, or full Conversion of this Note, the Holder shall promptly surrender this Note to or as directed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.</B> <U>Registration of Transfers and Exchanges</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Different
Denominations</U>. This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations,
as requested by the Holder surrendering the same. No service charge will be payable for such registration of transfer or exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Investment
Representations</U>. This Note has been issued subject to certain investment representations of the original Holder set forth in the
Purchase Agreement and may be transferred or exchanged only in compliance with the Purchase Agreement and applicable federal and state
securities laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Reliance
on Note Register</U>. Prior to due presentment for transfer to the Company of this Note, the Company and any agent of the Company may
treat the Person in whose name this Note is duly registered on the Note Register as the owner hereof for the purpose of receiving payment
as herein provided and for all other purposes, whether or not this Note is overdue, and neither the Company nor any such agent shall
be affected by notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.</B> <U>Negative Covenants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
long as any portion of this Note remains outstanding, unless the holder(s) of a majority in Original Principal Amount of the then outstanding
Notes (including the Lead Investor, if it then holds any Notes) shall have otherwise given their prior written consent, the Company shall
not, directly or indirectly:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) change
the nature of its business without approval of majority in Original Principal Amount of the then outstanding Notes (including the Lead
Investor, if it then holds any Notes) unless the Notes shall be repaid or converted in full;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) effect
any Asset Sale with respect to twenty percent (20%) or more of the total assets of the Company and its Subsidiaries <I>unless </I>the
net cash proceeds thereof are in excess of the aggregate outstanding Original Principal Amount of all Notes and Permitted Additional
Debt then outstanding and all applied and utilized in accordance with Section 4.05(c) of the Purchase Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) enter
into any VRT Transactions (other than a Permitted ATM);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) enter
into or accept any new &ldquo;merchant-cash-advances (MCA) or similar financing instruments having an Annual Percentage Rate (APR) in
excess of thirty percent (30%);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) enter
into, create, incur, assume, guarantee or suffer to exist any Indebtedness that is senior to or (other than Permitted Additional Debt)
<I>pari passu</I> with the Notes on a contractual basis and/or the Lien on the Collateral (as defined in the Security Agreement);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) amend
its certificate of incorporation and bylaws, in any manner that materially and adversely affects any rights of the Holder unless consented
to by the Holder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) repay,
repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its Common Stock or Common Stock
Equivalents other than as to (i) repurchases of Common Stock or Common Stock Equivalents of departing officers and directors of the Company,
provided that such repurchases shall not exceed an aggregate of $25,000 for all officers and directors during the term of this Note,
or (ii) shares of Common Stock and Common Stock Equivalents which do not vest or are otherwise forfeited, provided (in case of forfeiture)
that such Common Stock and Common Stock Equivalents are not acquired for cash;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) repay,
repurchase or offer to repay, repurchase or otherwise acquire any secured Indebtedness other than the Notes and Prior $1,000,000 Debt
(on a pro rata basis as permitted under the Purchase Agreement) and other than regularly scheduled interest payments with respect to
Permitted Additional Debt (for the sake of clarity, any existing unsecured debt, trade payables and working capital expenses can be paid
back in the ordinary course of business);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) pay
cash dividends or distributions on any of its Common Stock equity securities of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) create,
permit or suffer to exist any Lien on any of its or any Subsidiaries properties and assets other than (x) Permitted Liens and (y) Liens
that are fully subordinated to the Liens granted under the Security Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) enter
into any material transaction with any Affiliate of the Company, unless such transaction is made on an arm&rsquo;s-length basis and expressly
approved by a majority of the disinterested directors of the Company (even if less than a quorum otherwise required for board approval);
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) enter
into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.</B> <U>Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Optional
Conversion</U>. From and after the Convertibility Date, the Holder shall have the right, at the Holder&rsquo;s option, to convert the
entire Payment Amount (or, if an Event of Default shall have previously occurred, the Default Amount) of this Note (as the case may be,
the &ldquo;<B>Conversion Amount</B>&rdquo;) into Conversion Shares by following the mechanics of conversion set forth in Section 5(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Mechanics
of Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Conversion
Notice</U>. Holder may, at any time and from time to time from and after the Convertibility Date, convert all or any portion of the Conversion
Amount of this Note into Conversion Shares at the Conversion Price, by delivering to the Company: (A) written notice of its election
to convert this Note pursuant to this Section 5, including the Conversion Amount, and (B) in the case of a Conversion of the entire Conversion
Amount of this Note, the original Note instrument (or a notice to the effect that such original Note has been lost, stolen or destroyed).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Delivery
of Conversion Shares upon Conversion</U>. With respect to each Conversion of this Note, the Company shall deliver, or cause to be delivered,
to the Holder the Conversion Shares no later than the date that is the earlier of: (i) two (2) Business Days after the delivery to the
Company of the notice of such Conversion; and (ii) the number of Trading days comprising the Standard Settlement Period after the delivery
to the Company of such (such date, the &ldquo;<B>Share Delivery Date</B>&rdquo;). As used herein, &ldquo;<B>Standard Settlement Period</B>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <U>Failure
to Deliver Conversion Shares</U>. If the Conversion Shares are not delivered to or as directed by the applicable Holder by the Share
Delivery Date, the Holder shall be entitled to elect by written notice to the Company at any time on or before its receipt of such Conversion
Shares to rescind the Conversion, in which event the Company shall promptly return to the Holder any original Note delivered to the Company
and the Holder shall promptly return to the Company the Conversion Shares (if any) issued to such Holder pursuant to the rescinded Conversion
Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) <U>Obligation
Absolute; Partial Liquidated Damages</U>. The Company&rsquo;s obligations to issue and deliver the Conversion Shares upon Conversion
of this Note on the relevant Share Delivery Date in accordance with the terms hereof are absolute and unconditional, irrespective of
any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of
any judgment against any Person or any action to enforce the same, or any set off, counter claim, recoupment, limitation or termination,
or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation
of law by the Holder or any other Person (unless the Conversion would violate any law applicable to the Company), and irrespective of
any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection with the issuance of such
Conversion Shares; <I>provided, however, </I>that such delivery shall not operate as a waiver by the Company of any such action the Company
may have against the Holder. In the event the Holder of this Note shall elect to convert any or all of the Conversion Amount hereof,
the Company may not refuse conversion based on any claim that the Holder or anyone associated or affiliated with the Holder has been
engaged in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice to Holder, restraining
and or enjoining conversion of all or part of this Note shall have been sought and obtained, and the Company posts a surety bond for
the benefit of the Holder in the amount of 150% of the greater of (i) the Default Amount of this Note and (ii) the converted value of
this Note, which is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of the
underlying dispute and the proceeds of which shall be payable to the Holder to the extent it obtains judgment. In the absence of such
injunction, the Company shall issue Conversion Shares or, if applicable, cash, upon a properly noticed Conversion. If the Company fails
for any reason to deliver to the Holder such Conversion Shares pursuant to Section 5(b)(ii) by the Share Delivery Date, the Company shall
pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Conversion Amount being converted, the sum
of (1) $20 per Trading Day (increasing to $35 per Trading Day on the fifth (5th) Trading Day after such liquidated damages begin to accrue)
for each Trading Day after such Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such conversion, and
(2) the product of (i) the number of Conversion Shares issuable upon such conversion and (ii) the difference between the highest trade
price and the lowest trade price during the period beginning on the Conversion Date of such Conversion and the date on which the Conversion
Shares are delivered to Holder&rsquo;s prime broker and are available to be sold. The Company agrees to maintain a transfer agent that
is a participant in the FAST program so long as this Note remains outstanding. Nothing herein shall prohibit the Holder from seeking
to enforce damages pursuant to any other section hereof or under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) <U>Fractional
Shares</U>: No fractional shares or scrip representing fractional shares shall be issued upon any Conversion. As to any fraction of a
share which the Holder would otherwise be entitled to purchase upon any Conversion, the Company shall at its election, either pay a cash
adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion Price or round up to the
next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) <U>Transfer
Taxes and Expenses</U>. The issuance of Conversion Shares on conversion of this Note shall be made without charge to the Holder hereof
for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares, <I>provided</I>
that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery
of any such Conversion Shares upon conversion in a name other than that of the Holder of this Note so converted. The Company shall pay
all transfer agent fees required for same-day processing of any conversion and all fees to the Depository Trust Company (or another established
clearing corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares. The Company shall
pay all attorney fees required for the issuance of attorney legal opinions for removal of restrictive legends on Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Holder&rsquo;s
Conversion Limitations</U>. The Company shall not affect any Conversion of this Note, and a Holder shall not have the right to convert
any portion of this Note, to the extent that after giving effect to such Conversion, the Holder (together with the Holder&rsquo;s Affiliates,
and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B>Attribution
Parties</B>&rdquo;)) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the
foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon Conversion of this Note, but shall exclude the number of shares which
are issuable upon conversion of the unconverted or unexercised portion of any other securities of the Company subject to a limitation
on conversion or exercise analogous to the limitation contained herein (including, without limitation, any Warrants) beneficially owned
by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section
5(c), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. To the extent that the limitation contained in this Section 5(c) applies, the determination of whether this Note is convertible
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which Conversion Amount
of this Note is convertible shall be in the sole discretion of the Holder. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 5(c), in determining the number of outstanding Common Stock, the Holder may rely on the number of outstanding
Common Stock as stated in the most recent of the following: (A) the Company&rsquo;s most recent periodic or annual report filed with
the Commission, as the case may be, (B) a more recent public announcement by the Company, or (C) a more recent written notice by the
Company or the Company&rsquo;s transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral
request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding. In any case, the number of outstanding Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Note and any Warrants, by the Holder or its Affiliates since the date as of
which such number of outstanding Common Stock was reported. The &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo; shall be 4.99% of
the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of Common Stock issuable upon Conversion
of this Note. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this
Section 5(c), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of Common Stock upon Conversion of this Note held by the Holder and the Beneficial
Ownership Limitation provisions of this Section 5(c) shall continue to apply. Any increase in the Beneficial Ownership Limitation will
not be effective until the 61st day after such notice is delivered to the Company. Notwithstanding the foregoing, in the event the Holder
elects to increase the Beneficial Ownership Limitation above 4.99%, the Holder covenants and agrees that, without the prior written consent
of the Company, it shall not, directly or indirectly, act in concert with, form a &ldquo;group&rdquo; (as defined in Section 13(d)(3)
of the Exchange Act), or otherwise coordinate or collaborate with any other person or entity that is a filer or required to be a filer
under Schedule 13D with respect to the Common Stock of the Company, in any manner that is intended to or would reasonably be expected
to oppose, challenge, or act in a manner adverse to the Company&rsquo;s management or Board. The Beneficial Ownership Limitation provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 5(c)
to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation
contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6.</B> <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Stock
Dividends and Stock Splits</U>. If the Company, at any time while this Note is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions payable in Common Stock on Common Stock or any Common Stock Equivalents (which, for avoidance of doubt,
shall not include any Common Stock issued by the Company upon conversion of, or payment of interest on, the Notes), (ii) subdivides outstanding
Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding Common Stock into
a smaller number of shares or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock
of the Company, then the Maximum Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock (excluding any treasury shares of the Company) outstanding immediately before such event, and of which the denominator
shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section
5 shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or
distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Fundamental
Transactions</U>. If, at any time while this Note is outstanding: (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any
sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series
of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another
Person) is completed pursuant to which, at any time while this Note is outstanding on or after the date of the occurrence (if any) of
an Event of Default, holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property
and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one
or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock are effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person whereby such other Person acquires more than 50% of the outstanding Common Stock (not including any Common Stock held by the other
Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share
purchase agreement or other business combination) (each a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then, upon any subsequent conversion
of this Note, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion
immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in Section 5(c) on the Conversion
of this Note), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving
corporation, and any additional consideration (the &ldquo;<B>Alternate Consideration</B>&rdquo;) receivable as a result of such Fundamental
Transaction by a holder of the number of shares of Common Stock issuable upon Conversion of this Note is convertible immediately prior
to such Fundamental Transaction (without regard to any limitations on conversion hereof, including without limitation, the Beneficial
Ownership Limitation). For purposes of any such conversion, the determination of the Maximum Conversion Price and/or Conversion Price
shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one (1) share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Conversion Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders
of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder
shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Note following such Fundamental
Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the
&ldquo;<B>Successor Entity</B>&rdquo;) to assume in writing all of the obligations of the Company under this Note and the other Transaction
Documents (as defined in the Purchase Agreement) in accordance with the provisions of this Section 6(b) pursuant to written agreements
in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the holder of this Note, deliver to the Holder in exchange for this Note a security of the Successor
Entity evidenced by a written instrument substantially similar in form and substance to this Note which is convertible for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Common Stock acquirable and receivable
upon Conversion of this Note (without regard to any limitations in Section 5(c) on the Conversion of this Note) prior to such Fundamental
Transaction, and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into
account the relative value of the Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Note
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Note and the other Transaction Documents referring
to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and
shall assume all of the obligations of the Company under this Note and the other Transaction Documents with the same effect as if such
Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Calculations</U>.
All calculations under this Section 5 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 6, the number of shares of Common Stock <U>deemed</U> to be issued and outstanding as of a given date shall be the sum
of the number of shares of Common Stock (excluding any treasury shares of the Company) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Adjustment
to Conversion Price</U>. Whenever the Conversion Price or Maximum Conversion Price is adjusted pursuant to any provision of this Section
6, the Company shall promptly deliver to each Holder a notice setting forth the Conversion Price and/or Maximum Conversion Price (as
applicable) after such adjustment and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.</B> <U>Events of Default</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
shall be considered an event of default if any of the following events listed in this Section 4 (each, an &ldquo;<U>Event of Default</U>&rdquo;)
shall occur:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Failure
to Pay Principal or Interest</U><B>.</B> The Company fails to pay the principal hereof or interest thereon when due on this Note, whether
at maturity, upon acceleration or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Failure
to Reserve or Deliver Shares</U>. (1) The Company fails to reserve the Required Reserve Amount of shares of Common Stocks Stock required
under the terms of the Purchase Agreement, fails to issue Common Stock to the Holder (or announces or threatens in writing that it will
not honor its obligation to do so) upon exercise by the Holder of the conversion rights of the Holder in accordance with the terms of
this Note, fails to transfer or cause its transfer agent to transfer (issue) (electronically or in certificated form) Common Stock issued
to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note, the Company directs its transfer
agent not to transfer or delays, impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated
form) Common Stock to be issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note,
or fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing)
any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any Common Stock issued to the Holder upon
conversion of or otherwise pursuant to this Note as and when required by this Note subject to regulations (or makes any written announcement,
statement or threat that it does not intend to honor the obligations described in this paragraph), or fails to supply an opinion letter
specific to the fact that Common Stock issued pursuant to conversion of the Note, as well as the shares issued pursuant to the Warrant
are exempt from Registration Requirements pursuant to Rule 144, and any such failure shall continue uncured (or any written announcement,
statement or threat not to honor its obligations shall not be rescinded in writing) for three (3) business days after the Holder shall
have delivered a Notice of Conversion. It is an obligation of the Company to remain current in its obligations to its transfer agent.
It shall be an event of default of this Note, if a conversion of this Note is delayed, hindered or frustrated due to a balance owed by
the Company to its transfer agent. If at the option of the Holder, the Holder advances any funds to the Company&rsquo;s transfer agent
in order to process a conversion, such advanced funds shall be paid by The Company to the Holder within five (5) business days of a demand
from the Holder, either in cash or as an addition to the outstanding Principal Amount of the Note, and such choice of payment method
is at the discretion of The Company. (2) The Company establishes a reserve of its Common Stock for the benefit of a party other than
the Holder, without obtaining prior approval in writing by the Lead Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Breach
of Covenants</U>. The Company, or the relevant related party, as the case may be, breaches any covenant, post-closing obligation or other
term or condition contained in any Transaction Document that has a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Breach
of Representations and Warranties</U>. Any representation or warranty of the Company made herein or in any agreement, statement or certificate
given pursuant hereto or in connection herewith, shall be false or misleading in any respect when made and the breach of which has (or
with the passage of time will have) a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Receiver
or Trustee</U>. The Company or any Subsidiary of the Company shall make an assignment for the benefit of creditors, or apply for or consent
to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or such a receiver or trustee
shall otherwise be appointed, except as part of the Crown Medical Collection initiative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Judgments or Settlements</U>. (1) Any money judgment, writ or similar process shall be entered or filed against the Company or any
Subsidiary of the Company or any of its property or other assets for more than $500,000, and shall remain unvacated, unbonded or unstayed
for a period of thirty (30) days unless otherwise consented to by the Holder; or (2) the settlement of any claim or litigation, creating
an obligation on the Company in amount over $2,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Bankruptcy</U>.
The bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings, voluntary or involuntary, for relief under
any bankruptcy law or any law for the relief shall be instituted by or against the Company or any Subsidiary of the Company, except any
filing related to the Company&rsquo;s Crown Medical Collections initiative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>Delisting
of Common Stocks</U>. If at any time on or after the date hereof, (i) the Company shall fail to maintain the listing or quotation of
the Common Stock on a national securities exchange or any tier of the over-the-counter market maintained by OTC Markets Group, Inc. (&ldquo;OTC&rdquo;)
other than the OTC&rsquo;s Expert Market, or (ii) subsequent to an uplisting of the Company&rsquo;s Common Stock to a National Exchange
(as defined in the Exchange Act), the Company shall fail to maintain such listing or quotation on a National Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Failure
to Comply with Regulatory Reporting Requirements</U>. The Company fails to be in material compliance with, or ceases to be subject to,
the reporting requirements of the Exchange Act (including but not limited to becoming delinquent in its filings).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <U>Change
of Control or Liquidation</U>. Any Change of Control of the Company, or the dissolution, liquidation, or winding up of The Company or
any substantial portion of its business. As used herein, a &ldquo;<B>Change of Control</B>&rdquo; shall be deemed to occur upon the consummation
of any of the following events: (a) any person or persons acting together which would constitute a &ldquo;group&rdquo; for purposes of
Section 13(d) of the Exchange Act (other than the Company or any Subsidiary of the Company) shall beneficially own (as defined in Rule
13d-3 of the Exchange Act), directly or indirectly, at least 50% of the total voting power of all classes of capital stock of the Company
entitled to vote generally in the election of the Board; (b) Current Directors (as herein defined) shall cease for any reason to constitute
at least a majority of the members of the Board (for this purpose, a &ldquo;<B>Current Director</B>&rdquo; shall mean any member of the
Board as of the date hereof and any successor of a Current Director whose election, or nomination for election by the Company&rsquo;s
shareholders, was approved by at least a majority of the Current Directors then on the Board); (c) (i) the complete liquidation of the
Company or (ii) the merger or consolidation of the Company, other than a merger or consolidation in which (x) the holders of the Common
Stock of the Company immediately prior to the consolidation or merger have, directly or indirectly, at least a majority of the Common
Stocks of the continuing or surviving corporation immediately after such consolidation or merger or (y) the Board immediately prior to
the merger or consolidation would, immediately after the merger or consolidation, constitute a majority of the board of directors of
the continuing or surviving corporation, which liquidation, merger or consolidation has been approved by the shareholders of the Company;
(d) the sale or other disposition (in one transaction or a series of transactions) of all or substantially all of the assets of the Company
pursuant to an agreement (or agreements) which has (have) been approved by the shareholders of the Company; or (e) the termination of
the current Chief Executive Officer of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <U>Cessation
of Operations</U>. Any cessation of operations by the Company or the Company admits it is otherwise generally unable to pay its debts
as such debts become due, provided, however, that any disclosure of the Company&rsquo;s ability to continue as a &ldquo;going concern&rdquo;
shall not be an admission that the Company cannot pay its debts as they become due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <U>Maintenance
of Assets</U>. The failure by the Company to maintain any intellectual property rights, personal, real property or other assets which
are necessary to conduct its business (whether now or in the future), to the extent that such failure would result in a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <U>Financial
Statement Restatement</U>. The Company restates any financial statements for any date or period from two years prior to the Original
Issue Date and until this Note is no longer outstanding, if the result of such restatement would, by comparison to the un-restated financial
statement, have constituted a material adverse effect on the rights of the Holder with respect to this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) <U>Challenge
to Validity or Enforceability</U>. The Company, the undersigned, or any party acting on their behalf contests, disputes, or otherwise
challenges the validity, enforceability, or authorization of this Note or any of the other Transaction Documents, or any obligations
arising hereunder or thereunder, or (ii) the Company, the undersigned, or any party acting on their behalf, asserts, directly or indirectly,
that the execution, delivery, or performance of this Note, or any of the other Transaction Documents, was not duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) <U>Illegality</U>.
Any court of competent jurisdiction issues an order declaring this Note, any of the other Transaction Documents or any provision hereunder
or thereunder to be illegal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
 <U>Cross-Default</U>. Notwithstanding anything to the contrary contained in this Note or any
of the other Transaction Documents, a breach or default by the Company of any covenant or other term or condition contained in any of
the other financial instrument, including but not limited to all promissory notes, currently issued, or hereafter issued, by the Company,
to the Holder or any other third party (the &ldquo;Other Agreements&rdquo;), after the passage of all applicable notice and cure or grace
periods, that results in a Material Adverse Effect shall, at the option of the Holder, be considered a default under this Note, in which
event the Holder shall be entitled to apply all rights and remedies of the Holder under the terms of this Note by reason of a default
under said Other Agreement or hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) <U>Reverse
Splits</U>. The Company effectuates a reverse split of its Common Shares without ten (10) days prior written notice to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) <U>Replacement
of Transfer Agent</U>. In the event that the Company proposes to replace its transfer agent, the Company fails to provide, prior to the
effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered pursuant
to the Purchase Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved Amount)
signed by the successor transfer agent to Company and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) <U>DWAC
Eligibility</U>. In addition to the Event of Default in Section 4.1.21, the Common Stock is otherwise not eligible for trading through
the DTC&rsquo;s Fast Automated Securities Transfer or Deposit/Withdrawal at Custodian programs, or if the Company is not registered with
DTC on the Issue Date, Company fails to become DTC registered within 30 days of the Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) <U>Inside
Information</U>. Unless such information is requested by the Holder, any attempt by the Company or its officers, directors, and/or affiliates
to transmit, convey, disclose, or any actual transmittal, conveyance, or disclosure by the Company or its officers, directors, and/or
affiliates of, material non-public information concerning the Company, to the Holder or its successors and assigns, which is not immediately
cured by Company&rsquo;s filing of a Form 8-K pursuant to Regulation FD on that same date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) <U>Failure
of Security Interest</U>. (a) Any material provision of the Security Agreement shall at any time for any reason (other than pursuant
to the express terms thereof) cease to be valid and binding on or enforceable against the Company or any Subsidiary intended to be a
party thereto, or the validity or enforceability thereof shall be contested by any party thereto, or a proceeding shall be commenced
by the Company or any Subsidiary or any governmental authority having jurisdiction over any of them, seeking to establish the invalidity
or unenforceability thereof, or the Company or any Subsidiary shall deny in writing that it has any liability or obligation purported
to be created under the Security and Pledge Agreement; (b) the Security Agreement, after delivery thereof pursuant hereto, shall for
any reason fail or cease to create a valid and perfected and, except to the extent permitted by the terms hereof or thereof, first priority
Lien in favor of the Holder on any Collateral (as defined in the Security Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) <U>Failure
to Register Shares</U>. The Company shall fail to cause the Underlying Shares (as defined in the Purchase Agreement) to be registered
pursuant to the terms of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) <FONT STYLE="background-color: white"><U>Chief
Executive Officer Conduct</U>. The Chief Executive Officer is indicted or arrested for violating any law, rule, regulation, or cease-and-desist
order, or is convicted of a criminal offense in a state of federal court (but not including traffic violations or similar offenses) and
the arrest or indictment has a Material Adverse Effect</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) <U>Section
3(a)(10) Transactions</U>. The Company shall enter into a transaction structured in accordance with, based upon, or related or pursuant
to, in whole or in part, Section 3(a)(10) of the Securities Act (&ldquo;3(a)(10) Transaction&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Failure to Obtain Stockholder Approval</U>. The Company shall fail to obtain the Stockholder Approval by November 22, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties agree that it shall not be an &ldquo;Event of Default&rdquo; if a UCC that was unknown is subsequently discovered, on the condition
that RDM files UCC-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any Event of Default occurs the Default Amount shall become immediately due and payable in cash, and the Company shall pay to the holders
of Notes (pro rata, in accordance with their respective Original Principal Amounts) an aggregate monthly monitoring fee of $10,000 per
month, payable upon the occurrence of such Event of Default and on each Interest Payment Date thereafter. The Holder need not provide,
and the Company hereby waives, any presentment, demand, protest or other notice of any kind, and the Holder may immediately and without
expiration of any grace period enforce any and all of its rights and remedies hereunder and/or all other Transaction Documents (including
the Security Agreement) and all other remedies available to it under applicable law. Any acceleration may be rescinded and annulled by
Holder at any time prior to payment hereunder and the Holder shall have all rights as a holder of the Note until such time, if any, as
the Holder receives full payment of this Note. No such rescission or annulment shall affect any subsequent Event of Default or impair
any right consequent thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8. <U>Miscellaneous</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holder hereunder shall be in writing and delivered personally,
by email attachment, or sent by a nationally recognized overnight courier service, addressed to the Company, at the address set forth
in the Purchase Agreement, or such other, email address, or address as the Company may specify for such purposes by notice to the Holder
delivered in accordance with this Section 8(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Absolute
Obligation; Ranking</U>. Except as expressly provided herein, no provision of this Note shall alter or impair the obligation of the Company,
which is absolute and unconditional, to pay the principal of, and accrued interest on, as applicable, this Note at the time, place, and
rate, and in the coin or currency, herein prescribed. This Note: (i) is a direct debt obligation of the Company; (ii) ranks <I>pari-passu</I>
with all other senior obligations of the Company and senior to all subordinated and junior obligations of the Company; and (iii) is secured
by the Security Agreement and the Collateral (as defined therein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Lost
or Mutilated Note</U>. If this Note shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver, in exchange
and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed Note,
a new Note for the principal amount of this Note so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss,
theft or destruction of such Note, and of the ownership hereof, reasonably satisfactory to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Note shall be determined in accordance
with Section 5.08 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Waiver</U>.
Any waiver by the Company or the Holder of a breach of any provision of this Note shall not operate as or be construed to be a waiver
of any other breach of such provision or of any breach of any other provision of this Note. The failure of the Company or the Holder
to insist upon strict adherence to any term of this Note on one or more occasions shall not be considered a waiver or deprive that party
of the right thereafter to insist upon strict adherence to that term or any other term of this Note on any other occasion. Any waiver
by the Company or the Holder must be in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Severability</U>.
If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note shall remain in effect, and if any provision
is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it
shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable
rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law. The
Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any manner whatsoever
claim or take the benefit or advantage of, any stay, extension or usury law or other law which would prohibit or forgive the Company
from paying all or any portion of the principal of or interest on this Note as contemplated herein, wherever enacted, now or at any time
hereafter in force, or which may affect the covenants or the performance of this Note, and the Company (to the extent it may lawfully
do so) hereby expressly waives all benefits or advantage of any such law, and covenants that it will not, by resort to any such law,
hinder, delay or impede the execution of any power herein granted to the Holder, but will suffer and permit the execution of every such
as though no such law has been enacted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Remedies,
Characterizations, Other Obligations, Breaches and Injunctive Relief</U>. The remedies provided in this Note shall be cumulative and
in addition to all other remedies available under this Note and any of the other Transaction Documents at law or in equity (including
a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the Holder&rsquo;s right to pursue actual
and consequential damages for any failure by the Company to comply with the terms of this Note. The Company covenants to the Holder that
there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided
for herein with respect to payments and the like (and the computation thereof) shall be the amounts to be received by the Holder and
shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for
any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the Holder
shall be entitled, in addition to all other available remedies, to an injunction restraining any such breach or any such threatened breach,
without the necessity of showing economic loss and without any bond or other security being required. The Company shall provide all information
and documentation to the Holder that is reasonably requested by the Holder to enable the Holder to confirm the Company&rsquo;s compliance
with the terms and conditions of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>Next
Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall
be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Headings</U>.
The headings contained herein are for convenience only, do not constitute a part of this Note and shall not be deemed to limit or affect
any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <U>Amendments;
Waivers</U>. Any modifications, amendments or waivers of the provisions hereof shall be subject to Section 5.05 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9. Intentionally Omitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10. </B><U>Usury</U>. To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever
claim and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at
any time hereafter in force, in connection with any Action or Proceeding that may be brought by any Holder in order to enforce any right
or remedy under any Transaction Document. Notwithstanding any provision to the contrary contained in any Transaction Document, it is
expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments in the nature of interest
shall not exceed the maximum lawful rate authorized under applicable law (the &ldquo;<B>Maximum Rate</B>&rdquo;), and, without limiting
the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums in the
nature of interest that the Company may be obligated to pay under the Transaction Documents exceed such Maximum Rate. It is agreed that
if the maximum contract rate of interest allowed by law and applicable to the Transaction Documents is increased or decreased by statute
or any official governmental action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the
Maximum Rate applicable to the Transaction Documents from the effective date thereof forward, unless such application is precluded by
applicable law. If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to any Holder with
respect to indebtedness evidenced by the Transaction Documents, such excess shall be applied by such Holder to the unpaid principal amount
of any such indebtedness or be refunded to the Company, the manner of handling such excess to be at such Holder&rsquo;s election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the Company has caused this Note to be duly executed by a duly authorized officer as of the date first above indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPHASE LABS, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 50%">Original Issue Date: July 22, 2025</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 28%; text-align: left">Subscription Amount:</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">500,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Scheduled Maturity Date: July 22, 2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Original Issue Discount:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">125,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Original Interest Discount: 20%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Original Principal Amount:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">625,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPHASE
LABS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20%
OID SENIOR SECURED CONVERTIBLE NOTE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
20% OID SENIOR SECURED CONVERTIBLE NOTE is one of a series of duly authorized and validly issued senior secured promissory notes of ProPhase
Labs, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), designated as its 20% OID Senior Secured Convertible Notes (this
note, the &ldquo;<B>Note</B>&rdquo; and, collectively with the other notes of such series, the &ldquo;<B>Notes</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the Company promises to pay to <B>REDACTED,</B> or its registered assigns (the &ldquo;<B>Holder</B>&rdquo;), the principal
sum of $625,000 (the &ldquo;<B>Original Principal Amount</B>&rdquo;) on the earlier to occur the Scheduled Maturity Date set forth
hereinabove, or such earlier date as this Note is required or permitted to be repaid as provided hereunder or under the Purchase Agreement
(as defined below) (as the case may be, the &ldquo;<B>Maturity Date</B>&rdquo;). This Note is subject to the following additional provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1.</B> <U>Definitions</U>. For the purposes hereof, in addition to the terms defined elsewhere in this Note: (a) capitalized terms not
otherwise defined herein shall have the meanings set forth in the Purchase Agreement, and (b) the following terms shall have the following
meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Applicable
Rate</U>&rdquo; means ten percent (10%) prior to the occurrence of an Event of Default and twenty-four percent (24%) from and after the
occurrence of any Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion</U>&rdquo;
means a conversion of this Note pursuant to Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Amount</U>&rdquo; shall have the meaning set forth in Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Date</U>&rdquo; means the date on or after the Convertibility Date of any Conversion in accordance with the terms of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; means, as of any Conversion Date, the lower of: (A) the greater of (1) eighty percent (80%) of the VWAP of the Common
Stock for such Conversion Date and (2) the Floor Price, and (B) the Maximum Conversion Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; with respect to any Conversion, a number of shares of Common Stock equal to the number obtained (rounded up to the
nearest whole share) by <I>dividing</I> the Conversion Amount thereof <I>by</I> the Conversion Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Convertibility
Date</U>&rdquo; means the earlier to occur of: (i) the date that is four (4) months after the Original Issue Date, and (ii) the Maturity
Date; and (ii) such earlier date as may be approved in advance by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Default
Amount</U>&rdquo; means the product of: (A) the sum of (1) the outstanding Original Principal Amount of this Note, <I>plus</I> (2) all
accrued and unpaid interest (including compounded interest) thereon, if any, <I>plus</I> (3) all liquidated damages due under this Note,
the Purchase Agreement or any other Transaction Document, <I>plus</I> (4) all other costs and expenses due under or in respect of this
Note, if any, and (B)(1) 112% until the one-month anniversary of the relevant Event(s) of Default, (2) 124% from and after the two month
anniversary of the relevant Event(s) of Default, and (3) 136% from and after three- month anniversary of the relevant Event(s) of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event
of Default</U>&rdquo; shall have the meaning set forth in Section 7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Floor
Price</U>&rdquo; means the product of: (A)(i) prior to the Stockholder Approval Date, 50%, and (ii) on and after the Stockholder Approval
Date, 20%; and (B) the lesser of: (i) the last closing price of the Common Stock immediately preceding the date of this Agreement, and
(ii) the average closing price of the Common Stock on for the five Trading Days immediately preceding the date of this Agreement; <I>provided</I>
that from and after the occurrence of any Event of Default under Section 7(h) hereof the Floor Price shall be zero ($0).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Interest
Payment Date</U>&rdquo; means the 28<SUP>th</SUP> day of each calendar month from and after the Original Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Maximum
Conversion Price</U>&rdquo; means $1.25.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Note
Register</U>&rdquo; shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Issue Date</U>&rdquo; means the date of the first issuance of the Notes, regardless of any transfers of any Note and regardless of the
number of instruments which may be issued to evidence such Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Payment
Amount</U>&rdquo; means 100% of the sum of: (1) the outstanding Original Principal Amount of this Note, <I>plus</I> (2) all accrued and
unpaid simple interest thereon, if any, <I>plus</I> (3) all liquidated damages due under this Note, the Purchase Agreement or any other
Transaction Document, <I>plus</I> (4) all other costs and expenses due under or in respect of this Note, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Premium
Amount</U>&rdquo; means 110% of the sum of: (1) the outstanding Original Principal Amount of this Note, <I>plus</I> (2) all accrued and
unpaid interest(including compounded interest) thereon, if any, <I>plus</I> (3) all liquidated damages due under this Note, the Purchase
Agreement or any other Transaction Document, <I>plus</I> (4) all other costs and expenses due under or in respect of this Note, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchase
Agreement</U>&rdquo; means the Securities Purchase Agreement, dated as of July 16, 2025, by and among the Company and the original Holders,
as amended, modified, or supplemented from time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Share
Delivery Date</U>&rdquo; shall have the meaning set forth in Section 4(b)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means any day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed for trading or quoted on the date
in question: the NYSE, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, or the Nasdaq Global Select Market (or
any successors of any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any Conversion Date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
listed or quoted on a Trading Market, the lowest daily volume weighted average price of the Common Stock within the ten (10) Trading
Days immediately prior to such Conversion Date (or the nearest preceding date) on the Trading Market on which the Common Stock is then
listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City
time)) (or a similar organization or agency succeeding to its functions of reporting prices), (b) if the Common Stock is not then listed
or quoted for trading on a Trading Market, the lowest volume weighted average price of the Common Stock within the ten (10) Trading Days
immediately prior to such Conversion Date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is
not then listed or quoted for trading on a Trading Market, OTCQB or OTCQX and if prices for the Common Stock are then reported in the
&ldquo;Pink Sheets&rdquo; published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting
prices), the lowest bid price per share of the Common Stock so reported within the ten (10) Trading Days immediately prior to such Conversion
Date (or the nearest preceding date), or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall
be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.</B> <U>Payments; Interest, Etc.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Payment</U>.
The entire unpaid Payment Amount shall be due and payable on the Maturity Date; <I>provided</I> that if an Event of Default shall have
previously occurred (whether before or after the Maturity Date) then the Default Amount shall become immediately due and payable. The
Company hereby waives, any presentment, demand, protest or other notice of any kind, and the Holder may immediately and without expiration
of any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Interest</U>.
Interest shall accrue on the outstanding Payment Amount (or, if an Event of Default shall have previously occurred, the Default Amount)
at an annual rate equal to the Applicable Rate. Such interest shall be calculated on the basis of a 360-day year, consisting of twelve
30 calendar day periods, and shall accrue daily commencing on the issue of this Note until payment (or conversion) in full of the Payment
Amount (or, if an Event of Default shall have previously occurred, the Default Amount). Interest shall cease to accrue with respect to
any Notes converted hereunder, <I>provided </I>that the Company actually delivers the Conversion Shares within the time period required
hereunder. Payments of interest hereunder will be paid to the Person in whose name this Note is registered on the Note Register.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Voluntary Prepayment</U>. <FONT STYLE="background-color: white">The Company may prepay this Note in full at any time after the Original
Issue Date in an amount equal to the Payment Amount (or, if an Event of Default shall have previously occurred, the Default Amount).
Voluntary prepayment shall not be offered to any holder of Notes unless voluntary prepayment is offered on a <I>pro rata</I> basis to
all holders of Notes on identical terms. The Company shall give at least five (5) days&rsquo; prior written notice to Holder of such
proposed prepayment by email to the Holder and Lead Investor (the latter at </FONT>REDACTED<FONT STYLE="background-color: white">),
and Holder may, by written Notice of Conversion to the Company delivered on or before 4:00 p.m. (New York City time) on the fifth day
(5th) after such notice of proposed prepayment by email to REDACTED, elect to convert up to $500,000 of the outstanding principal balance
of this Note into Conversion Shares hereunder.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Note
Register</U>. All payments and prepayments hereunder will be paid to the Person in whose name this Note is registered on the records
of the Company regarding registration and transfers of this Note (the &ldquo;<B>Note Register</B>&rdquo;). Upon the payment in full of
the Payment Amount (or, if an Event of Default shall have previously occurred, the Default Amount) in accordance with the terms of this
Note, or full Conversion of this Note, the Holder shall promptly surrender this Note to or as directed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.</B> <U>Registration of Transfers and Exchanges</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Different
Denominations</U>. This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations,
as requested by the Holder surrendering the same. No service charge will be payable for such registration of transfer or exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Investment
Representations</U>. This Note has been issued subject to certain investment representations of the original Holder set forth in the
Purchase Agreement and may be transferred or exchanged only in compliance with the Purchase Agreement and applicable federal and state
securities laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Reliance
on Note Register</U>. Prior to due presentment for transfer to the Company of this Note, the Company and any agent of the Company may
treat the Person in whose name this Note is duly registered on the Note Register as the owner hereof for the purpose of receiving payment
as herein provided and for all other purposes, whether or not this Note is overdue, and neither the Company nor any such agent shall
be affected by notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.</B> <U>Negative Covenants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
long as any portion of this Note remains outstanding, unless the holder(s) of a majority in Original Principal Amount of the then outstanding
Notes (including the Lead Investor, if it then holds any Notes) shall have otherwise given their prior written consent, the Company shall
not, directly or indirectly:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) change
the nature of its business without approval of majority in Original Principal Amount of the then outstanding Notes (including the Lead
Investor, if it then holds any Notes) unless the Notes shall be repaid or converted in full;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) effect
any Asset Sale with respect to twenty percent (20%) or more of the total assets of the Company and its Subsidiaries <I>unless </I>the
net cash proceeds thereof are in excess of the aggregate outstanding Original Principal Amount of all Notes and Permitted Additional
Debt then outstanding and all applied and utilized in accordance with Section 4.05(c) of the Purchase Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) enter
into any VRT Transactions (other than a Permitted ATM);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) enter
into or accept any new &ldquo;merchant-cash-advances (MCA) or similar financing instruments having an Annual Percentage Rate (APR) in
excess of thirty percent (30%);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) enter
into, create, incur, assume, guarantee or suffer to exist any Indebtedness that is senior to or (other than Permitted Additional Debt)
<I>pari passu</I> with the Notes on a contractual basis and/or the Lien on the Collateral (as defined in the Security Agreement);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) amend
its certificate of incorporation and bylaws, in any manner that materially and adversely affects any rights of the Holder unless consented
to by the Holder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) repay,
repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its Common Stock or Common Stock
Equivalents other than as to (i) repurchases of Common Stock or Common Stock Equivalents of departing officers and directors of the Company,
provided that such repurchases shall not exceed an aggregate of $25,000 for all officers and directors during the term of this Note,
or (ii) shares of Common Stock and Common Stock Equivalents which do not vest or are otherwise forfeited, provided (in case of forfeiture)
that such Common Stock and Common Stock Equivalents are not acquired for cash;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) repay,
repurchase or offer to repay, repurchase or otherwise acquire any secured Indebtedness other than the Notes and Prior $1,000,000 Debt
(on a pro rata basis as permitted under the Purchase Agreement) and other than regularly scheduled interest payments with respect to
Permitted Additional Debt (for the sake of clarity, any existing unsecured debt, trade payables and working capital expenses can be paid
back in the ordinary course of business);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) pay
cash dividends or distributions on any of its Common Stock equity securities of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) create,
permit or suffer to exist any Lien on any of its or any Subsidiaries properties and assets other than (x) Permitted Liens and (y) Liens
that are fully subordinated to the Liens granted under the Security Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) enter
into any material transaction with any Affiliate of the Company, unless such transaction is made on an arm&rsquo;s-length basis and expressly
approved by a majority of the disinterested directors of the Company (even if less than a quorum otherwise required for board approval);
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) enter
into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.</B> <U>Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Optional
Conversion</U>. From and after the Convertibility Date, the Holder shall have the right, at the Holder&rsquo;s option, to convert the
entire Payment Amount (or, if an Event of Default shall have previously occurred, the Default Amount) of this Note (as the case may be,
the &ldquo;<B>Conversion Amount</B>&rdquo;) into Conversion Shares by following the mechanics of conversion set forth in Section 5(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Mechanics
of Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Conversion
Notice</U>. Holder may, at any time and from time to time from and after the Convertibility Date, convert all or any portion of the Conversion
Amount of this Note into Conversion Shares at the Conversion Price, by delivering to the Company: (A) written notice of its election
to convert this Note pursuant to this Section 5, including the Conversion Amount, and (B) in the case of a Conversion of the entire Conversion
Amount of this Note, the original Note instrument (or a notice to the effect that such original Note has been lost, stolen or destroyed).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Delivery
of Conversion Shares upon Conversion</U>. With respect to each Conversion of this Note, the Company shall deliver, or cause to be delivered,
to the Holder the Conversion Shares no later than the date that is the earlier of: (i) two (2) Business Days after the delivery to the
Company of the notice of such Conversion; and (ii) the number of Trading days comprising the Standard Settlement Period after the delivery
to the Company of such (such date, the &ldquo;<B>Share Delivery Date</B>&rdquo;). As used herein, &ldquo;<B>Standard Settlement Period</B>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <U>Failure
to Deliver Conversion Shares</U>. If the Conversion Shares are not delivered to or as directed by the applicable Holder by the Share
Delivery Date, the Holder shall be entitled to elect by written notice to the Company at any time on or before its receipt of such Conversion
Shares to rescind the Conversion, in which event the Company shall promptly return to the Holder any original Note delivered to the Company
and the Holder shall promptly return to the Company the Conversion Shares (if any) issued to such Holder pursuant to the rescinded Conversion
Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) <U>Obligation
Absolute; Partial Liquidated Damages</U>. The Company&rsquo;s obligations to issue and deliver the Conversion Shares upon Conversion
of this Note on the relevant Share Delivery Date in accordance with the terms hereof are absolute and unconditional, irrespective of
any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of
any judgment against any Person or any action to enforce the same, or any set off, counter claim, recoupment, limitation or termination,
or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation
of law by the Holder or any other Person (unless the Conversion would violate any law applicable to the Company), and irrespective of
any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection with the issuance of such
Conversion Shares; <I>provided, however, </I>that such delivery shall not operate as a waiver by the Company of any such action the Company
may have against the Holder. In the event the Holder of this Note shall elect to convert any or all of the Conversion Amount hereof,
the Company may not refuse conversion based on any claim that the Holder or anyone associated or affiliated with the Holder has been
engaged in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice to Holder, restraining
and or enjoining conversion of all or part of this Note shall have been sought and obtained, and the Company posts a surety bond for
the benefit of the Holder in the amount of 150% of the greater of (i) the Default Amount of this Note and (ii) the converted value of
this Note, which is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of the
underlying dispute and the proceeds of which shall be payable to the Holder to the extent it obtains judgment. In the absence of such
injunction, the Company shall issue Conversion Shares or, if applicable, cash, upon a properly noticed Conversion. If the Company fails
for any reason to deliver to the Holder such Conversion Shares pursuant to Section 5(b)(ii) by the Share Delivery Date, the Company shall
pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Conversion Amount being converted, the sum
of (1) $20 per Trading Day (increasing to $35 per Trading Day on the fifth (5th) Trading Day after such liquidated damages begin to accrue)
for each Trading Day after such Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such conversion, and
(2) the product of (i) the number of Conversion Shares issuable upon such conversion and (ii) the difference between the highest trade
price and the lowest trade price during the period beginning on the Conversion Date of such Conversion and the date on which the Conversion
Shares are delivered to Holder&rsquo;s prime broker and are available to be sold. The Company agrees to maintain a transfer agent that
is a participant in the FAST program so long as this Note remains outstanding. Nothing herein shall prohibit the Holder from seeking
to enforce damages pursuant to any other section hereof or under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) <U>Fractional
Shares</U>: No fractional shares or scrip representing fractional shares shall be issued upon any Conversion. As to any fraction of a
share which the Holder would otherwise be entitled to purchase upon any Conversion, the Company shall at its election, either pay a cash
adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion Price or round up to the
next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) <U>Transfer
Taxes and Expenses</U>. The issuance of Conversion Shares on conversion of this Note shall be made without charge to the Holder hereof
for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares, <I>provided</I>
that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery
of any such Conversion Shares upon conversion in a name other than that of the Holder of this Note so converted. The Company shall pay
all transfer agent fees required for same-day processing of any conversion and all fees to the Depository Trust Company (or another established
clearing corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares. The Company shall
pay all attorney fees required for the issuance of attorney legal opinions for removal of restrictive legends on Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Holder&rsquo;s
Conversion Limitations</U>. The Company shall not affect any Conversion of this Note, and a Holder shall not have the right to convert
any portion of this Note, to the extent that after giving effect to such Conversion, the Holder (together with the Holder&rsquo;s Affiliates,
and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B>Attribution
Parties</B>&rdquo;)) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the
foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon Conversion of this Note, but shall exclude the number of shares which
are issuable upon conversion of the unconverted or unexercised portion of any other securities of the Company subject to a limitation
on conversion or exercise analogous to the limitation contained herein (including, without limitation, any Warrants) beneficially owned
by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section
5(c), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. To the extent that the limitation contained in this Section 5(c) applies, the determination of whether this Note is convertible
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which Conversion Amount
of this Note is convertible shall be in the sole discretion of the Holder. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 5(c), in determining the number of outstanding Common Stock, the Holder may rely on the number of outstanding
Common Stock as stated in the most recent of the following: (A) the Company&rsquo;s most recent periodic or annual report filed with
the Commission, as the case may be, (B) a more recent public announcement by the Company, or (C) a more recent written notice by the
Company or the Company&rsquo;s transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral
request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding. In any case, the number of outstanding Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Note and any Warrants, by the Holder or its Affiliates since the date as of
which such number of outstanding Common Stock was reported. The &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo; shall be 4.99% of
the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of Common Stock issuable upon Conversion
of this Note. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this
Section 5(c), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of Common Stock upon Conversion of this Note held by the Holder and the Beneficial
Ownership Limitation provisions of this Section 5(c) shall continue to apply. Any increase in the Beneficial Ownership Limitation will
not be effective until the 61st day after such notice is delivered to the Company. Notwithstanding the foregoing, in the event the Holder
elects to increase the Beneficial Ownership Limitation above 4.99%, the Holder covenants and agrees that, without the prior written consent
of the Company, it shall not, directly or indirectly, act in concert with, form a &ldquo;group&rdquo; (as defined in Section 13(d)(3)
of the Exchange Act), or otherwise coordinate or collaborate with any other person or entity that is a filer or required to be a filer
under Schedule 13D with respect to the Common Stock of the Company, in any manner that is intended to or would reasonably be expected
to oppose, challenge, or act in a manner adverse to the Company&rsquo;s management or Board. The Beneficial Ownership Limitation provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 5(c)
to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation
contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6.</B> <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Stock
Dividends and Stock Splits</U>. If the Company, at any time while this Note is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions payable in Common Stock on Common Stock or any Common Stock Equivalents (which, for avoidance of doubt,
shall not include any Common Stock issued by the Company upon conversion of, or payment of interest on, the Notes), (ii) subdivides outstanding
Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding Common Stock into
a smaller number of shares or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock
of the Company, then the Maximum Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock (excluding any treasury shares of the Company) outstanding immediately before such event, and of which the denominator
shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section
5 shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or
distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Fundamental
Transactions</U>. If, at any time while this Note is outstanding: (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any
sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series
of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another
Person) is completed pursuant to which, at any time while this Note is outstanding on or after the date of the occurrence (if any) of
an Event of Default, holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property
and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one
or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock are effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person whereby such other Person acquires more than 50% of the outstanding Common Stock (not including any Common Stock held by the other
Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share
purchase agreement or other business combination) (each a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then, upon any subsequent conversion
of this Note, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion
immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in Section 5(c) on the Conversion
of this Note), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving
corporation, and any additional consideration (the &ldquo;<B>Alternate Consideration</B>&rdquo;) receivable as a result of such Fundamental
Transaction by a holder of the number of shares of Common Stock issuable upon Conversion of this Note is convertible immediately prior
to such Fundamental Transaction (without regard to any limitations on conversion hereof, including without limitation, the Beneficial
Ownership Limitation). For purposes of any such conversion, the determination of the Maximum Conversion Price and/or Conversion Price
shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one (1) share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Conversion Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders
of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder
shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Note following such Fundamental
Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the
&ldquo;<B>Successor Entity</B>&rdquo;) to assume in writing all of the obligations of the Company under this Note and the other Transaction
Documents (as defined in the Purchase Agreement) in accordance with the provisions of this Section 6(b) pursuant to written agreements
in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the holder of this Note, deliver to the Holder in exchange for this Note a security of the Successor
Entity evidenced by a written instrument substantially similar in form and substance to this Note which is convertible for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Common Stock acquirable and receivable
upon Conversion of this Note (without regard to any limitations in Section 5(c) on the Conversion of this Note) prior to such Fundamental
Transaction, and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into
account the relative value of the Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Note
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Note and the other Transaction Documents referring
to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and
shall assume all of the obligations of the Company under this Note and the other Transaction Documents with the same effect as if such
Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Calculations</U>.
All calculations under this Section 5 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 6, the number of shares of Common Stock <U>deemed</U> to be issued and outstanding as of a given date shall be the sum
of the number of shares of Common Stock (excluding any treasury shares of the Company) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Adjustment
to Conversion Price</U>. Whenever the Conversion Price or Maximum Conversion Price is adjusted pursuant to any provision of this Section
6, the Company shall promptly deliver to each Holder a notice setting forth the Conversion Price and/or Maximum Conversion Price (as
applicable) after such adjustment and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.</B> <U>Events of Default</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
shall be considered an event of default if any of the following events listed in this Section 4 (each, an &ldquo;<U>Event of Default</U>&rdquo;)
shall occur:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Failure
to Pay Principal or Interest</U><B>.</B> The Company fails to pay the principal hereof or interest thereon when due on this Note, whether
at maturity, upon acceleration or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Failure
to Reserve or Deliver Shares</U>. (1) The Company fails to reserve the Required Reserve Amount of shares of Common Stocks Stock required
under the terms of the Purchase Agreement, fails to issue Common Stock to the Holder (or announces or threatens in writing that it will
not honor its obligation to do so) upon exercise by the Holder of the conversion rights of the Holder in accordance with the terms of
this Note, fails to transfer or cause its transfer agent to transfer (issue) (electronically or in certificated form) Common Stock issued
to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note, the Company directs its transfer
agent not to transfer or delays, impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated
form) Common Stock to be issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note,
or fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing)
any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any Common Stock issued to the Holder upon
conversion of or otherwise pursuant to this Note as and when required by this Note subject to regulations (or makes any written announcement,
statement or threat that it does not intend to honor the obligations described in this paragraph), or fails to supply an opinion letter
specific to the fact that Common Stock issued pursuant to conversion of the Note, as well as the shares issued pursuant to the Warrant
are exempt from Registration Requirements pursuant to Rule 144, and any such failure shall continue uncured (or any written announcement,
statement or threat not to honor its obligations shall not be rescinded in writing) for three (3) business days after the Holder shall
have delivered a Notice of Conversion. It is an obligation of the Company to remain current in its obligations to its transfer agent.
It shall be an event of default of this Note, if a conversion of this Note is delayed, hindered or frustrated due to a balance owed by
the Company to its transfer agent. If at the option of the Holder, the Holder advances any funds to the Company&rsquo;s transfer agent
in order to process a conversion, such advanced funds shall be paid by The Company to the Holder within five (5) business days of a demand
from the Holder, either in cash or as an addition to the outstanding Principal Amount of the Note, and such choice of payment method
is at the discretion of The Company. (2) The Company establishes a reserve of its Common Stock for the benefit of a party other than
the Holder, without obtaining prior approval in writing by the Lead Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Breach
of Covenants</U>. The Company, or the relevant related party, as the case may be, breaches any covenant, post-closing obligation or other
term or condition contained in any Transaction Document that has a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Breach
of Representations and Warranties</U>. Any representation or warranty of the Company made herein or in any agreement, statement or certificate
given pursuant hereto or in connection herewith, shall be false or misleading in any respect when made and the breach of which has (or
with the passage of time will have) a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Receiver
or Trustee</U>. The Company or any Subsidiary of the Company shall make an assignment for the benefit of creditors, or apply for or consent
to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or such a receiver or trustee
shall otherwise be appointed, except as part of the Crown Medical Collection initiative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Judgments or Settlements</U>. (1) Any money judgment, writ or similar process shall be entered or filed against the Company or any
Subsidiary of the Company or any of its property or other assets for more than $500,000, and shall remain unvacated, unbonded or unstayed
for a period of thirty (30) days unless otherwise consented to by the Holder; or (2) the settlement of any claim or litigation, creating
an obligation on the Company in amount over $2,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Bankruptcy</U>.
The bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings, voluntary or involuntary, for relief under
any bankruptcy law or any law for the relief shall be instituted by or against the Company or any Subsidiary of the Company, except any
filing related to the Company&rsquo;s Crown Medical Collections initiative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>Delisting
of Common Stocks</U>. If at any time on or after the date hereof, (i) the Company shall fail to maintain the listing or quotation of
the Common Stock on a national securities exchange or any tier of the over-the-counter market maintained by OTC Markets Group, Inc. (&ldquo;OTC&rdquo;)
other than the OTC&rsquo;s Expert Market, or (ii) subsequent to an uplisting of the Company&rsquo;s Common Stock to a National Exchange
(as defined in the Exchange Act), the Company shall fail to maintain such listing or quotation on a National Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Failure
to Comply with Regulatory Reporting Requirements</U>. The Company fails to be in material compliance with, or ceases to be subject to,
the reporting requirements of the Exchange Act (including but not limited to becoming delinquent in its filings).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <U>Change
of Control or Liquidation</U>. Any Change of Control of the Company, or the dissolution, liquidation, or winding up of The Company or
any substantial portion of its business. As used herein, a &ldquo;<B>Change of Control</B>&rdquo; shall be deemed to occur upon the consummation
of any of the following events: (a) any person or persons acting together which would constitute a &ldquo;group&rdquo; for purposes of
Section 13(d) of the Exchange Act (other than the Company or any Subsidiary of the Company) shall beneficially own (as defined in Rule
13d-3 of the Exchange Act), directly or indirectly, at least 50% of the total voting power of all classes of capital stock of the Company
entitled to vote generally in the election of the Board; (b) Current Directors (as herein defined) shall cease for any reason to constitute
at least a majority of the members of the Board (for this purpose, a &ldquo;<B>Current Director</B>&rdquo; shall mean any member of the
Board as of the date hereof and any successor of a Current Director whose election, or nomination for election by the Company&rsquo;s
shareholders, was approved by at least a majority of the Current Directors then on the Board); (c) (i) the complete liquidation of the
Company or (ii) the merger or consolidation of the Company, other than a merger or consolidation in which (x) the holders of the Common
Stock of the Company immediately prior to the consolidation or merger have, directly or indirectly, at least a majority of the Common
Stocks of the continuing or surviving corporation immediately after such consolidation or merger or (y) the Board immediately prior to
the merger or consolidation would, immediately after the merger or consolidation, constitute a majority of the board of directors of
the continuing or surviving corporation, which liquidation, merger or consolidation has been approved by the shareholders of the Company;
(d) the sale or other disposition (in one transaction or a series of transactions) of all or substantially all of the assets of the Company
pursuant to an agreement (or agreements) which has (have) been approved by the shareholders of the Company; or (e) the termination of
the current Chief Executive Officer of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <U>Cessation
of Operations</U>. Any cessation of operations by the Company or the Company admits it is otherwise generally unable to pay its debts
as such debts become due, provided, however, that any disclosure of the Company&rsquo;s ability to continue as a &ldquo;going concern&rdquo;
shall not be an admission that the Company cannot pay its debts as they become due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <U>Maintenance
of Assets</U>. The failure by the Company to maintain any intellectual property rights, personal, real property or other assets which
are necessary to conduct its business (whether now or in the future), to the extent that such failure would result in a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <U>Financial
Statement Restatement</U>. The Company restates any financial statements for any date or period from two years prior to the Original
Issue Date and until this Note is no longer outstanding, if the result of such restatement would, by comparison to the un-restated financial
statement, have constituted a material adverse effect on the rights of the Holder with respect to this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) <U>Challenge
to Validity or Enforceability</U>. The Company, the undersigned, or any party acting on their behalf contests, disputes, or otherwise
challenges the validity, enforceability, or authorization of this Note or any of the other Transaction Documents, or any obligations
arising hereunder or thereunder, or (ii) the Company, the undersigned, or any party acting on their behalf, asserts, directly or indirectly,
that the execution, delivery, or performance of this Note, or any of the other Transaction Documents, was not duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) <U>Illegality</U>.
Any court of competent jurisdiction issues an order declaring this Note, any of the other Transaction Documents or any provision hereunder
or thereunder to be illegal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
 <U>Cross-Default</U>. Notwithstanding anything to the contrary contained in this Note or any
of the other Transaction Documents, a breach or default by the Company of any covenant or other term or condition contained in any of
the other financial instrument, including but not limited to all promissory notes, currently issued, or hereafter issued, by the Company,
to the Holder or any other third party (the &ldquo;Other Agreements&rdquo;), after the passage of all applicable notice and cure or grace
periods, that results in a Material Adverse Effect shall, at the option of the Holder, be considered a default under this Note, in which
event the Holder shall be entitled to apply all rights and remedies of the Holder under the terms of this Note by reason of a default
under said Other Agreement or hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) <U>Reverse
Splits</U>. The Company effectuates a reverse split of its Common Shares without ten (10) days prior written notice to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) <U>Replacement
of Transfer Agent</U>. In the event that the Company proposes to replace its transfer agent, the Company fails to provide, prior to the
effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered pursuant
to the Purchase Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved Amount)
signed by the successor transfer agent to Company and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) <U>DWAC
Eligibility</U>. In addition to the Event of Default in Section 4.1.21, the Common Stock is otherwise not eligible for trading through
the DTC&rsquo;s Fast Automated Securities Transfer or Deposit/Withdrawal at Custodian programs, or if the Company is not registered with
DTC on the Issue Date, Company fails to become DTC registered within 30 days of the Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) <U>Inside
Information</U>. Unless such information is requested by the Holder, any attempt by the Company or its officers, directors, and/or affiliates
to transmit, convey, disclose, or any actual transmittal, conveyance, or disclosure by the Company or its officers, directors, and/or
affiliates of, material non-public information concerning the Company, to the Holder or its successors and assigns, which is not immediately
cured by Company&rsquo;s filing of a Form 8-K pursuant to Regulation FD on that same date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) <U>Failure
of Security Interest</U>. (a) Any material provision of the Security Agreement shall at any time for any reason (other than pursuant
to the express terms thereof) cease to be valid and binding on or enforceable against the Company or any Subsidiary intended to be a
party thereto, or the validity or enforceability thereof shall be contested by any party thereto, or a proceeding shall be commenced
by the Company or any Subsidiary or any governmental authority having jurisdiction over any of them, seeking to establish the invalidity
or unenforceability thereof, or the Company or any Subsidiary shall deny in writing that it has any liability or obligation purported
to be created under the Security and Pledge Agreement; (b) the Security Agreement, after delivery thereof pursuant hereto, shall for
any reason fail or cease to create a valid and perfected and, except to the extent permitted by the terms hereof or thereof, first priority
Lien in favor of the Holder on any Collateral (as defined in the Security Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) <U>Failure
to Register Shares</U>. The Company shall fail to cause the Underlying Shares (as defined in the Purchase Agreement) to be registered
pursuant to the terms of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) <FONT STYLE="background-color: white"><U>Chief
Executive Officer Conduct</U>. The Chief Executive Officer is indicted or arrested for violating any law, rule, regulation, or cease-and-desist
order, or is convicted of a criminal offense in a state of federal court (but not including traffic violations or similar offenses) and
the arrest or indictment has a Material Adverse Effect</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) <U>Section
3(a)(10) Transactions</U>. The Company shall enter into a transaction structured in accordance with, based upon, or related or pursuant
to, in whole or in part, Section 3(a)(10) of the Securities Act (&ldquo;3(a)(10) Transaction&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Failure to Obtain Stockholder Approval</U>. The Company shall fail to obtain the Stockholder Approval by November 22, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties agree that it shall not be an &ldquo;Event of Default&rdquo; if a UCC that was unknown is subsequently discovered, on the condition
that RDM files UCC-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any Event of Default occurs the Default Amount shall become immediately due and payable in cash, and the Company shall pay to the holders
of Notes (pro rata, in accordance with their respective Original Principal Amounts) an aggregate monthly monitoring fee of $10,000 per
month, payable upon the occurrence of such Event of Default and on each Interest Payment Date thereafter. The Holder need not provide,
and the Company hereby waives, any presentment, demand, protest or other notice of any kind, and the Holder may immediately and without
expiration of any grace period enforce any and all of its rights and remedies hereunder and/or all other Transaction Documents (including
the Security Agreement) and all other remedies available to it under applicable law. Any acceleration may be rescinded and annulled by
Holder at any time prior to payment hereunder and the Holder shall have all rights as a holder of the Note until such time, if any, as
the Holder receives full payment of this Note. No such rescission or annulment shall affect any subsequent Event of Default or impair
any right consequent thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8. <U>Miscellaneous</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holder hereunder shall be in writing and delivered personally,
by email attachment, or sent by a nationally recognized overnight courier service, addressed to the Company, at the address set forth
in the Purchase Agreement, or such other, email address, or address as the Company may specify for such purposes by notice to the Holder
delivered in accordance with this Section 8(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Absolute
Obligation; Ranking</U>. Except as expressly provided herein, no provision of this Note shall alter or impair the obligation of the Company,
which is absolute and unconditional, to pay the principal of, and accrued interest on, as applicable, this Note at the time, place, and
rate, and in the coin or currency, herein prescribed. This Note: (i) is a direct debt obligation of the Company; (ii) ranks <I>pari-passu</I>
with all other senior obligations of the Company and senior to all subordinated and junior obligations of the Company; and (iii) is secured
by the Security Agreement and the Collateral (as defined therein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Lost
or Mutilated Note</U>. If this Note shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver, in exchange
and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed Note,
a new Note for the principal amount of this Note so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss,
theft or destruction of such Note, and of the ownership hereof, reasonably satisfactory to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Note shall be determined in accordance
with Section 5.08 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Waiver</U>.
Any waiver by the Company or the Holder of a breach of any provision of this Note shall not operate as or be construed to be a waiver
of any other breach of such provision or of any breach of any other provision of this Note. The failure of the Company or the Holder
to insist upon strict adherence to any term of this Note on one or more occasions shall not be considered a waiver or deprive that party
of the right thereafter to insist upon strict adherence to that term or any other term of this Note on any other occasion. Any waiver
by the Company or the Holder must be in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Severability</U>.
If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note shall remain in effect, and if any provision
is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it
shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable
rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law. The
Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any manner whatsoever
claim or take the benefit or advantage of, any stay, extension or usury law or other law which would prohibit or forgive the Company
from paying all or any portion of the principal of or interest on this Note as contemplated herein, wherever enacted, now or at any time
hereafter in force, or which may affect the covenants or the performance of this Note, and the Company (to the extent it may lawfully
do so) hereby expressly waives all benefits or advantage of any such law, and covenants that it will not, by resort to any such law,
hinder, delay or impede the execution of any power herein granted to the Holder, but will suffer and permit the execution of every such
as though no such law has been enacted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Remedies,
Characterizations, Other Obligations, Breaches and Injunctive Relief</U>. The remedies provided in this Note shall be cumulative and
in addition to all other remedies available under this Note and any of the other Transaction Documents at law or in equity (including
a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the Holder&rsquo;s right to pursue actual
and consequential damages for any failure by the Company to comply with the terms of this Note. The Company covenants to the Holder that
there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided
for herein with respect to payments and the like (and the computation thereof) shall be the amounts to be received by the Holder and
shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for
any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the Holder
shall be entitled, in addition to all other available remedies, to an injunction restraining any such breach or any such threatened breach,
without the necessity of showing economic loss and without any bond or other security being required. The Company shall provide all information
and documentation to the Holder that is reasonably requested by the Holder to enable the Holder to confirm the Company&rsquo;s compliance
with the terms and conditions of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>Next
Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall
be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Headings</U>.
The headings contained herein are for convenience only, do not constitute a part of this Note and shall not be deemed to limit or affect
any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <U>Amendments;
Waivers</U>. Any modifications, amendments or waivers of the provisions hereof shall be subject to Section 5.05 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9. Intentionally Omitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10. </B><U>Usury</U>. To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever
claim and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at
any time hereafter in force, in connection with any Action or Proceeding that may be brought by any Holder in order to enforce any right
or remedy under any Transaction Document. Notwithstanding any provision to the contrary contained in any Transaction Document, it is
expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments in the nature of interest
shall not exceed the maximum lawful rate authorized under applicable law (the &ldquo;<B>Maximum Rate</B>&rdquo;), and, without limiting
the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums in the
nature of interest that the Company may be obligated to pay under the Transaction Documents exceed such Maximum Rate. It is agreed that
if the maximum contract rate of interest allowed by law and applicable to the Transaction Documents is increased or decreased by statute
or any official governmental action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the
Maximum Rate applicable to the Transaction Documents from the effective date thereof forward, unless such application is precluded by
applicable law. If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to any Holder with
respect to indebtedness evidenced by the Transaction Documents, such excess shall be applied by such Holder to the unpaid principal amount
of any such indebtedness or be refunded to the Company, the manner of handling such excess to be at such Holder&rsquo;s election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the Company has caused this Note to be duly executed by a duly authorized officer as of the date first above indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPHASE LABS, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex10-3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
10.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXCERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
SHARE PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPHASE
LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Shares: 4,375,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
Date: July 22, 2025 (&ldquo;<B>Issuance Date</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
COMMON SHARE PURCHASE WARRANT (this &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received in connection with the issuance
of the senior secured convertible promissory note of even date in the principal amount of $3,125,000 (the &ldquo;<B>Note</B>&rdquo;)
by ProPhase Labs, Inc., a corporation organized under the laws of the state of Delaware (the &ldquo;<B>Company</B>&rdquo;), <B>REDACTED
</B>(including any permitted and registered assigns, each a &ldquo;<B>Holder</B>&rdquo;), is entitled, upon the terms and subject to
the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase
from the Company up to 4,375,000 shares of common stock, $0.0005 par value, (the &ldquo;Common Shares&rdquo;; and such Common Shares
issuable upon exercise of this Warrant, the &ldquo;<B>Warrant Shares</B>&rdquo;) (whereby such number may be adjusted from time to time
pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company
in connection with that certain Securities Purchase Agreement, dated as of the Issuance Date, by and between the Company and the original
Holder of this Warrant (the &ldquo;<B>Purchase Agreement</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used in this Warrant shall have the meanings set forth in the Purchase Agreement unless otherwise defined in the body of this Warrant
or in Section 12 below. For purposes of this Warrant, the term &ldquo;<B>Exercise Price</B>&rdquo; shall mean $0.50, subject to adjustment
as provided herein (including but not limited to cashless exercise), and the term &ldquo;<B>Exercise Period</B>&rdquo; shall mean the
period commencing on the Issuance Date and ending on 6:00 p.m. eastern standard time on the five-year anniversary thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>EXERCISE OF WARRANT</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Mechanics of Exercise</I>. Subject to the terms and conditions hereof, the rights represented by this Warrant may be exercised in
whole or in part at any time or times during the Exercise Period by delivery of a written notice, in the form attached hereto as <U>Exhibit
A</U> (the &ldquo;<B>Exercise Notice</B>&rdquo;), of the Holder&rsquo;s election to exercise this Warrant. The Holder shall not be required
to deliver the original Warrant in order to effect an exercise hereunder. Partial exercises of this Warrant resulting in purchases of
a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. On or before the third Trading
Day (the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;) following the date on which the Company shall have received the Exercise Notice,
and upon receipt by the Company of payment to the Company of an amount equal to the applicable Exercise Price multiplied by the number
of Warrant Shares as to which all or a portion of this Warrant is being exercised (the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;
and together with the Exercise Notice, the &ldquo;<B>Exercise Delivery Documents</B>&rdquo;) in cash or by wire transfer of immediately
available funds (or by cashless exercise, in which case there shall be no Aggregate Exercise Price provided), the Company shall (or direct
its transfer agent to) issue the number of Warrant Shares to which the Holder is entitled pursuant to such exercise (such number referred
to hereinafter as the &ldquo;<B>Exercised Amount</B>&rdquo; and such shares to be issued referred to hereinafter as the &ldquo;<B>Exercised
Warrant Shares</B>&rdquo;), registered in the Company&rsquo;s share register in the name of the Holder or its designee. At the option
of the Holder, such Exercised Warrant Shares shall be issued either (i) in DRS book entry form, (ii) directly into a brokerage account
by DWAC transfer (if eligible), or (iii) on one or more certificates dispatched by overnight courier to the address as specified in the
Exercise Notice. Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes to have become
the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery
of the certificates evidencing such Warrant Shares. If this Warrant is submitted in connection with any exercise and the number of Warrant
Shares represented by this Warrant submitted for exercise is greater than the Exercised Amount, then the Company shall as soon as practicable
and in no event later than three (3) Business Days after any exercise and at its own expense, issue a new Warrant (in accordance with
Section 6) representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under this
Warrant, less the Exercised Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at any time after the 6 month anniversary of the Issuance Date, the Market Price of one Common Share is greater than the Exercise Price
and the Warrant Shares are not registered under an effective non-stale registration statement of the Company, the Holder may elect to
receive Warrant Shares pursuant to a cashless exercise, in lieu of a cash exercise, equal to the value of this Warrant determined in
the manner described below (or of any portion thereof remaining unexercised) by surrender of this Warrant and a Notice of Exercise, in
which event the Company shall issue to Holder a number of Warrant Shares computed using the following formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X
= <U>Y (A-B)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 41.2pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Where</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">X
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                            number of Warrant Shares to be issued to Holder.</FONT></TD></TR>
                                                                                                                                         <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                                                                         <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of Warrant Shares that the Holder elects to purchase under this Warrant (at the date
                                            of such calculation).</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
      Market Price (at the date of such calculation).</FONT></TD></TR>
                                                                                  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
      Price (as adjusted to the date of such calculation).</FONT></TD></TR>
                                                                                  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 77.2pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 77.2pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company fails to cause its transfer agent to transmit to the Holder the respective Warrant Shares by the respective Warrant Share
Delivery Date (each, a &ldquo;<B>Delivery Failure</B>&rdquo;), then the Holder will have the right to rescind such exercise in Holder&rsquo;s
sole discretion, and such failure shall be deemed an event of default under the Note to the extent the Note remains outstanding and any
portion thereof unpaid, and this Warrant. In addition, and without in any way limiting the Holder&rsquo;s right to pursue other remedies,
including but not limited to, actual damages and/or equitable relief, or the foregoing remedies, the parties agree that if the Company
causes the Exercised Warrant Shares to not be delivered by the second (2nd) Trading Day following the Warrant Share Delivery Date, Company
shall pay to the Holder the greater of (i) for each day after the Share Delivery Date and during such Delivery Failure an amount equal
to the greater of (x) $1,000 per day in cash, for each day beyond the Warrant Share Delivery Date that Company fails to deliver such
Exercised Warrant Shares, or (y) 2% of the product of (A) the sum of the number of shares of Common Stock not issued to the Holder on
or prior to the Share Delivery Date and to which the Holder is entitled (the &ldquo;<B>Undelivered Shares</B>&rdquo;), multiplied by
(B) any trading price of the Common Stock selected by the Holder in writing as in effect at any time during the period beginning on the
applicable Exercise Date and ending on the applicable Share Delivery Date (the &ldquo;<B>Undelivered Shares Value</B>&rdquo;), or (ii)
the excess of the product of (A) the Undelivered Shares, multiplied by (B) the Undelivered Shares Value, over the aggregate value of
the Common Stock actually delivered to the Holder based on the lowest trading price of the Common Stock during the five (5) trading days
following the date that such Common Shares are actually issued to the Holder. Such amount shall either be paid in cash to Holder by the
fifth day of the month following the month in which it has accrued or, at the option of the Holder (by written notice to Company by the
first day of the month following the month in which it has accrued), as follows: (1) in the event that the Note remains outstanding and
any portion thereof unpaid, such amount shall be added to the principal amount of the Note, in which event interest shall accrue thereon
in accordance with the terms of the Note and such additional principal amount shall be convertible into Common Shares in accordance with
the terms of the Note; (2) in the event that the Note is no longer outstanding and no portion thereof remains unpaid, such amount shall
be payable in Common Shares based on the number of shares that would have been due under (1) above, had the Note been outstanding, and
pursuant to a conversion of such amount added to the principal amount of the Note. Company agrees that the right to exercise is a valuable
right to the Holder, and as such, Company will not take any actions to hamper, delay or prevent any Holder exercise of this Warrant.
The damages resulting from a failure, attempt to frustrate, interference with such exercise right are difficult if not impossible to
qualify. Accordingly, the parties acknowledge that the liquidated damages provision contained in this section are justified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>No Fractional Shares</I>. No fractional shares shall be issued upon the exercise of this Warrant as a consequence of any adjustment
pursuant hereto. All Warrant Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining
whether the exercise would result in the issuance of any fractional share. If, after aggregation, the exercise would result in the issuance
of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction
a sum in cash equal to the product resulting from multiplying the then-current fair market value of a Warrant Share by such fraction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Holder&rsquo;s Exercise Limitations</I>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, to the extent that after giving effect to issuance of Warrant Shares upon exercise as
set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates), would beneficially own in excess of the Beneficial Ownership
Limitation, as defined below. For purposes of the foregoing sentence, the number of Common Shares beneficially owned by the Holder and
its Affiliates shall include the number of Common Shares issuable upon exercise of this Warrant with respect to which such determination
is being made, but shall exclude the number of Common Shares which would be issuable upon (i) exercise of the remaining, non-exercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised
or non-converted portion of any other securities of the Company (including without limitation any other Common Share Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates. Except as set forth in the preceding sentence, for purposes of this paragraph (d), beneficial ownership shall be calculated
in accordance with Section 13(d) of the Exchange Act, it being acknowledged by the Holder that the Company is not representing to the
Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules
required to be filed in accordance therewith. To the extent that the limitation contained in this paragraph applies, the determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any affiliates) and of which
portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the
Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership
Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this paragraph, in determining the number of outstanding Common Shares, a Holder may rely on the number of outstanding Common
Shares as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
a more recent public announcement by the Company or (C) a more recent written notice by the Company or its transfer agent setting forth
the number of Common Shares outstanding. Upon the request of a Holder, the Company shall within two Trading Days confirm to the Holder
the number of Common Shares then outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect
to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its affiliates since the date as
of which such number of outstanding Common Shares was reported. The &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo; shall initially
be 4.99% of the number of Common Shares outstanding immediately after giving effect to the issuance of Common Shares issuable upon exercise
of this Warrant. The Holder, upon notice to the Company, may increase this Beneficial Ownership Limitation, provided, however, that in
no event shall the Beneficial Ownership Limitation exceed 9.99% of the number of shares of the Common Stock outstanding immediately after
giving effect to such exercise.. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such
notice is delivered to the Company. The Beneficial Ownership Limitation provisions of this Section shall continue to apply unless and
until modified as set forth herein and shall apply to any successor holder of this Warrant. Notwithstanding the foregoing, in the event
the Holder elects to increase the Beneficial Ownership Limitation above 4.99%, the Holder covenants and agrees that, without the prior
written consent of the Company, it shall not, directly or indirectly, act in concert with, form a &ldquo;group&rdquo; (as defined in
Section 13(d)(3) of the Exchange Act), or otherwise coordinate or collaborate with any other person or entity that is a filer or required
to be a filer under Schedule 13D with respect to the Common Stock of the Company, in any manner that is intended to or would reasonably
be expected to oppose, challenge, or act in a manner adverse to the Company&rsquo;s management or Board of Directors. The Beneficial
Ownership Limitation provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity
with the terms of this Section to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to
such limitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>ADJUSTMENTS</U>. The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Distribution of Assets</I>. If the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire
its assets) to holders of Common Shares, by way of return of capital or otherwise (including without limitation any distribution of cash,
shares or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement or other similar
transaction) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after the issuance of this Warrant, then, in each such case:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any Exercise Price in effect immediately prior to the close of business on the record date fixed for the determination of holders of
Common Shares entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date, to a
price determined by multiplying such Exercise Price by a fraction (i) the numerator of which shall be the Closing Sale Price of the Common
Shares on the Trading Day immediately preceding such record date minus the value of the Distribution (as determined in good faith by
the Company&rsquo;s Board of Directors) applicable to one Common Share, and (ii) the denominator of which shall be the Closing Sale Price
of the Common Shares on the Trading Day immediately preceding such record date; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the number of Warrant Shares shall be increased to a number of shares equal to the number of Common Shares obtainable immediately prior
to the close of business on the record date fixed for the determination of holders of Common Shares entitled to receive the Distribution
multiplied by the reciprocal of the fraction set forth in the immediately preceding clause (i); provided, however, that in the event
that the Distribution is of Common Shares of a company (other than the Company) whose common stock is traded on a national securities
exchange or a national automated quotation system (&ldquo;Other Shares of Common Stock&rdquo;), then the Holder may elect to receive
a warrant to purchase Other Shares of Common Stock in lieu of an increase in the number of Warrant Shares, the terms of which shall be
identical to those of this Warrant, except that such warrant shall be exercisable into the number of Other Shares of Common Stock that
would have been payable to the Holder pursuant to the Distribution had the Holder exercised this Warrant immediately prior to such record
date and with an aggregate exercise price equal to the product of the amount by which the exercise price of this Warrant was decreased
with respect to the Distribution pursuant to the terms of the immediately preceding clause (i) and the number of Warrant Shares calculated
in accordance with the first part of this clause (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Proportional Adjustments of Outstanding Common Shares and Common Share Dividends</U>. If the Company shall at any time or from time
to time after the date hereof, issue additional Common Shares to all of its current shareholders on a pro rata basis or pay a share dividend
in Common Shares, then the Exercise Price and the number of Warrant Shares shall be proportionately adjusted. Any adjustments under this
Section 2(b) shall be effective at the close of business on the date the share split becomes effective or the date of payment of the
share dividend, as applicable. For the avoidance of doubt, this adjustment shall not apply when shares of outstanding Common Share are
merged proportionally across all shareholders to form a smaller number of outstanding shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>FUNDAMENTAL TRANSACTIONS</U>. If, at any time while this Warrant is outstanding, (i) the Company effects any merger of the Company
with or into another entity and the Company is not the surviving entity (such surviving entity, the &ldquo;<B>Successor Entity</B>&rdquo;),
(ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii) any tender
offer or exchange offer (whether by the Company or by another individual or entity, and approved by the Company) is completed pursuant
to which holders of Common Shares are permitted to tender or exchange their Common Shares for other securities, cash or property and
the holders of at least 50% of the Common Shares accept such offer, or (iv) the Company effects any reclassification of the Common Shares
or any compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities,
cash or property (other than as a result of a subdivision or combination of Common Shares) (in any such case, a &ldquo;<B>Fundamental
Transaction</B>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive the number of
Common Shares of the Successor Entity or of the Company and any additional consideration (the &ldquo;<B>Alternate Consideration</B>&rdquo;)
receivable upon or as a result of such reorganization, reclassification, merger, consolidation or disposition of assets by a holder of
the number of Common Shares for which this Warrant is exercisable immediately prior to such event (disregarding any limitation on exercise
contained herein solely for the purpose of such determination). For purposes of any such exercise, the determination of the Exercise
Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable
in respect of one Common Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders
of Common Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder
shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction. To the extent necessary to effectuate the foregoing provisions, any Successor Entity in such Fundamental Transaction shall
issue to the Holder a new warrant consistent with the foregoing provisions and evidencing the Holder&rsquo;s right to exercise such warrant
into Alternate Consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>NON-CIRCUMVENTION</U>. The Company covenants and agrees that it will not, by amendment of its certificate of formation, certificate
of incorporation, operating agreement, or bylaws, or through any reorganization, transfer of assets, consolidation, merger, scheme of
arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions of this Warrant and take all action
as may be required to protect the rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase
the par value of any Common Shares receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take
all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable
Common Shares upon the exercise of this Warrant, and (iii) shall, for so long as this Warrant is outstanding, have authorized and reserved,
free from preemptive rights, a sufficient number of Common Shares to provide for the exercise of the rights represented by this Warrant
(without regard to any limitations on exercise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>WARRANT HOLDER NOT DEEMED A SHAREHOLDER</U>. Except as otherwise specifically provided herein, this Warrant, in and of itself, shall
not entitle the Holder to any voting rights or other rights as a shareholder of the Company. In addition, nothing contained in this Warrant
shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise)
or as a shareholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>REISSUANCE</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Lost, Stolen or Mutilated Warrant</I>. If this Warrant is lost, stolen, mutilated or destroyed, the Company will, on such terms as
to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof),
issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Issuance of New Warrants</I>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such
new Warrant shall be of like tenor with this Warrant, and shall have an issuance date, as indicated on the face of such new Warrant which
is the same as the Issuance Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>TRANSFER</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Notice of Transfer</I>. The Holder agrees that, if practicable, but without any obligation to do so, it will give written notice to
the Company of its intent to transfer this Warrant or any Warrant Shares, describing briefly the manner of any proposed transfer. Promptly
upon receiving such written notice, the Company shall present copies thereof to the Company&rsquo;s counsel. If the proposed transfer
may be effected without registration or qualification (under any federal or state securities laws), the Company, as promptly as practicable,
shall notify the Holder thereof, whereupon the Holder shall be entitled to transfer this Warrant or to dispose of Warrant Shares received
upon the previous exercise of this Warrant, all in accordance with the terms of the notice delivered by the Holder to the Company; provided,
however, that an appropriate legend may be endorsed on this Warrant or the certificates for such Warrant Shares respecting restrictions
upon transfer thereof necessary or advisable in the opinion of counsel and satisfactory to the Company to prevent further transfers which
would be in violation of Section 5 of the Securities Act and applicable state securities laws; and provided further that the prospective
transferee or purchaser shall execute the Assignment of Warrant attached hereto as <U>Exhibit B</U> and such other documents and make
such representations, warranties, and agreements as may be required solely to comply with the exemptions relied upon by the Company for
the transfer or disposition of the Warrant or Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If the proposed transfer or disposition of this Warrant or such Warrant Shares described in the written notice given pursuant to this
Section 7 may not be effected without registration or qualification of this Warrant or such Warrant Shares, the Holder will limit its
activities in respect to such transfer or disposition as are permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Any transferee of all or a portion of this Warrant shall succeed to the rights and benefits of the initial Holder of this Warrant under
Section 5.6 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>NOTICES</U>. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given
in accordance with the notice provisions contained in the Purchase Agreement. The Company shall provide the Holder with prompt written
notice (i) immediately upon any adjustment of the Exercise Price, setting forth in reasonable detail, the calculation of such adjustment
and (ii) at least twenty (20) days prior to the date on which the Company closes its books or takes a record (A) with respect to any
dividend or distribution upon the Common Shares, (B) with respect to any grants, issuances or sales of any shares or other securities
directly or indirectly convertible into or exercisable or exchangeable for Common Shares or other property, pro rata to the holders of
Common Shares or (C) for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided
in each case that such information shall be made known to the public prior to or in conjunction with such notice being provided to the
Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>AMENDMENT AND WAIVER</U>. The terms of this Warrant may be amended or waived (either generally or in a particular instance and either
retroactively or prospectively) only with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>GOVERNING LAW &amp; AGREEMENT TO CONFIDENTIAL ARBITRATION</U>. This Warrant shall be governed and construed in accordance with the
laws of the State of Delaware without regard to principles of conflicts of law. Any dispute or controversy between the Parties relating
to or arising out of this Warrant or any amendment or modification hereof shall be determined by confidential arbitration in Wilmington,
Delaware administered by the American Arbitration Association under its Commercial Arbitration Rules, other than claims for injunctive
relief which shall be adjudicated only by the state and/or federal courts residing in Wilmington, Delaware. In any such arbitration,
the Parties shall be permitted to engage in any type of discovery permitted by the Federal Rules of Civil Procedure, including, without
limitation, the taking of depositions and the service of document requests, non-party subpoenas and interrogatories. The arbitration
award shall be final and binding upon the Parties and judgment may be entered thereon by any court of competent jurisdiction. The service
of any notice, process, motion or other document in connection with any arbitration under this Warrant or the enforcement of any arbitration
award hereunder may be effectuated either by personal service upon a Party or by certified mail duly addressed to him or it or to his
or its executors, administrators, personal representatives, next of kin, successors or assigns, at the last known address or addresses
of such Party or Parties. Notwithstanding the foregoing, the request by any Party for specific performance and temporary, preliminary
or permanent injunctive relief, whether prohibitive or mandatory, shall not be subject to arbitration and shall be adjudicated only by
the state and/or federal courts residing in Wilmington, Delaware. Each Party irrevocably submits to the exclusive jurisdiction of such
courts for such purposes, and waives and agrees not to assert in any such proceeding a claim that he or it is not personally subject
to the courts referred to above, that the suit or action was brought in an inconvenient forum or that the venue of the suit or action
is improper. Pursuant to Delaware Code Section 2708(a), the Parties agree that they are subject to the exclusive jurisdiction of the
courts of, or arbitration in, Wilmington, Delaware, and may be served with legal process within the State of Delaware or in any other
manner provided by law. In the event any Party institutes any legal proceeding (including arbitration) to enforce the provisions of this
Warrant, the court or arbitrator, as applicable, shall require the breaching Party (if any), as finally determined by a court of competent
jurisdiction or arbitrator, as applicable, to pay the non-breaching Party&rsquo;s costs and expenses (including such nonbreaching Party&rsquo;s
reasonable attorneys&rsquo; fees and expenses) associated with enforcing this Warrant and collecting any judgment related thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Holder and the Company acknowledge and agree that the rights of Holder under this Warrant are of a specialized and unique character and
that immediate and irreparable damage will result to Holder if the Company fails or refuses to perform his or its obligations under this
Warrant or otherwise breaches this Warrant and, notwithstanding an election by Holder to seek a remedy at law, Holder may, in addition
to the remedies at law described above, seek equitable relief, including without limitation temporary restraining orders, temporary and
permanent injunctions, and specific performance, and such equitable relief may be sought without the necessity of posting a bond or other
security. No claimed breach of contract or violation of law by Holder or any of its affiliates shall operate to extinguish the Company&rsquo;s
obligations under Section 10 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>ACCEPTANCE</U>. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions
contained herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>CERTAIN DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<U>Nasdaq</U>&rdquo; means The Nasdaq Stock Market (www.Nasdaq.com).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<U>Closing Sale Price</U>&rdquo; means, for any security as of any date, (i) the last closing trade price for such security on
the Principal Market, as reported by Nasdaq, or, if the Principal Market begins to operate on an extended hours basis and does not designate
the closing trade price, then the last trade price of such security prior to 4:00 p.m., New York time, as reported by Nasdaq, or (ii)
if the foregoing does not apply, the last trade price of such security in the over-the-counter market for such security as reported by
Nasdaq, or (iii) if no last trade price is reported for such security by Nasdaq, the average of the bid and ask prices of any market
makers for such security as reported by the OTC Markets or any other similar domestic or foreign exchange. If the Closing Sale Price
cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such
date shall be the fair market value as mutually determined by the Company and the Holder. All such determinations to be appropriately
adjusted for any share dividend, share split, share combination or other similar transaction during the applicable calculation period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<U>Common Share</U>&rdquo; means the Common Shares of the Company and any other class of securities into which such securities
may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<U>Common Share Equivalents</U>&rdquo; means any securities of the Company that would entitle the holder thereof to acquire at
any time Common Shares, including without limitation any debt, preferred shares, rights, options, warrants or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<U>Principal Market</U>&rdquo; means the primary national securities exchange or over the counter market on which the Common Shares
are then traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<U>Market Price</U>&rdquo; means the highest traded price of the Common Shares during the thirty (30) Trading Days prior to the
date of the respective Exercise Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<U>Trading Day</U>&rdquo; means (i) any day on which the Common Shares are listed or quoted and traded on its Principal Market,
(ii) if the Common Shares are not then listed or quoted and traded on any national securities exchange, then a day on which trading occurs
on any over-the-counter markets, or (iii) if trading does not occur on the over-the-counter markets, any Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signature
page follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Issuance Date set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PROPHASE LABS, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Ted Karkus</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chairman of the Board and Chief Executive Officer</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.25in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.25in; text-align: justify"></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
A</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXERCISE
NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
be executed by the registered holder to exercise this Common Share Purchase Warrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">The
Undersigned</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">holder hereby exercises the right to purchase
_________________ of the Common Shares (&ldquo;Warrant Shares&rdquo;) of <B>PROPHASE LABS, INC.</B>, a Delaware corporation (the &ldquo;Company&rdquo;),
evidenced by the attached copy of the Common Share Purchase Warrant (the &ldquo;Warrant&rdquo;). Capitalized terms used herein and not
otherwise defined shall have the respective meanings set forth in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Form
                                            of Exercise Price</U>. The Holder intends that payment of the Exercise Price shall be made
                                            as (check one):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            cash exercise with respect to _________________ Warrant Shares; or</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">by
                                            cashless exercise pursuant to the Warrant.</FONT></TD></TR>
                                                                                                                               </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Payment
                                            of Exercise Price</U>. If cash exercise is selected above, the holder shall pay the applicable
                                            Aggregate Exercise Price in the sum of $___________________ to the Company in accordance
                                            with the terms of the Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery
                                            of Warrant Shares</U>. The Company shall deliver to the holder __________________ Warrant
                                            Shares in accordance with the terms of the Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
__________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print Name of Registered Holder)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.25in; text-align: justify"></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
B</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
OF WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
be signed only upon authorized transfer of the Warrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">For
Value Received</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, the undersigned hereby sells, assigns,
and transfers unto ____________________ the right to purchase _______________ Common Shares of <B>PROPHASE LABS, INC.</B>, to which the
within Common Share Purchase Warrant relates and appoints ____________________, as attorney-in-fact, to transfer said right on the books
of ProPhase Labs, Inc. with full power of substitution and re-substitution in the premises. By accepting such transfer, the transferee
has agreed to be bound in all respects by the terms and conditions of the within Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
__________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 50%"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature) *</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(Address)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Social Security or Tax Identification No.)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.25in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
The signature on this Assignment of Warrant must correspond to the name as written upon the face of the Common Share Purchase Warrant
in every particular without alteration or enlargement or any change whatsoever. When signing on behalf of a corporation, partnership,
trust or other entity, please indicate your position(s) and title(s) with such entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXCERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
SHARE PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPHASE
LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Shares: 875,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
Date: July 22, 2025 (&ldquo;<B>Issuance Date</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
COMMON SHARE PURCHASE WARRANT (this &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received in connection with the issuance
of the senior secured convertible promissory note of even date in the principal amount of $625,000 (the &ldquo;<B>Note</B>&rdquo;)
by ProPhase Labs, Inc., a corporation organized under the laws of the state of Delaware (the &ldquo;<B>Company</B>&rdquo;), <B>REDACTED
</B>(including any permitted and registered assigns, each a &ldquo;<B>Holder</B>&rdquo;), is entitled, upon the terms and subject to
the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase
from the Company up to 875,000 shares of common stock, $0.0005 par value, (the &ldquo;Common Shares&rdquo;; and such Common Shares
issuable upon exercise of this Warrant, the &ldquo;<B>Warrant Shares</B>&rdquo;) (whereby such number may be adjusted from time to time
pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company
in connection with that certain Securities Purchase Agreement, dated as of the Issuance Date, by and between the Company and the original
Holder of this Warrant (the &ldquo;<B>Purchase Agreement</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used in this Warrant shall have the meanings set forth in the Purchase Agreement unless otherwise defined in the body of this Warrant
or in Section 12 below. For purposes of this Warrant, the term &ldquo;<B>Exercise Price</B>&rdquo; shall mean $0.50, subject to adjustment
as provided herein (including but not limited to cashless exercise), and the term &ldquo;<B>Exercise Period</B>&rdquo; shall mean the
period commencing on the Issuance Date and ending on 6:00 p.m. eastern standard time on the five-year anniversary thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>EXERCISE OF WARRANT</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Mechanics of Exercise</I>. Subject to the terms and conditions hereof, the rights represented by this Warrant may be exercised in
whole or in part at any time or times during the Exercise Period by delivery of a written notice, in the form attached hereto as <U>Exhibit
A</U> (the &ldquo;<B>Exercise Notice</B>&rdquo;), of the Holder&rsquo;s election to exercise this Warrant. The Holder shall not be required
to deliver the original Warrant in order to effect an exercise hereunder. Partial exercises of this Warrant resulting in purchases of
a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. On or before the third Trading
Day (the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;) following the date on which the Company shall have received the Exercise Notice,
and upon receipt by the Company of payment to the Company of an amount equal to the applicable Exercise Price multiplied by the number
of Warrant Shares as to which all or a portion of this Warrant is being exercised (the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;
and together with the Exercise Notice, the &ldquo;<B>Exercise Delivery Documents</B>&rdquo;) in cash or by wire transfer of immediately
available funds (or by cashless exercise, in which case there shall be no Aggregate Exercise Price provided), the Company shall (or direct
its transfer agent to) issue the number of Warrant Shares to which the Holder is entitled pursuant to such exercise (such number referred
to hereinafter as the &ldquo;<B>Exercised Amount</B>&rdquo; and such shares to be issued referred to hereinafter as the &ldquo;<B>Exercised
Warrant Shares</B>&rdquo;), registered in the Company&rsquo;s share register in the name of the Holder or its designee. At the option
of the Holder, such Exercised Warrant Shares shall be issued either (i) in DRS book entry form, (ii) directly into a brokerage account
by DWAC transfer (if eligible), or (iii) on one or more certificates dispatched by overnight courier to the address as specified in the
Exercise Notice. Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes to have become
the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery
of the certificates evidencing such Warrant Shares. If this Warrant is submitted in connection with any exercise and the number of Warrant
Shares represented by this Warrant submitted for exercise is greater than the Exercised Amount, then the Company shall as soon as practicable
and in no event later than three (3) Business Days after any exercise and at its own expense, issue a new Warrant (in accordance with
Section 6) representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under this
Warrant, less the Exercised Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at any time after the 6 month anniversary of the Issuance Date, the Market Price of one Common Share is greater than the Exercise Price
and the Warrant Shares are not registered under an effective non-stale registration statement of the Company, the Holder may elect to
receive Warrant Shares pursuant to a cashless exercise, in lieu of a cash exercise, equal to the value of this Warrant determined in
the manner described below (or of any portion thereof remaining unexercised) by surrender of this Warrant and a Notice of Exercise, in
which event the Company shall issue to Holder a number of Warrant Shares computed using the following formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X
= <U>Y (A-B)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 41.2pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Where</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">X
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                            number of Warrant Shares to be issued to Holder.</FONT></TD></TR>
                                                                                                                                         <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                                                                         <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of Warrant Shares that the Holder elects to purchase under this Warrant (at the date
                                            of such calculation).</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
      Market Price (at the date of such calculation).</FONT></TD></TR>
                                                                                  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
      Price (as adjusted to the date of such calculation).</FONT></TD></TR>
                                                                                  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 77.2pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 77.2pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company fails to cause its transfer agent to transmit to the Holder the respective Warrant Shares by the respective Warrant Share
Delivery Date (each, a &ldquo;<B>Delivery Failure</B>&rdquo;), then the Holder will have the right to rescind such exercise in Holder&rsquo;s
sole discretion, and such failure shall be deemed an event of default under the Note to the extent the Note remains outstanding and any
portion thereof unpaid, and this Warrant. In addition, and without in any way limiting the Holder&rsquo;s right to pursue other remedies,
including but not limited to, actual damages and/or equitable relief, or the foregoing remedies, the parties agree that if the Company
causes the Exercised Warrant Shares to not be delivered by the second (2nd) Trading Day following the Warrant Share Delivery Date, Company
shall pay to the Holder the greater of (i) for each day after the Share Delivery Date and during such Delivery Failure an amount equal
to the greater of (x) $1,000 per day in cash, for each day beyond the Warrant Share Delivery Date that Company fails to deliver such
Exercised Warrant Shares, or (y) 2% of the product of (A) the sum of the number of shares of Common Stock not issued to the Holder on
or prior to the Share Delivery Date and to which the Holder is entitled (the &ldquo;<B>Undelivered Shares</B>&rdquo;), multiplied by
(B) any trading price of the Common Stock selected by the Holder in writing as in effect at any time during the period beginning on the
applicable Exercise Date and ending on the applicable Share Delivery Date (the &ldquo;<B>Undelivered Shares Value</B>&rdquo;), or (ii)
the excess of the product of (A) the Undelivered Shares, multiplied by (B) the Undelivered Shares Value, over the aggregate value of
the Common Stock actually delivered to the Holder based on the lowest trading price of the Common Stock during the five (5) trading days
following the date that such Common Shares are actually issued to the Holder. Such amount shall either be paid in cash to Holder by the
fifth day of the month following the month in which it has accrued or, at the option of the Holder (by written notice to Company by the
first day of the month following the month in which it has accrued), as follows: (1) in the event that the Note remains outstanding and
any portion thereof unpaid, such amount shall be added to the principal amount of the Note, in which event interest shall accrue thereon
in accordance with the terms of the Note and such additional principal amount shall be convertible into Common Shares in accordance with
the terms of the Note; (2) in the event that the Note is no longer outstanding and no portion thereof remains unpaid, such amount shall
be payable in Common Shares based on the number of shares that would have been due under (1) above, had the Note been outstanding, and
pursuant to a conversion of such amount added to the principal amount of the Note. Company agrees that the right to exercise is a valuable
right to the Holder, and as such, Company will not take any actions to hamper, delay or prevent any Holder exercise of this Warrant.
The damages resulting from a failure, attempt to frustrate, interference with such exercise right are difficult if not impossible to
qualify. Accordingly, the parties acknowledge that the liquidated damages provision contained in this section are justified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>No Fractional Shares</I>. No fractional shares shall be issued upon the exercise of this Warrant as a consequence of any adjustment
pursuant hereto. All Warrant Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining
whether the exercise would result in the issuance of any fractional share. If, after aggregation, the exercise would result in the issuance
of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction
a sum in cash equal to the product resulting from multiplying the then-current fair market value of a Warrant Share by such fraction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Holder&rsquo;s Exercise Limitations</I>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, to the extent that after giving effect to issuance of Warrant Shares upon exercise as
set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates), would beneficially own in excess of the Beneficial Ownership
Limitation, as defined below. For purposes of the foregoing sentence, the number of Common Shares beneficially owned by the Holder and
its Affiliates shall include the number of Common Shares issuable upon exercise of this Warrant with respect to which such determination
is being made, but shall exclude the number of Common Shares which would be issuable upon (i) exercise of the remaining, non-exercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised
or non-converted portion of any other securities of the Company (including without limitation any other Common Share Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates. Except as set forth in the preceding sentence, for purposes of this paragraph (d), beneficial ownership shall be calculated
in accordance with Section 13(d) of the Exchange Act, it being acknowledged by the Holder that the Company is not representing to the
Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules
required to be filed in accordance therewith. To the extent that the limitation contained in this paragraph applies, the determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any affiliates) and of which
portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the
Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership
Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this paragraph, in determining the number of outstanding Common Shares, a Holder may rely on the number of outstanding Common
Shares as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
a more recent public announcement by the Company or (C) a more recent written notice by the Company or its transfer agent setting forth
the number of Common Shares outstanding. Upon the request of a Holder, the Company shall within two Trading Days confirm to the Holder
the number of Common Shares then outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect
to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its affiliates since the date as
of which such number of outstanding Common Shares was reported. The &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo; shall initially
be 4.99% of the number of Common Shares outstanding immediately after giving effect to the issuance of Common Shares issuable upon exercise
of this Warrant. The Holder, upon notice to the Company, may increase this Beneficial Ownership Limitation, provided, however, that in
no event shall the Beneficial Ownership Limitation exceed 9.99% of the number of shares of the Common Stock outstanding immediately after
giving effect to such exercise.. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such
notice is delivered to the Company. The Beneficial Ownership Limitation provisions of this Section shall continue to apply unless and
until modified as set forth herein and shall apply to any successor holder of this Warrant. Notwithstanding the foregoing, in the event
the Holder elects to increase the Beneficial Ownership Limitation above 4.99%, the Holder covenants and agrees that, without the prior
written consent of the Company, it shall not, directly or indirectly, act in concert with, form a &ldquo;group&rdquo; (as defined in
Section 13(d)(3) of the Exchange Act), or otherwise coordinate or collaborate with any other person or entity that is a filer or required
to be a filer under Schedule 13D with respect to the Common Stock of the Company, in any manner that is intended to or would reasonably
be expected to oppose, challenge, or act in a manner adverse to the Company&rsquo;s management or Board of Directors. The Beneficial
Ownership Limitation provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity
with the terms of this Section to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to
such limitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>ADJUSTMENTS</U>. The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Distribution of Assets</I>. If the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire
its assets) to holders of Common Shares, by way of return of capital or otherwise (including without limitation any distribution of cash,
shares or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement or other similar
transaction) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after the issuance of this Warrant, then, in each such case:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any Exercise Price in effect immediately prior to the close of business on the record date fixed for the determination of holders of
Common Shares entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date, to a
price determined by multiplying such Exercise Price by a fraction (i) the numerator of which shall be the Closing Sale Price of the Common
Shares on the Trading Day immediately preceding such record date minus the value of the Distribution (as determined in good faith by
the Company&rsquo;s Board of Directors) applicable to one Common Share, and (ii) the denominator of which shall be the Closing Sale Price
of the Common Shares on the Trading Day immediately preceding such record date; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the number of Warrant Shares shall be increased to a number of shares equal to the number of Common Shares obtainable immediately prior
to the close of business on the record date fixed for the determination of holders of Common Shares entitled to receive the Distribution
multiplied by the reciprocal of the fraction set forth in the immediately preceding clause (i); provided, however, that in the event
that the Distribution is of Common Shares of a company (other than the Company) whose common stock is traded on a national securities
exchange or a national automated quotation system (&ldquo;Other Shares of Common Stock&rdquo;), then the Holder may elect to receive
a warrant to purchase Other Shares of Common Stock in lieu of an increase in the number of Warrant Shares, the terms of which shall be
identical to those of this Warrant, except that such warrant shall be exercisable into the number of Other Shares of Common Stock that
would have been payable to the Holder pursuant to the Distribution had the Holder exercised this Warrant immediately prior to such record
date and with an aggregate exercise price equal to the product of the amount by which the exercise price of this Warrant was decreased
with respect to the Distribution pursuant to the terms of the immediately preceding clause (i) and the number of Warrant Shares calculated
in accordance with the first part of this clause (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Proportional Adjustments of Outstanding Common Shares and Common Share Dividends</U>. If the Company shall at any time or from time
to time after the date hereof, issue additional Common Shares to all of its current shareholders on a pro rata basis or pay a share dividend
in Common Shares, then the Exercise Price and the number of Warrant Shares shall be proportionately adjusted. Any adjustments under this
Section 2(b) shall be effective at the close of business on the date the share split becomes effective or the date of payment of the
share dividend, as applicable. For the avoidance of doubt, this adjustment shall not apply when shares of outstanding Common Share are
merged proportionally across all shareholders to form a smaller number of outstanding shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>FUNDAMENTAL TRANSACTIONS</U>. If, at any time while this Warrant is outstanding, (i) the Company effects any merger of the Company
with or into another entity and the Company is not the surviving entity (such surviving entity, the &ldquo;<B>Successor Entity</B>&rdquo;),
(ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii) any tender
offer or exchange offer (whether by the Company or by another individual or entity, and approved by the Company) is completed pursuant
to which holders of Common Shares are permitted to tender or exchange their Common Shares for other securities, cash or property and
the holders of at least 50% of the Common Shares accept such offer, or (iv) the Company effects any reclassification of the Common Shares
or any compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities,
cash or property (other than as a result of a subdivision or combination of Common Shares) (in any such case, a &ldquo;<B>Fundamental
Transaction</B>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive the number of
Common Shares of the Successor Entity or of the Company and any additional consideration (the &ldquo;<B>Alternate Consideration</B>&rdquo;)
receivable upon or as a result of such reorganization, reclassification, merger, consolidation or disposition of assets by a holder of
the number of Common Shares for which this Warrant is exercisable immediately prior to such event (disregarding any limitation on exercise
contained herein solely for the purpose of such determination). For purposes of any such exercise, the determination of the Exercise
Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable
in respect of one Common Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders
of Common Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder
shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction. To the extent necessary to effectuate the foregoing provisions, any Successor Entity in such Fundamental Transaction shall
issue to the Holder a new warrant consistent with the foregoing provisions and evidencing the Holder&rsquo;s right to exercise such warrant
into Alternate Consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>NON-CIRCUMVENTION</U>. The Company covenants and agrees that it will not, by amendment of its certificate of formation, certificate
of incorporation, operating agreement, or bylaws, or through any reorganization, transfer of assets, consolidation, merger, scheme of
arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions of this Warrant and take all action
as may be required to protect the rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase
the par value of any Common Shares receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take
all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable
Common Shares upon the exercise of this Warrant, and (iii) shall, for so long as this Warrant is outstanding, have authorized and reserved,
free from preemptive rights, a sufficient number of Common Shares to provide for the exercise of the rights represented by this Warrant
(without regard to any limitations on exercise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>WARRANT HOLDER NOT DEEMED A SHAREHOLDER</U>. Except as otherwise specifically provided herein, this Warrant, in and of itself, shall
not entitle the Holder to any voting rights or other rights as a shareholder of the Company. In addition, nothing contained in this Warrant
shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise)
or as a shareholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>REISSUANCE</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Lost, Stolen or Mutilated Warrant</I>. If this Warrant is lost, stolen, mutilated or destroyed, the Company will, on such terms as
to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof),
issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Issuance of New Warrants</I>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such
new Warrant shall be of like tenor with this Warrant, and shall have an issuance date, as indicated on the face of such new Warrant which
is the same as the Issuance Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>TRANSFER</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Notice of Transfer</I>. The Holder agrees that, if practicable, but without any obligation to do so, it will give written notice to
the Company of its intent to transfer this Warrant or any Warrant Shares, describing briefly the manner of any proposed transfer. Promptly
upon receiving such written notice, the Company shall present copies thereof to the Company&rsquo;s counsel. If the proposed transfer
may be effected without registration or qualification (under any federal or state securities laws), the Company, as promptly as practicable,
shall notify the Holder thereof, whereupon the Holder shall be entitled to transfer this Warrant or to dispose of Warrant Shares received
upon the previous exercise of this Warrant, all in accordance with the terms of the notice delivered by the Holder to the Company; provided,
however, that an appropriate legend may be endorsed on this Warrant or the certificates for such Warrant Shares respecting restrictions
upon transfer thereof necessary or advisable in the opinion of counsel and satisfactory to the Company to prevent further transfers which
would be in violation of Section 5 of the Securities Act and applicable state securities laws; and provided further that the prospective
transferee or purchaser shall execute the Assignment of Warrant attached hereto as <U>Exhibit B</U> and such other documents and make
such representations, warranties, and agreements as may be required solely to comply with the exemptions relied upon by the Company for
the transfer or disposition of the Warrant or Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If the proposed transfer or disposition of this Warrant or such Warrant Shares described in the written notice given pursuant to this
Section 7 may not be effected without registration or qualification of this Warrant or such Warrant Shares, the Holder will limit its
activities in respect to such transfer or disposition as are permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Any transferee of all or a portion of this Warrant shall succeed to the rights and benefits of the initial Holder of this Warrant under
Section 5.6 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>NOTICES</U>. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given
in accordance with the notice provisions contained in the Purchase Agreement. The Company shall provide the Holder with prompt written
notice (i) immediately upon any adjustment of the Exercise Price, setting forth in reasonable detail, the calculation of such adjustment
and (ii) at least twenty (20) days prior to the date on which the Company closes its books or takes a record (A) with respect to any
dividend or distribution upon the Common Shares, (B) with respect to any grants, issuances or sales of any shares or other securities
directly or indirectly convertible into or exercisable or exchangeable for Common Shares or other property, pro rata to the holders of
Common Shares or (C) for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided
in each case that such information shall be made known to the public prior to or in conjunction with such notice being provided to the
Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>AMENDMENT AND WAIVER</U>. The terms of this Warrant may be amended or waived (either generally or in a particular instance and either
retroactively or prospectively) only with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>GOVERNING LAW &amp; AGREEMENT TO CONFIDENTIAL ARBITRATION</U>. This Warrant shall be governed and construed in accordance with the
laws of the State of Delaware without regard to principles of conflicts of law. Any dispute or controversy between the Parties relating
to or arising out of this Warrant or any amendment or modification hereof shall be determined by confidential arbitration in Wilmington,
Delaware administered by the American Arbitration Association under its Commercial Arbitration Rules, other than claims for injunctive
relief which shall be adjudicated only by the state and/or federal courts residing in Wilmington, Delaware. In any such arbitration,
the Parties shall be permitted to engage in any type of discovery permitted by the Federal Rules of Civil Procedure, including, without
limitation, the taking of depositions and the service of document requests, non-party subpoenas and interrogatories. The arbitration
award shall be final and binding upon the Parties and judgment may be entered thereon by any court of competent jurisdiction. The service
of any notice, process, motion or other document in connection with any arbitration under this Warrant or the enforcement of any arbitration
award hereunder may be effectuated either by personal service upon a Party or by certified mail duly addressed to him or it or to his
or its executors, administrators, personal representatives, next of kin, successors or assigns, at the last known address or addresses
of such Party or Parties. Notwithstanding the foregoing, the request by any Party for specific performance and temporary, preliminary
or permanent injunctive relief, whether prohibitive or mandatory, shall not be subject to arbitration and shall be adjudicated only by
the state and/or federal courts residing in Wilmington, Delaware. Each Party irrevocably submits to the exclusive jurisdiction of such
courts for such purposes, and waives and agrees not to assert in any such proceeding a claim that he or it is not personally subject
to the courts referred to above, that the suit or action was brought in an inconvenient forum or that the venue of the suit or action
is improper. Pursuant to Delaware Code Section 2708(a), the Parties agree that they are subject to the exclusive jurisdiction of the
courts of, or arbitration in, Wilmington, Delaware, and may be served with legal process within the State of Delaware or in any other
manner provided by law. In the event any Party institutes any legal proceeding (including arbitration) to enforce the provisions of this
Warrant, the court or arbitrator, as applicable, shall require the breaching Party (if any), as finally determined by a court of competent
jurisdiction or arbitrator, as applicable, to pay the non-breaching Party&rsquo;s costs and expenses (including such nonbreaching Party&rsquo;s
reasonable attorneys&rsquo; fees and expenses) associated with enforcing this Warrant and collecting any judgment related thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Holder and the Company acknowledge and agree that the rights of Holder under this Warrant are of a specialized and unique character and
that immediate and irreparable damage will result to Holder if the Company fails or refuses to perform his or its obligations under this
Warrant or otherwise breaches this Warrant and, notwithstanding an election by Holder to seek a remedy at law, Holder may, in addition
to the remedies at law described above, seek equitable relief, including without limitation temporary restraining orders, temporary and
permanent injunctions, and specific performance, and such equitable relief may be sought without the necessity of posting a bond or other
security. No claimed breach of contract or violation of law by Holder or any of its affiliates shall operate to extinguish the Company&rsquo;s
obligations under Section 10 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>ACCEPTANCE</U>. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions
contained herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>CERTAIN DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<U>Nasdaq</U>&rdquo; means The Nasdaq Stock Market (www.Nasdaq.com).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<U>Closing Sale Price</U>&rdquo; means, for any security as of any date, (i) the last closing trade price for such security on
the Principal Market, as reported by Nasdaq, or, if the Principal Market begins to operate on an extended hours basis and does not designate
the closing trade price, then the last trade price of such security prior to 4:00 p.m., New York time, as reported by Nasdaq, or (ii)
if the foregoing does not apply, the last trade price of such security in the over-the-counter market for such security as reported by
Nasdaq, or (iii) if no last trade price is reported for such security by Nasdaq, the average of the bid and ask prices of any market
makers for such security as reported by the OTC Markets or any other similar domestic or foreign exchange. If the Closing Sale Price
cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such
date shall be the fair market value as mutually determined by the Company and the Holder. All such determinations to be appropriately
adjusted for any share dividend, share split, share combination or other similar transaction during the applicable calculation period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<U>Common Share</U>&rdquo; means the Common Shares of the Company and any other class of securities into which such securities
may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<U>Common Share Equivalents</U>&rdquo; means any securities of the Company that would entitle the holder thereof to acquire at
any time Common Shares, including without limitation any debt, preferred shares, rights, options, warrants or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<U>Principal Market</U>&rdquo; means the primary national securities exchange or over the counter market on which the Common Shares
are then traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<U>Market Price</U>&rdquo; means the highest traded price of the Common Shares during the thirty (30) Trading Days prior to the
date of the respective Exercise Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<U>Trading Day</U>&rdquo; means (i) any day on which the Common Shares are listed or quoted and traded on its Principal Market,
(ii) if the Common Shares are not then listed or quoted and traded on any national securities exchange, then a day on which trading occurs
on any over-the-counter markets, or (iii) if trading does not occur on the over-the-counter markets, any Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>signature
page follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Issuance Date set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PROPHASE LABS, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Ted Karkus</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chairman of the Board and Chief Executive Officer</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.25in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.25in; text-align: justify"></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
A</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXERCISE
NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
be executed by the registered holder to exercise this Common Share Purchase Warrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif">The
Undersigned</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">holder hereby exercises the right to purchase
_________________ of the Common Shares (&ldquo;Warrant Shares&rdquo;) of <B>PROPHASE LABS, INC.</B>, a Delaware corporation (the &ldquo;Company&rdquo;),
evidenced by the attached copy of the Common Share Purchase Warrant (the &ldquo;Warrant&rdquo;). Capitalized terms used herein and not
otherwise defined shall have the respective meanings set forth in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Form
                                            of Exercise Price</U>. The Holder intends that payment of the Exercise Price shall be made
                                            as (check one):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            cash exercise with respect to _________________ Warrant Shares; or</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">by
                                            cashless exercise pursuant to the Warrant.</FONT></TD></TR>
                                                                                                                               </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Payment
                                            of Exercise Price</U>. If cash exercise is selected above, the holder shall pay the applicable
                                            Aggregate Exercise Price in the sum of $___________________ to the Company in accordance
                                            with the terms of the Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery
                                            of Warrant Shares</U>. The Company shall deliver to the holder __________________ Warrant
                                            Shares in accordance with the terms of the Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
__________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print Name of Registered Holder)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.25in; text-align: justify"></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
B</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
OF WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
be signed only upon authorized transfer of the Warrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif">For
Value Received</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, the undersigned hereby sells, assigns,
and transfers unto ____________________ the right to purchase _______________ Common Shares of <B>PROPHASE LABS, INC.</B>, to which the
within Common Share Purchase Warrant relates and appoints ____________________, as attorney-in-fact, to transfer said right on the books
of ProPhase Labs, Inc. with full power of substitution and re-substitution in the premises. By accepting such transfer, the transferee
has agreed to be bound in all respects by the terms and conditions of the within Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
__________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 50%"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature) *</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(Address)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Social Security or Tax Identification No.)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.25in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
The signature on this Assignment of Warrant must correspond to the name as written upon the face of the Common Share Purchase Warrant
in every particular without alteration or enlargement or any change whatsoever. When signing on behalf of a corporation, partnership,
trust or other entity, please indicate your position(s) and title(s) with such entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex10-4.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Registration
Rights Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
REGISTRATION RIGHTS AGREEMENT (this &ldquo;<B>Agreement</B>&rdquo;), dated as of July 22, 2025, is by and among ProPhase Labs, Inc.,
a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and the undersigned purchasers of Notes and Warrants (each, a &ldquo;<B>Purchaser</B>&rdquo;;
and collectively, the &ldquo;<B>Purchasers</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RECITALS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
In connection with the Securities Purchase Agreement, dated as of the date hereof by and between parties hereto (the &ldquo;<B>Purchase
Agreement</B>&rdquo;), the Company has agreed, upon the terms and subject to the conditions of the Purchase Agreement, to issue and sell
to each Purchaser Notes and Warrants (as such terms are defined in the Purchase Agreement) which will be convertible into Conversion
Shares and exercisable for Warrant Shares (as such terms are defined in the Purchase Agreement) in accordance with the terms thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
To induce the Purchasers to consummate the transactions contemplated by the Purchase Agreement, the Company has agreed to provide certain
registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor
statute (collectively, the &ldquo;<B>Securities Act</B>&rdquo;), and applicable state securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AGREEMENT
</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW</B>,
<B>THEREFORE</B>, in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and each of the Purchasers hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Definitions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement. As used in
this Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New
York are authorized or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not
be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential
employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental
authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York
generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<B>Closing Date</B>&rdquo; shall have the meaning set forth in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<B>Effective Date</B>&rdquo; means the date that the applicable Registration Statement has been declared effective by the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<B>Effectiveness Deadline</B>&rdquo; means (i) with respect to the initial Registration Statement required to be filed pursuant
to Section 2(a), the 30<SUP>th</SUP> calendar day (or, if such Registration Statement is subject to a full review by the SEC, the 60<SUP>th</SUP>
calendar day) after the Stockholder Approval (as defined in the Purchase Agreement) is obtained, or November 18, 2025, whichever is earlier;
and (ii) with respect to any additional Registration Statements that may be required to be filed by the Company pursuant to this Agreement,
the earlier of the (A) 60<SUP>h</SUP> calendar day (or, if such Registration Statement is subject to a full review by the SEC, 90<SUP>th</SUP>
calendar day) after the Closing Date and (B) 2nd Business Day after the date the Company is notified (orally or in writing, whichever
is earlier) by the SEC that such Registration Statement will not be reviewed or will not be subject to further review.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<B>Filing Deadline</B>&rdquo; means (i) with respect to the initial Registration Statement required to be filed pursuant to Section
2(a), immediately after the Stockholder Approval (as defined in the Purchase Agreement), which shall be no later than October 18, 2025,
and (ii) with respect to any additional Registration Statements that may be required to be filed by the Company pursuant to this Agreement,
the date on which the Company was required to file such additional Registration Statement pursuant to the terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<B>Investor</B>&rdquo; means a Purchaser or any transferee or assignee of any Registrable Securities or Notes or Warrants, as
applicable, to whom a Purchaser assigns its rights under this Agreement who becomes bound by the provisions of this Agreement in accordance
with Section 9 and any transferee or assignee thereof to whom a transferee or assignee of any Registrable Securities or Notes or Warrants,
as applicable, assigns its rights under this Agreement who becomes bound by the provisions of this Agreement in accordance with Section
9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<B>register</B>,&rdquo; &ldquo;<B>registered</B>,&rdquo; and &ldquo;<B>registration</B>&rdquo; refer to a registration effected
by preparing and filing one or more Registration Statements in compliance with the Securities Act and pursuant to Rule 415 and the declaration
of effectiveness of such Registration Statement(s) by the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<B>Registrable Securities</B>&rdquo; means (i) the Conversion Shares, (ii) the Warrant Shares, and (iii) any capital stock of
the Company issued or issuable with respect to the Conversion Shares or Warrant Shares, including, without limitation, (1) as a result
of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise and (2) shares of capital stock of the Company
into which the shares of Common Stock are converted or exchanged and shares of capital stock of a Successor Entity (as defined in the
Notes) into which the shares of Common Stock are converted or exchanged, in each case, without regard to any limitations on conversion
of the Notes or exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&ldquo;<B>Registration Statement</B>&rdquo; means a registration statement or registration statements of the Company filed under the
Securities Act covering Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<B>Required Holders</B>&rdquo; shall mean, at any time, the holder(s) of a majority in Original Principal Amount of Notes then
outstanding including (if it shall then hold any Notes) the Lead Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&ldquo;<B>Required Registration Amount</B>&rdquo; means, as of any time of determination, the sum of (i) the maximum number of Conversion
Shares issuable upon conversion of the maximum Original Principal Amount of Notes issuable pursuant to the Purchase Agreement, and (ii)
the maximum number of Warrant Shares issuable upon exercise of the maximum number of Warrants issuable pursuant to the Purchase Agreement,
assuming for purposes of the foregoing clauses (i) and (ii) that any such conversion or exercise shall not take into account any limitations
on the conversion of the Notes set forth in the Notes or on the exercise of Warrants set forth in the Warrants).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
&ldquo;<B>Rule 144</B>&rdquo; means Rule 144 promulgated by the SEC under the Securities Act, as such rule may be amended from time to
time, or any other similar or successor rule or regulation of the SEC that may at any time permit the Investors to sell securities of
the Company to the public without registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&ldquo;<B>Rule 415</B>&rdquo; means Rule 415 promulgated by the SEC under the Securities Act, as such rule may be amended from time to
time, or any other similar or successor rule or regulation of the SEC providing for offering securities on a continuous or delayed basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
&ldquo;<B>SEC</B>&rdquo; means the United States Securities and Exchange Commission or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Mandatory Registration</U>. The Company shall prepare and, as soon as practicable, but in no event later than the Filing Deadline,
file with the SEC an initial Registration Statement on Form S-1 covering the resale of all of the Registrable Securities, <I>provided</I>
that such initial Registration Statement shall register for resale at least the number of shares of Common Stock equal to the Required
Registration Amount as of the date such Registration Statement is initially filed with the SEC. Such initial Registration Statement,
and each other Registration Statement required to be filed pursuant to the terms of this Agreement, shall contain (except if otherwise
directed by the Required Holders) the &ldquo;<B>Selling Stockholders</B>&rdquo; and &ldquo;<B>Plan of Distribution</B>&rdquo; sections
in substantially the form attached hereto as <B><U>Exhibit B</U></B>. The Company shall use its best efforts to have such initial Registration
Statement, and each other Registration Statement required to be filed pursuant to the terms of this Agreement, declared effective by
the SEC as soon as practicable, but in no event later than the applicable Effectiveness Deadline for such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Intentionally Omitted. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Ineligibility to Use Form S-3</U>. The Company shall undertake to register the resale of the Registrable Securities on Form S-3 as
soon as such form is available to the Company, <I>provided</I> that the Company shall maintain the effectiveness of all Registration
Statements then in effect until such time as a Registration Statement on Form S-3 covering the resale of all the Registrable Securities
has been declared effective by the SEC and the prospectus contained therein is available for use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Sufficient Number of Shares Registered</U>. In the event the number of shares available under any Registration Statement is insufficient
to cover all of the Registrable Securities required to be covered by such Registration Statement or an Investor&rsquo;s allocated portion
of the Registrable Securities pursuant to Section 2(g), the Company shall amend such Registration Statement (if permissible), or file
with the SEC a new Registration Statement (on the short form available therefor, if applicable), or both, so as to cover at least the
Required Registration Amount as of the Trading Day immediately preceding the date of the filing of such amendment or new Registration
Statement, in each case, as soon as practicable, but in any event not later than fifteen (15) days after the necessity therefor arises
(but taking account of any Staff position with respect to the date on which the Staff will permit such amendment to the Registration
Statement and/or such new Registration Statement (as the case may be) to be filed with the SEC). The Company shall use its best efforts
to cause such amendment to such Registration Statement and/or such new Registration Statement (as the case may be) to become effective
as soon as practicable following the filing thereof with the SEC, but in no event later than the applicable Effectiveness Deadline for
such Registration Statement. For purposes of the foregoing provision, the number of shares available under a Registration Statement shall
be deemed &ldquo;insufficient to cover all of the Registrable Securities&rdquo; if at any time the number of shares of Common Stock available
for resale under the applicable Registration Statement is less than the product determined by multiplying (i) the Required Registration
Amount as of such time by (ii) 0.90. The calculation set forth in the foregoing sentence shall be made without regard to any limitations
on conversion, amortization and/or redemption of the Notes or Warrants (and such calculation shall assume (A) that the Notes are then
convertible in full into shares of Common Stock at the then prevailing Conversion Price (as defined in the Notes) and that the Warrants
are then exercisable in full in to shares of Common Stock at the Exercise Price (as defined in the Warrants), (B) the initial outstanding
Notes and Warrants remain outstanding through the Termination Date (as defined in the Warrants).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Effect of Failure to File and Obtain and Maintain Effectiveness of any Registration Statement</U>. If (i) a Registration Statement
covering the resale of all of the Registrable Securities required to be covered thereby (disregarding any reduction pursuant to Section
2(f)) and required to be filed by the Company pursuant to this Agreement is (A) not filed with the SEC on or before the Filing Deadline
for such Registration Statement (a &ldquo;<B>Filing Failure</B>&rdquo;) (it being understood that if the Company files a Registration
Statement without affording each Investor the opportunity to review and comment on the same as required by Section 3(c) hereof, the Company
shall be deemed to not have satisfied this clause (i)(A) and such event shall be deemed to be a Filing Failure or (B) not declared effective
by the SEC on or before the Effectiveness Deadline for such Registration Statement (an &ldquo;<B>Effectiveness Failure</B>&rdquo;) (it
being understood that if on the Business Day immediately following the Effective Date for such Registration Statement the Company shall
not have filed a &ldquo;final&rdquo; prospectus for such Registration Statement with the SEC under Rule 424(b) in accordance with Section
3(b) (whether or not such a prospectus is technically required by such rule), the Company shall be deemed to not have satisfied this
clause (i)(B) and such event shall be deemed to be an Effectiveness Failure), (ii) other than during an Allowable Grace Period (as defined
below), on any day after the Effective Date of a Registration Statement sales of all of the Registrable Securities required to be included
on such Registration Statement (disregarding any reduction pursuant to Section 2(f)) cannot be made pursuant to such Registration Statement
(including, without limitation, because of a failure to keep such Registration Statement effective, a failure to disclose such information
as is necessary for sales to be made pursuant to such Registration Statement, a suspension or delisting of (or a failure to timely list)
the Common Stock on the Principal Market (as defined in the Purchase Agreement) or any other limitations imposed by the Principal Market,
or a failure to register a sufficient number of shares of Common Stock or by reason of a stop order) or the prospectus contained therein
is not available for use for any reason (a &ldquo;<B>Maintenance Failure</B>&rdquo;), or (iii) if a Registration Statement is not effective
for any reason or the prospectus contained therein is not available for use for any reason, and either (x) the Company fails for any
reason to satisfy the requirements of Rule 144(c)(1), including, without limitation, the failure to satisfy the current public information
requirement under Rule 144(c) or (y) the Company has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in
the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<B>Current Public Information Failure</B>&rdquo;)
as a result of which any of the Investors are unable to sell Registrable Securities without restriction under Rule 144 (including, without
limitation, volume restrictions), then, as partial relief for the damages to any holder by reason of any such delay in, or reduction
of, its ability to sell the Underlying Shares (which remedy shall not be exclusive of any other remedies available at law or in equity,
including, without limitation, specific performance), the Company shall pay to each holder of Registrable Securities relating to such
Registration Statement an amount in cash equal to two percent (2%) of such Investor&rsquo;s Original Principal Amount of such Investor&rsquo;s
Note on the Closing Date on the date of such Filing Failure, Effectiveness Failure, Maintenance Failure or Current Public Information
Failure, as applicable, and (2) on every thirty (30) day anniversary of (I) a Filing Failure until such Filing Failure is cured; (II)
an Effectiveness Failure until such Effectiveness Failure is cured; (III) a Maintenance Failure until such Maintenance Failure is cured;
and (IV) a Current Public Information Failure until the earlier of (i) the date such Current Public Information Failure is cured and
(ii) such time that such public information is no longer required pursuant to Rule 144 (in each case, prorated for periods totaling less
than thirty (30) days). In the case of an Effectiveness Failure, the initial such 2% payment shall be for each 30-day period (and prorated
for each partial 30-day period) from the Stockholder Approval Deadline (i.e., September 18, 2025) until such Effectiveness Failure shall
be cured. The payments to which a holder of Registrable Securities shall be entitled pursuant to this Section 2(e) are referred to herein
as &ldquo;<B>Registration Delay Payments</B>.&rdquo; Following the initial Registration Delay Payment for any particular event or failure
(which shall be paid on the date of such event or failure, as set forth above), without limiting the foregoing, if an event or failure
giving rise to the Registration Delay Payments is cured prior to any thirty (30) day anniversary of such event or failure, then such
Registration Delay Payment shall be made on the third (3rd) Business Day after such cure. In the event the Company fails to make Registration
Delay Payments in a timely manner in accordance with the foregoing, such Registration Delay Payments shall bear interest at the rate
of two percent (2%) per month (prorated for partial months) until paid in full. Notwithstanding the foregoing, no Registration Delay
Payments shall be owed to an Investor (other than with respect to a Maintenance Failure resulting from a suspension or delisting of (or
a failure to timely list) the Common Stock on the Principal Market) with respect to any period during which all of such Investor&rsquo;s
Registrable Securities may be sold by such Investor without restriction under Rule 144 (including, without limitation, volume restrictions)
and without the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Offering</U>. Notwithstanding anything to the contrary contained in this Agreement, but subject to the payment of the Registration
Delay Payments pursuant to Section 2(e), in the event the staff of the SEC (the &ldquo;<B>Staff</B>&rdquo;) or the SEC seeks to characterize
any offering pursuant to a Registration Statement filed pursuant to this Agreement as constituting an offering of securities by, or on
behalf of, the Company, or in any other manner, such that the Staff or the SEC do not permit such Registration Statement to become effective
and used for resales in a manner that does not constitute such an offering and that permits the continuous resale at the market by the
Investors participating therein (or as otherwise may be acceptable to each Investor) without being named therein as an &ldquo;underwriter,&rdquo;
then the Company shall reduce the number of shares to be included in such Registration Statement by all Investors until such time as
the Staff and the SEC shall so permit such Registration Statement to become effective as aforesaid. In making such reduction, the Company
shall reduce the number of shares to be included by all Investors on a pro rata basis (based upon the number of Registrable Securities
otherwise required to be included for each Investor) unless the inclusion of shares by a particular Investor or a particular set of Investors
are resulting in the Staff or the SEC&rsquo;s &ldquo;by or on behalf of the Company&rdquo; offering position, in which event the shares
held by such Investor or set of Investors shall be the only shares subject to reduction (and if by a set of Investors on a pro rata basis
by such Investors or on such other basis as would result in the exclusion of the least number of shares by all such Investors); provided,
that, with respect to such pro rata portion allocated to any Investor, such Investor may elect the allocation of such pro rata portion
among the Registrable Securities of such Investor. In addition, in the event that the Staff or the SEC requires any Investor seeking
to sell securities under a Registration Statement filed pursuant to this Agreement to be specifically identified as an &ldquo;underwriter&rdquo;
in order to permit such Registration Statement to become effective, and such Investor does not consent to being so named as an underwriter
in such Registration Statement, then, in each such case, the Company shall reduce the total number of Registrable Securities to be registered
on behalf of such Investor, until such time as the Staff or the SEC does not require such identification or until such Investor accepts
such identification and the manner thereof. Any reduction pursuant to this paragraph will first reduce all Registrable Securities other
than those issued pursuant to the Purchase Agreement. In the event of any reduction in Registrable Securities pursuant to this paragraph,
an affected Investor shall have the right to require, upon delivery of a written request to the Company signed by such Investor, the
Company to file a registration statement within twenty (20) days of such request (subject to any restrictions imposed by Rule 415 or
required by the Staff or the SEC) for resale by such Investor in a manner acceptable to such Investor, and the Company shall following
such request cause to be and keep effective such registration statement in the same manner as otherwise contemplated in this Agreement
for registration statements hereunder, in each case until such time as: (i) all Registrable Securities held by such Investor have been
registered and sold pursuant to an effective Registration Statement in a manner acceptable to such Investor or (ii) all Registrable Securities
may be resold by such Investor without restriction (including, without limitation, volume limitations) pursuant to Rule 144 (taking account
of any Staff position with respect to &ldquo;affiliate&rdquo; status) and without the need for current public information required by
Rule 144(c)(1) (or Rule 144(i)(2), if applicable) or (iii) such Investor agrees to be named as an underwriter in any such Registration
Statement in a manner acceptable to such Investor as to all Registrable Securities held by such Investor and that have not theretofore
been included in a Registration Statement under this Agreement (it being understood that the special demand right under this sentence
may be exercised by an Investor multiple times and with respect to limited amounts of Registrable Securities in order to permit the resale
thereof by such Investor as contemplated above).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Piggyback Registrations</U>. Without limiting any obligation of the Company hereunder or under the Purchase Agreement, if there is
not an effective Registration Statement covering all of the Registrable Securities or the prospectus contained therein is not available
for use and the Company shall determine to prepare and file with the SEC a registration statement or offering statement relating to an
offering for its own account or the account of others under the Securities Act of any of its equity securities (other than on Form S-4
or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely
in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock
option or other employee benefit plans), then the Company shall deliver to each Investor a written notice of such determination and,
if within fifteen (15) days after the date of the delivery of such notice, any such Investor shall so request in writing, the Company
shall include in such registration statement or offering statement all or any part of such Registrable Securities such Investor requests
to be registered; provided, however, the Company shall not be required to register any Registrable Securities pursuant to this Section
2(g) that are eligible for resale pursuant to Rule 144 without restriction (including, without limitation, volume restrictions) and without
the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable) or that are the subject of a then-effective
Registration Statement, subject to compliance with securities laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Allocation of Registrable Securities</U>. The initial number of Registrable Securities included in any Registration Statement and
any increase in the number of Registrable Securities included therein shall be allocated pro rata among the Investors based on the number
of Registrable Securities held by each Investor at the time such Registration Statement covering such initial number of Registrable Securities
or increase thereof is declared effective by the SEC. In the event that an Investor sells or otherwise transfers any of such Investor&rsquo;s
Registrable Securities, each transferee or assignee (as the case may be) that becomes an Investor shall be allocated a pro rata portion
of the then-remaining number of Registrable Securities included in such Registration Statement for such transferor or assignee (as the
case may be). Any shares of Common Stock included in a Registration Statement and which remain allocated to any Person which ceases to
hold any Registrable Securities covered by such Registration Statement shall be allocated to the remaining Investors, pro rata based
on the number of Registrable Securities then held by such Investors which are covered by such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>No Inclusion of Other Securities</U>. The Company shall in no event include any securities other than Registrable Securities on any
Registration Statement filed in accordance herewith without the prior written consent of the Required Holders. The Company shall not
enter into any agreement providing any registration rights to any of its security holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Related Obligations</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall use its best efforts to effect the registration of the Registrable Securities in accordance with the intended method of
disposition thereof, and, pursuant thereto, the Company shall have the following obligations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company shall promptly prepare and file with the SEC a Registration Statement with respect to all the Registrable Securities (but
in no event later than the applicable Filing Deadline) and use its best efforts to cause such Registration Statement to become effective
as soon as practicable after such filing (but in no event later than the Effectiveness Deadline). Subject to Allowable Grace Periods,
the Company shall keep each Registration Statement effective (and the prospectus contained therein available for use) pursuant to Rule
415 for resales by the Investors on a delayed or continuous basis at then-prevailing market prices (and not fixed prices) at all times
until the earlier of (i) the date as of which all of the Investors may sell all of the Registrable Securities required to be covered
by such Registration Statement (disregarding any reduction pursuant to Section 2(f)) without restriction pursuant to Rule 144 (including,
without limitation, volume restrictions) and without the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2),
if applicable) or (ii) the date on which the Investors shall have sold all of the Registrable Securities covered by such Registration
Statement (the &ldquo;<B>Registration Period</B>&rdquo;). Notwithstanding anything to the contrary contained in this Agreement, the Company
shall ensure that, when filed and at all times while effective, each Registration Statement (including, without limitation, all amendments
and supplements thereto) and the prospectus (including, without limitation, all amendments and supplements thereto) used in connection
with such Registration Statement (1) shall not contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light of the circumstances in
which they were made) not misleading and (2) will disclose (whether directly or through incorporation by reference to other SEC filings
to the extent permitted) all material information regarding the Company and its securities. The Company shall submit to the SEC, within
one (1) Business Day after the Company learns that no review of a particular Registration Statement will be made by the Staff or that
the Staff has no further comments on a particular Registration Statement (as the case may be), a request for acceleration of effectiveness
of such Registration Statement to a time and date not later than twenty-four (24) hours after the submission of such request. The Company
shall respond in writing to comments made by the SEC in respect of a Registration Statement as soon as practicable, but in no event later
than fifteen (15) days after the receipt of comments by or notice from the SEC that an amendment is required in order for a Registration
Statement to be declared effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Subject to Section 3(r) of this Agreement, the Company shall prepare and file with the SEC such amendments (including, without limitation,
post-effective amendments) and supplements to each Registration Statement and the prospectus used in connection with each such Registration
Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the Securities Act, as may be necessary to keep each
such Registration Statement effective at all times during the Registration Period for such Registration Statement, and, during such period,
comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company required
to be covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance
with the intended methods of disposition by the seller or sellers thereof as set forth in such Registration Statement; provided, however,
by 8:30 a.m. (New York time) on the Business Day immediately following each Effective Date, the Company shall file with the SEC in accordance
with Rule 424(b) under the Securities Act the final prospectus to be used in connection with sales pursuant to the applicable Registration
Statement (whether or not such a prospectus is technically required by such rule). In the case of amendments and supplements to any Registration
Statement which are required to be filed pursuant to this Agreement (including, without limitation, pursuant to this Section 3(b)) by
reason of the Company filing a report on Form 8-K, Form 10-K or Form 10-Q or any analogous report under the Exchange Act, the Company
shall, if permitted under the applicable rules and regulations of the SEC, have incorporated such report by reference into such Registration
Statement, if applicable, or shall file such amendments or supplements with the SEC on the same day on which the Exchange Act report
is filed which created the requirement for the Company to amend or supplement such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company shall (A) permit each Investor to review and comment upon (i) each Registration Statement at least three (3) Business Days
prior to its filing with the SEC and (ii) all amendments and supplements to each Registration Statement (including, without limitation,
the prospectus contained therein) (except for Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K,
and any similar or successor reports) within a reasonable number of days prior to their filing with the SEC, and (B) not file any Registration
Statement or amendment or supplement thereto in a form to which for any other Investor reasonably objects; provided, however, that if
any Investor does not provide comments to such Registration Statement within three (3) Business Days of receipt thereof, such failure
to respond shall be construed as approval to file the Registration Statement. The Company shall not submit a request for acceleration
of the effectiveness of a Registration Statement or any amendment or supplement thereto or to any prospectus contained therein without
the prior consent of each Investor, which consent shall not be unreasonably withheld. The Company shall promptly furnish to each Investor,
without charge, (i) copies of any correspondence from the SEC or the Staff to the Company or its representatives relating to each Registration
Statement, provided that such correspondence shall not contain any material, non-public information regarding the Company or any of its
Subsidiaries (as defined in the Purchase Agreement), (ii) after the same is prepared and filed with the SEC, one (1) copy of each Registration
Statement and any amendment(s) and supplement(s) thereto, including, without limitation, financial statements and schedules, all documents
incorporated therein by reference, if requested by an Investor, and all exhibits and (iii) upon the effectiveness of each Registration
Statement, one (1) copy of the prospectus included in such Registration Statement and all amendments and supplements thereto. The Company
shall reasonably cooperate with each Investor in performing the Company&rsquo;s obligations pursuant to this Section</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company shall promptly furnish to each Investor whose Registrable Securities are included in any Registration Statement, without
charge, (i) after the same is prepared and filed with the SEC, at least one (1) copy of each Registration Statement and any amendment(s)
and supplement(s) thereto, including, without limitation, financial statements and schedules, all documents incorporated therein by reference,
if requested by an Investor, all exhibits and each preliminary prospectus, (ii) upon the effectiveness of each Registration Statement,
ten (10) copies of the prospectus included in such Registration Statement and all amendments and supplements thereto (or such other number
of copies as such Investor may reasonably request from time to time) and (iii) such other documents, including, without limitation, copies
of any preliminary or final prospectus, as such Investor may reasonably request from time to time in order to facilitate the disposition
of the Registrable Securities owned by such Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The Company shall use its best efforts to (i) register and qualify, unless an exemption from registration and qualification applies,
the resale by Investors of the Registrable Securities covered by a Registration Statement under such other securities or &ldquo;blue
sky&rdquo; laws of all applicable jurisdictions in the United States, (ii) prepare and file in those jurisdictions, such amendments (including,
without limitation, post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain
the effectiveness thereof during the Registration Period, (iii) take such other actions as may be necessary to maintain such registrations
and qualifications in effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary or advisable
to qualify the Registrable Securities for sale in such jurisdictions; provided, however, the Company shall not be required in connection
therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify
but for this Section 3(e), (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to service
of process in any such jurisdiction. The Company shall promptly provide notification pursuant to the Notice Provision in Section 11(b)
of the receipt by the Company of any notification with respect to the suspension of the registration or qualification of any of the Registrable
Securities for sale under the securities or &ldquo;blue sky&rdquo; laws of any jurisdiction in the United States or its receipt of actual
notice of the initiation or threatening of any proceeding for such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Company shall provide notification pursuant to the Notice Provision in Section 11(b) in writing of the happening of any event, as
promptly as practicable after becoming aware of such event, as a result of which the prospectus included in a Registration Statement,
as then in effect, may include an untrue statement of a material fact or omission to state a material fact required to be stated therein
or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading (provided that
in no event shall such notice contain any material, non-public information regarding the Company or any of its Subsidiaries), and, subject
to Section 3(r), promptly prepare a supplement or amendment to such Registration Statement and such prospectus contained therein to correct
such untrue statement or omission and deliver ten (10) copies of such supplement or amendment to Legal Counsel, legal counsel for each
other Investor and each Investor (or such other number of copies as Legal Counsel, legal counsel for each other Investor or such Investor
may reasonably request). The Company shall also promptly provide notification pursuant to the Notice Provision in Section 11(b) in writing
(i) when a prospectus or any prospectus supplement or post-effective amendment has been filed, when a Registration Statement or any post-effective
amendment has become effective (notification of such effectiveness shall be delivered to Legal Counsel, legal counsel for each other
Investor and each Investor by e-mail on the same day of such effectiveness and by overnight mail), and when the Company receives written
notice from the SEC that a Registration Statement or any post-effective amendment will be reviewed by the SEC, (ii) of any request by
the SEC for amendments or supplements to a Registration Statement or related prospectus or related information, (iii) of the Company&rsquo;s
reasonable determination that a post-effective amendment to a Registration Statement would be appropriate; and (iv) of the receipt of
any request by the SEC or any other federal or state governmental authority for any additional information relating to the Registration
Statement or any amendment or supplement thereto or any related prospectus. The Company shall respond as promptly as practicable to any
comments received from the SEC with respect to each Registration Statement or any amendment thereto (it being understood and agreed that
the Company&rsquo;s response to any such comments shall be delivered to the SEC no later than fifteen (15) Business Days after the receipt
thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
The Company shall (i) use its best efforts to prevent the issuance of any stop order or other suspension of effectiveness of each Registration
Statement or the use of any prospectus contained therein, or the suspension of the qualification, or the loss of an exemption from qualification,
of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is issued, to obtain the withdrawal
of such order or suspension at the earliest possible moment and (ii) provide notification pursuant to the Notice Provision in Section
11(b) of the Purchase Agreement of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation
or threat of any proceeding for such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
If any Investor may be required under applicable securities law to be described in any Registration Statement as an underwriter and such
Investor consents to so being named an underwriter, at the request of any Investor, the Company shall furnish to such Investor, on the
date of the effectiveness of such Registration Statement and thereafter from time to time on such dates as an Investor may reasonably
request (i) a letter, dated such date, from the Company&rsquo;s independent certified public accountants in form and substance as is
customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the Investors,
and (ii) an opinion, dated as of such date, of counsel representing the Company for purposes of such Registration Statement, in form,
scope and substance as is customarily given in an underwritten public offering, addressed to the Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
If any Investor may be required under applicable securities law to be described in any Registration Statement as an underwriter and such
Investor consents to so being named an underwriter, upon the written request of such Investor, the Company shall make available for inspection
by (i) such Investor, (ii) legal counsel for such Investor and (iii) one (1) firm of accountants or other agents retained by such Investor
(collectively, the &ldquo;<B>Inspectors</B>&rdquo;), all pertinent financial and other records, and pertinent corporate documents and
properties of the Company (collectively, the &ldquo;<B>Records</B>&rdquo;), as shall be reasonably deemed necessary by each Inspector,
and cause the Company&rsquo;s officers, directors and employees to supply all information which any Inspector may reasonably request;
provided, however, each Inspector shall agree in writing to hold in strict confidence and not to make any disclosure (except to such
Investor) or use of any Record or other information which the Company&rsquo;s board of directors determines in good faith to be confidential,
and of which determination the Inspectors are so notified, unless (1) the disclosure of such Records is necessary to avoid or correct
a misstatement or omission in any Registration Statement or is otherwise required under the Securities Act, (2) the release of such Records
is ordered pursuant to a final, non-appealable subpoena or order from a court or government body of competent jurisdiction, or (3) the
information in such Records has been made generally available to the public other than by disclosure in violation of this Agreement or
any other Transaction Document (as defined in the Purchase Agreement). Such Investor agrees that it shall, upon learning that disclosure
of such Records is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt notice
to the Company and allow the Company, at its expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective
order for, the Records deemed confidential. Nothing herein (or in any other confidentiality agreement between the Company and such Investor,
if any) shall be deemed to limit any Investor&rsquo;s ability to sell Registrable Securities in a manner which is otherwise consistent
with applicable laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
The Company shall hold in confidence and not make any disclosure of information concerning an Investor provided to the Company unless
(i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information
is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed in
such Registration Statement pursuant to the Securities Act, (iii) the release of such information is ordered pursuant to a subpoena or
other final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made
generally available to the public other than by disclosure in violation of this Agreement or any other Transaction Document. The Company
agrees that it shall, upon learning that disclosure of such information concerning an Investor is sought in or by a court or governmental
body of competent jurisdiction or through other means, give prompt written notice to such Investor and allow such Investor, at such Investor&rsquo;s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Without limiting any obligation of the Company under the Purchase Agreement, the Company shall use its best efforts either to (i) cause
all of the Registrable Securities covered by each Registration Statement to be listed on each securities exchange on which securities
of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted
under the rules of such exchange, (ii) secure designation and quotation of all of the Registrable Securities covered by each Registration
Statement on an Eligible Market (as defined in the Purchase Agreement), or (iii) if, despite the Company&rsquo;s best efforts to satisfy
the preceding clauses (i) or (ii) the Company is unsuccessful in satisfying the preceding clauses (i) or (ii), without limiting the generality
of the foregoing, to use its best efforts to arrange for at least two market makers to register with the Financial Industry Regulatory
Authority (&ldquo;<B>FINRA</B>&rdquo;) as such with respect to such Registrable Securities. In addition, the Company shall cooperate
with each Investor and any broker or dealer through which any such Investor proposes to sell its Registrable Securities in effecting
a filing with FINRA pursuant to FINRA Rule 5110 as requested by such Investor. The Company shall pay all fees and expenses in connection
with satisfying its obligations under this Section 3(k).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
The Company shall cooperate with the Investors who hold Registrable Securities being offered and, to the extent applicable, facilitate
the timely preparation and delivery of certificates (not bearing any restrictive legend) representing the Registrable Securities to be
offered pursuant to a Registration Statement and enable such certificates to be in such denominations or amounts (as the case may be)
as the Investors may reasonably request from time to time and registered in such names as the Investors may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
If requested by an Investor, the Company shall as soon as practicable after receipt of notice from such Investor and subject to Section
3(r) hereof, (i) incorporate in a prospectus supplement or post-effective amendment such information as an Investor reasonably requests
to be included therein relating to the sale and distribution of Registrable Securities, including, without limitation, information with
respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other terms of
the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of such prospectus supplement
or post-effective amendment after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment;
and (iii) supplement or make amendments to any Registration Statement or prospectus contained therein if reasonably requested by an Investor
holding any Registrable Securities,.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
The Company shall use its best efforts to cause the Registrable Securities covered by a Registration Statement to be registered with
or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
The Company shall make generally available to its security holders as soon as practical, but not later than ninety (90) days after the
close of the period covered thereby, an earnings statement (in form complying with, and in the manner provided by, the provisions of
Rule 158 under the Securities Act) covering a twelve-month period beginning not later than the first day of the Company&rsquo;s fiscal
quarter next following the applicable Effective Date of each Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
The Company shall otherwise use its best efforts to comply with all applicable rules and regulations of the SEC in connection with any
registration hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
Within one (1) Business Day after a Registration Statement which covers Registrable Securities is declared effective by the SEC, the
Company shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities
(with copies to the Investors whose Registrable Securities are included in such Registration Statement) confirmation that such Registration
Statement has been declared effective by the SEC in the form attached hereto as <B><U>Exhibit A</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
The Company shall take all other reasonable actions necessary to expedite and facilitate disposition by each Investors of its Registrable
Securities pursuant to each Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
Neither the Company nor any Subsidiary or affiliate thereof shall identify any Investor as an underwriter in any public disclosure or
filing with the SEC, the Principal Market or any Eligible Market and any Purchaser being deemed an underwriter by the SEC shall not relieve
the Company of any obligations it has under this Agreement or any other Transaction Document (as defined in the Purchase Agreement);
provided, however, that the foregoing shall not prohibit the Company from including the disclosure found in the &ldquo;Plan of Distribution&rdquo;
section attached hereto as <B><U>Exhibit B</U></B> in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries,
on or after the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing
the rights granted to the Purchasers in this Agreement or otherwise conflicts with the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Obligations of the Investors</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
At least five (5) Business Days prior to the first anticipated filing date of each Registration Statement, the Company shall notify each
Investor in writing of the information the Company requires from each such Investor with respect to such Registration Statement. It shall
be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the
Registrable Securities of a particular Investor that such Investor shall furnish to the Company such information regarding itself, the
Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it, as shall be reasonably
required to effect and maintain the effectiveness of the registration of such Registrable Securities and shall execute such documents
in connection with such registration as the Company may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each Investor, by such Investor&rsquo;s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably
requested by the Company in connection with the preparation and filing of each Registration Statement hereunder, unless such Investor
has notified the Company in writing of such Investor&rsquo;s election to exclude all of such Investor&rsquo;s Registrable Securities
from such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Each Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section
3(g) or the first sentence of 3(f), such Investor will immediately discontinue disposition of Registrable Securities pursuant to any
Registration Statement(s) covering such Registrable Securities until such Investor&rsquo;s receipt of the copies of the supplemented
or amended prospectus contemplated by Section 3(g) or the first sentence of Section 3(f) or receipt of notice that no supplement or amendment
is required. Notwithstanding anything to the contrary in this Section 4(c), the Company shall cause its transfer agent to deliver unlegended
shares of Common Stock to a transferee of an Investor in accordance with the terms of the Purchase Agreement in connection with any sale
of Registrable Securities with respect to which such Investor has entered into a contract for sale prior to the Investor&rsquo;s receipt
of a notice from the Company of the happening of any event of the kind described in Section 3(g) or the first sentence of Section 3(f)
and for which such Investor has not yet settled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Expenses of Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
reasonable expenses, other than underwriting discounts and commissions, incurred in connection with registrations, filings or qualifications
pursuant to Sections 2 and 3, including, without limitation, all registration, listing and qualifications fees, printers and accounting
fees, FINRA filing fees (if any) and fees and disbursements of counsel for the Company shall be paid by the Company. <U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend each Investor and each
of its directors, officers, shareholders, members, partners, employees, agents, advisors, representatives (and any other Persons with
a functionally equivalent role of a Person holding such titles notwithstanding the lack of such title or any other title) and each Person,
if any, who controls such Investor within the meaning of the Securities Act or the Exchange Act and each of the directors, officers,
shareholders, members, partners, employees, agents, advisors, representatives (and any other Persons with a functionally equivalent role
of a Person holding such titles notwithstanding the lack of such title or any other title) of such controlling Persons (each, an &ldquo;<B>Indemnified
Person</B>&rdquo;), against any losses, obligations, claims, damages, liabilities, contingencies, judgments, fines, penalties, charges,
costs (including, without limitation, court costs, reasonable attorneys&rsquo; fees and costs of defense and investigation), amounts
paid in settlement or expenses, joint or several, (collectively, &ldquo;<B>Claims</B>&rdquo;) incurred in investigating, preparing or
defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental,
administrative or other regulatory agency, body or the SEC, whether pending or threatened, whether or not an Indemnified Person is or
may be a party thereto (&ldquo;<B>Indemnified Damages</B>&rdquo;), to which any of them may become subject insofar as such Claims (or
actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue statement
or alleged untrue statement of a material fact in a Registration Statement or any post-effective amendment thereto or in any filing made
in connection with the qualification of the offering under the securities or other &ldquo;blue sky&rdquo; laws of any jurisdiction in
which Registrable Securities are offered (&ldquo;<B>Blue Sky Filing</B>&rdquo;), or the omission or alleged omission to state a material
fact required to be stated therein or necessary to make the statements therein not misleading, (ii) any untrue statement or alleged untrue
statement of a material fact contained in any preliminary prospectus if used prior to the effective date of such Registration Statement,
or contained in the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto with
the SEC) or the omission or alleged omission to state therein any material fact necessary to make the statements made therein, in light
of the circumstances under which the statements therein were made, not misleading or (iii) any violation or alleged violation by the
Company of the Securities Act, the Exchange Act, any other law, including, without limitation, any state securities law, or any rule
or regulation thereunder relating to the offer or sale of the Registrable Securities pursuant to a Registration Statement or (iv) any
violation of this Agreement (the matters in the foregoing clauses (i) through (iv) being, collectively, &ldquo;<B>Violations</B>&rdquo;).
Subject to Section 6(c), the Company shall reimburse the Indemnified Persons, promptly as such expenses are incurred and are due and
payable, for any legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Claim.
Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section 6(a): (i) shall not
apply to a Claim by an Indemnified Person arising out of or based upon a Violation which occurs in reliance upon and in conformity with
information furnished in writing to the Company by such Indemnified Person for such Indemnified Person expressly for use in connection
with the preparation of such Registration Statement or any such amendment thereof or supplement thereto, if such prospectus was timely
made available by the Company pursuant to Section 3(d); and (ii) shall not apply to amounts paid in settlement of any Claim if such settlement
is effected without the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity
shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive
the transfer of any of the Registrable Securities by any of the Investors pursuant to Section 9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Promptly after receipt by an Indemnified Person under this Section 6 of notice of the commencement of any action or proceeding (including,
without limitation, any governmental action or proceeding) involving a Claim, such Indemnified Person shall, if a Claim in respect thereof
is to be made against any indemnifying party under this Section 6, deliver to the indemnifying party a written notice of the commencement
thereof, and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly
with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually satisfactory to the
indemnifying party and the Indemnified Person ; provided, however, an Indemnified Person shall have the right to retain its own counsel
with the fees and expenses of such counsel to be paid by the indemnifying party if: (i) the indemnifying party has agreed in writing
to pay such fees and expenses; (ii) the indemnifying party shall have failed promptly to assume the defense of such Claim and to employ
counsel reasonably satisfactory to such Indemnified Person in any such Claim; or (iii) the named parties to any such Claim (including,
without limitation, any impleaded parties) include both such Indemnified Person and the indemnifying party, and such Indemnified Person
shall have been advised by counsel that a conflict of interest is likely to exist if the same counsel were to represent such Indemnified
Person and the indemnifying party (in which case, if such Indemnified Person notifies the indemnifying party in writing that it elects
to employ separate counsel at the expense of the indemnifying party, then the indemnifying party shall not have the right to assume the
defense thereof and such counsel shall be at the expense of the indemnifying party, provided further that in the case of clause (iii)
above the indemnifying party shall not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel
for such Indemnified Person ). The Indemnified Person shall reasonably cooperate with the indemnifying party in connection with any negotiation
or defense of any such action or Claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably
available to the Indemnified Person which relates to such action or Claim. The indemnifying party shall keep the Indemnified Person reasonably
apprised at all times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall
be liable for any settlement of any action, claim or proceeding effected without its prior written consent; provided, however, the indemnifying
party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent
of the Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise which does not include as
an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Person of a release from all liability in respect
to such Claim or litigation, and such settlement shall not include any admission as to fault on the part of the Indemnified Person. Following
indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Person with respect
to all third parties, firms or corporations relating to the matter for which indemnification has been made. The failure to deliver written
notice to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such indemnifying
party of any liability to the Indemnified Person under this Section 6, except to the extent that the indemnifying party is materially
and adversely prejudiced in its ability to defend such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified
Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant to the law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Contribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law;
provided, however: (i) no contribution shall be made under circumstances where the maker would not have been liable for indemnification
under the fault standards set forth in Section 6 of this Agreement, (ii) no Person involved in the sale of Registrable Securities which
Person is guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) in connection with such
sale shall be entitled to contribution from any Person involved in such sale of Registrable Securities who was not guilty of fraudulent
misrepresentation; and (iii) contribution by any seller of Registrable Securities shall be limited in amount to the amount of net proceeds
received by such seller from the applicable sale of such Registrable Securities pursuant to such Registration Statement. Notwithstanding
the provisions of this Section 7, no Investor shall be required to contribute, in the aggregate, any amount in excess of the amount by
which the net proceeds actually received by such Investor from the applicable sale of the Registrable Securities subject to the Claim
exceeds the amount of any damages that such Investor has otherwise been required to pay, or would otherwise be required to pay under
Section 6(b), by reason of such untrue or alleged untrue statement or omission or alleged omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Reports Under the Exchange Act</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a view to making available to the Investors the benefits of Rule 144, the Company agrees to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
make and keep public information available, as those terms are understood and defined in Rule 144;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange
Act so long as the Company remains subject to such requirements (it being understood and agreed that nothing herein shall limit any rights
or obligations of the Company under the Purchase Agreement) and the filing of such reports and other documents is required for the applicable
provisions of Rule 144; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
furnish to each Investor so long as such Investor owns Registrable Securities, promptly upon request, (i) a written statement by the
Company, if true, that it has complied with the reporting, submission and posting requirements of Rule 144, the Securities Act and the
Exchange Act, (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed
by the Company with the SEC if such reports are not publicly available via EDGAR, and (iii) such other information as may be reasonably
requested to permit the Investors to sell such securities pursuant to Rule 144 without registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Transfer or Assignment of Registration Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All or any portion of the rights under this Agreement shall be automatically assignable by each Investor to any transferee or assignee
(as the case may be) of all or any portion of such Investor&rsquo;s Registrable Securities or Notes, if: (i) such Investor agrees in
writing with such transferee or assignee (as the case may be) to assign all or any portion of such rights, and a copy of such agreement
is furnished to the Company within a reasonable time after such transfer or assignment (as the case may be); (ii) the Company is, within
a reasonable time after such transfer or assignment (as the case may be), furnished with written notice of (a) the name and address of
such transferee or assignee (as the case may be), and (b) the securities with respect to which such registration rights are being transferred
or assigned (as the case may be); (iii) immediately following such transfer or assignment (as the case may be) the further disposition
of such securities by such transferee or assignee (as the case may be) is restricted under the Securities Act or applicable state securities
laws if so required; (iv) at or before the time the Company receives the written notice contemplated by clause (ii) of this sentence
such transferee or assignee (as the case may be) agrees in writing with the Company to be bound by all of the provisions contained herein
(v) such transfer or assignment (as the case may be) shall have been made in accordance with the applicable requirements of the Purchase
Agreement and the Notes (as the case may be); and such transfer or assignment (as the case may be) shall have been conducted in accordance
with all applicable federal and state securities laws, rules, and regulations, any applicable exchange rules and regulations, and any
applicable SRO rules and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Amendment of Registration Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
of this Agreement may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively
or prospectively), only with the written consent of the Company and the Required Holders; provided that any such amendment or waiver
that complies with the foregoing, but that disproportionately, materially and adversely affects the rights and obligations of any Investor
relative to the comparable rights and obligations of the other Investors shall require the prior written consent of such adversely affected
Investor. Any amendment or waiver effected in accordance with this Section 10 shall be binding upon each Investor and the Company, provided
that no such amendment shall be effective to the extent that it (1) applies to less than all of the holders of Registrable Securities
or (2) imposes any obligation or liability on any Investor without such Investor&rsquo;s prior written consent (which may be granted
or withheld in such Investor&rsquo;s sole discretion). No waiver shall be effective unless it is in writing and signed by an authorized
representative of the waiving party. No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification
of any provision of this Agreement unless the same consideration (other than the reimbursement of legal fees) also is offered to all
of the parties to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Solely for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns, or is deemed
to own, of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more
Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received
from such record owner of such Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in
writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by electronic
mail (provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the sending party
does not receive an automatically generated message from the recipient&rsquo;s email server that such e-mail could not be delivered to
such recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each
case, properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications shall be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
to Purchasers: as provided in the Purchase Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (that shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REDACTED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Labs, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">626
RXR Plaza, 6th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uniondale,
New York 11556</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Ted Karkus, CEO Email: karkus@prophaselabs.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (that shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REDACTED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Transfer Agent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equiniti
Trust Company, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28
Liberty Street, Floor 53</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10005</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Administration</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
Admin3@equiniti.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to a Purchaser, to its mailing address and/or email address set forth on the Schedule of Purchasers attached to the Purchase Agreement,
with copies to such Purchaser&rsquo;s representatives as set forth on the Schedule of Purchasers, or to such other mailing address and/or
email address and/or to the attention of such other Person as the recipient party has specified by written notice given to each other
party five (5) Business Days prior to the effectiveness of such change, provided that Lead Investor&rsquo;s Counsel shall only be provided
notices sent to the Lead Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Any Investor may deliver a written notice (an &ldquo;<B>Opt-Out Notice</B>&rdquo;) to the Company requesting that such Investor not receive
notices from the Company otherwise required by the last sentence of Section 3(e), the first sentence of Section 3(f) or Section 3(g)(ii);
<I>provided, however,</I> that the Investor may later revoke any such Opt-Out Notice in writing. Following receipt of an Opt-Out Notice
from the Investor (unless subsequently revoked), (i) the Company shall not deliver any such notices to the Investor and the Investor
shall no longer be entitled to the rights associated with any such notice and (ii) each time prior to the Investor&rsquo;s intended use
of an effective Registration Statement, the Investor will notify the Company in writing at least two (2) Business Days in advance of
such intended use, and if a notice of an event contemplated by Section 3 was previously delivered (or would have been delivered but for
the provisions of this Section 11(c)) and a related suspension period remains in effect, the Company will so notify the Investor within
one (1) Business Day of the Investor&rsquo;s notification to the Company by delivering to the Investor a copy of such previous notice
provided to the other Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right
or remedy, shall not operate as a waiver thereof. The Company and each Investor acknowledge and agree that irreparable damage would occur
in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that each party hereto shall be entitled to an injunction or injunctions to prevent or cure breaches
of the provisions of this Agreement by any other party hereto and to enforce specifically the terms and provisions hereof (without the
necessity of showing economic loss and without any bond or other security being required), this being in addition to any other remedy
to which any party may be entitled by law or equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by Section 5.08
of the Purchase Agreement. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR
THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED
HEREBY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent
jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest
extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity
of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without material change,
the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the
provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical
realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations
to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible
to that of the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
This Agreement, the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced
herein and therein constitute the entire agreement among the parties hereto and thereto solely with respect to the subject matter hereof
and thereof. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein.
This Agreement, the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced
herein and therein supersede all prior agreements and understandings among the parties hereto solely with respect to the subject matter
hereof and thereof; provided, however, nothing contained in this Agreement or any other Transaction Document shall (or shall be deemed
to) (i) have any effect on any agreements any Investor has entered into with the Company or any of its Subsidiaries prior to the date
hereof with respect to any prior investment made by such Investor in the Company, (ii) waive, alter, modify or amend in any respect any
obligations of the Company or any of its Subsidiaries or any rights of or benefits to any Investor or any other Person in any agreement
entered into prior to the date hereof between or among the Company and/or any of its Subsidiaries and any Investor and all such agreements
shall continue in full force and effect or (iii) limit any obligations of the Company under any of the other Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Subject to compliance with Section 9 (if applicable), this Agreement shall inure to the benefit of and be binding upon the permitted
successors and assigns of each of the parties hereto. This Agreement is not for the benefit of, nor may any provision hereof be enforced
by, any Person, other than the parties hereto, their respective permitted successors and assigns and the Persons referred to in Sections
6 and 7 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless
the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and
plural forms thereof. The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall
be construed broadly as if followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo;
&ldquo;hereof&rdquo; and words of like import refer to this entire Agreement instead of just the provision in which they are found.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
This Agreement may be executed in two or more identical counterparts, each of which shall be deemed an original, but all of which shall
be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to
the other party. In the event that any signature is delivered by facsimile transmission or by an email which contains a portable document
format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party. Notwithstanding anything to the contrary set forth in Section 10, terms used
in this Agreement but defined in the other Transaction Documents shall have the meanings ascribed to such terms on the Closing Date in
such other Transaction Documents unless otherwise consented to in writing by each Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
All consents and other determinations required to be made by the Investors pursuant to this Agreement shall be made, unless otherwise
specified in this Agreement, by the Required Holders, determined as if all of the outstanding Notes then held by the Investors have been
converted for Registrable Securities without regard to any limitations on redemption, amortization and/or conversion of the Notes then
held by Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for
the benefit of, nor may any provision hereof be enforced by, any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
The obligations of each Investor under this Agreement and the other Transaction Documents are several and not joint with the obligations
of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under
this Agreement or any other Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken
by any Investor pursuant hereto or thereto, shall be deemed to constitute the Investors as, and the Company acknowledges that the Investors
do not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that
the Investors are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated
by the Transaction Documents or any matters, and the Company acknowledges that the Investors are not acting in concert or as a group,
and the Company shall not assert any such claim, with respect to such obligations or the transactions contemplated by this Agreement
or any of the other the Transaction Documents. Each Investor shall be entitled to independently protect and enforce its rights, including,
without limitation, the rights arising out of this Agreement or out of any other Transaction Documents, and it shall not be necessary
for any other Investor to be joined as an additional party in any proceeding for such purpose. The use of a single agreement with respect
to the obligations of the Company contained herein was solely in the control of the Company, not the action or decision of any Investor,
and was done solely for the convenience of the Company and not because it was required or requested to do so by any Investor. It is expressly
understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and
an Investor, solely, and not between the Company and the Investors collectively and not between and among Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
page follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, each Purchaser and the Company have caused their respective signature page to this Registration Rights Agreement
to be duly executed as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPHASE
    LABS, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, each Purchaser and the Company have caused their respective signature page to this Registration Rights Agreement
to be duly executed as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REDACTED</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REDACTED</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF NOTICE OF EFFECTIVENESS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
REGISTRATION STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
__________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:
PROPHASE LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[We
are][I am] counsel to <B>PROPHASE LABS, INC.</B>, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and have represented the
Company in connection with that certain Securities Purchase Agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;) entered into by and
among the Company and the purchasers named therein (collectively, the &ldquo;<B>Purchasers</B>&rdquo;) pursuant to which the Company
issued to the holders 20% OID Senior Secured Convertible Notes (the &ldquo;<B>Notes</B>&rdquo;) and Warrants to Purchase Common Stock
(the &ldquo;<B>Warrants</B>&rdquo; and, together with the Notes, the &ldquo;<B>Securities</B>&rdquo;) convertible into or exercisable
for the Company&rsquo;s Common Stock, par value $0.0005 per share (the &ldquo;<B>Common Stock</B>&rdquo;). Pursuant to the Purchase Agreement,
the Company also has entered into a Registration Rights Agreement with the Purchasers (the &ldquo;<B>Registration Rights Agreement</B>&rdquo;)
pursuant to which the Company agreed, among other things, to register the Registrable Securities (as defined in the Registration Rights
Agreement), including the shares of Common Stock issuable upon conversion of the Notes or exercise of the Warrants, under the Securities
Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;). In connection with the Company&rsquo;s obligations under the Registration
Rights Agreement, on __________ __, 20__, the Company filed a Registration Statement on Form S-1 (File No. 333- ________) (the &ldquo;<B>Registration
Statement</B>&rdquo;) with the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) relating to the Registrable Securities
which names each of the Purchasers as a selling stockholder thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the foregoing, [we][I] advise you that [a member of the SEC&rsquo;s staff has advised [us][me] by telephone that [the
SEC has entered an order declaring the Registration Statement effective under the Securities Act at [ENTER TIME OF EFFECTIVENESS] on
[ENTER DATE OF EFFECTIVENESS]] [an order declaring the Registration Statement effective under the Securities Act at [ENTER TIME OF EFFECTIVENESS]
on [ENTER DATE OF EFFECTIVENESS]] has been posted on the web site of the SEC at www.sec.gov] and [we][I] have no knowledge, after a review
of information posted on the website of the SEC at http://www.sec.gov/litigation/stoporders.shtml, that any stop order suspending its
effectiveness has been issued or that any proceedings for that purpose are pending before, or threatened by, the SEC and the Registrable
Securities are available for resale under the Securities Act pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
letter shall serve as our standing opinion to you that the shares of Common Stock underlying the Securities are freely transferable by
the Purchasers pursuant to the Registration Statement. You need not require further letters from us to effect any future legend-free
issuance or reissuance of such shares of Common Stock to the Purchasers as contemplated by the Company&rsquo;s Irrevocable Transfer Agent
Instructions dated _________ __, 20__.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
  truly yours,</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ISSUER&rsquo;S
  COUNSEL]</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: justify"></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cc:
                                            REDACTED</FONT></P>

</TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: justify"></P>


<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">CA-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLING
STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock being offered by the selling stockholders are those issuable to the selling stockholders upon conversion of the
notes and exercise of warrants. For additional information regarding the issuance of such securities, see &ldquo;Private Placement of
Securities&rdquo; above. We are registering the shares of common stock in order to permit the selling stockholders to offer the shares
for resale from time to time. Except for the ownership of the notes and warrants issued pursuant to the Purchase Agreement, the selling
stockholders have not had any material relationship with us within the past three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the selling stockholders and other information regarding the beneficial ownership (as determined under Section 13(d)
of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder) of the shares of common stock held by each
of the selling stockholders. The second column lists the number of shares of common stock beneficially owned by the selling stockholders,
based on their respective ownership of common stock and notes, as of _________, 20__, assuming conversion of the notes and exercise of
the warrants held by each such selling stockholder on that date but taking account of any limitations on conversion set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of common stock being offered by this prospectus by the selling stockholders and does not take in account
any limitations on conversion of the notes and exercise of warrants set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of a registration rights agreement with the holders of the securities, this prospectus generally covers the
resale of the sum of (i) the maximum number of shares of common stock issued or issuable pursuant to the securities. Because the conversion
price of the notes and exercise price of the warrants may be adjusted, the number of shares that will actually be issued may be more
or less than the number of shares being offered by this prospectus. The fourth column assumes the sale of all of the shares offered by
the selling stockholders pursuant to this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the securities, a selling stockholder may not convert the notes or exercise warrants to the extent (but only to the extent)
such selling stockholder or any of its affiliates would beneficially own a number of shares of common stock which would exceed 4.99%
of the outstanding shares of the Company. The number of shares in the second column reflects these limitations. The selling stockholders
may sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 37%; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of Selling Stockholder</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 17%; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of Shares of Common Stock Owned</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prior
    to Offering</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 22%; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum
                                            Number of Shares of Common Stock to be Sold</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
    to this Prospectus</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 18%; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of Shares of Common Stock</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Owned
    After Offering</B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>ex10-5.htm
<DESCRIPTION>EX-10.5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.5</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Security
Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SECURITY AGREEMENT, dated as of July 22, 2025 (this &ldquo;<B>Agreement</B>&rdquo;), is by and among (1) ProPhase Labs, Inc., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), and each of its Subsidiaries who shall have executed this Agreement below (collectively
with the Company, &ldquo;<B>Debtor</B>&rdquo;), on the one hand, and (2) the holder(s) of the Company&rsquo;s 20% OID Senior Secured
Convertible Notes in the aggregate Original Principal Amount (as defined in the Purchase Agreement) of $3,750,0000 (the &ldquo;<B>Notes</B>&rdquo;)
signatory hereto, their endorsees, transferees and assigns (each holder a &ldquo;<B>Secured Party</B>,&rdquo; and collectively, the &ldquo;<B>Secured
Parties</B>&rdquo;), on the other. Each of the Company and the Secured Parties are a &ldquo;party&rdquo; to this Agreement, and one or
more of them are the &ldquo;parties&rdquo; hereto as the context may require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WITNESSETH:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,</B>
the Notes have been issued to the Securities pursuant to that certain Securities Purchase Agreement, dated as of the date hereof, between
the Company and original holders of Notes (as amended, modified, or supplemented from time to time in accordance with its terms, the
&ldquo;<B>Purchase Agreement</B>&rdquo;), and pursuant thereto the Secured Parties have severally agreed to extend loans to the Company
evidenced by the Notes; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,</B>
in order to induce the Secured Parties to extend the loans evidenced by the Notes, the Debtor has agreed to execute and deliver to the
Secured Parties this Agreement and to grant the Secured Parties a lien security interest in all of the assets of the Company to secure
the prompt payment, performance and discharge in full of all of the Company&rsquo;s obligations (whether at the stated maturity, by acceleration
or otherwise) under the Purchase Agreement and the Notes and the other Obligations (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE,</B> in consideration of the agreements herein contained and for other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the parties hereto hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1 <U>Certain Definitions.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this Agreement, the following terms shall have the meanings set forth in this Section 1. Terms used but not otherwise defined
in this Agreement that are defined in Article 9 of the UCC (such as &lsquo;<B>account</B>&rsquo;, &lsquo;<B>chattel paper&rsquo;</B>,
&lsquo;<B>commercial tort claim&rsquo;</B>, &lsquo;<B>deposit account&rsquo;</B>, &lsquo;<B>document</B>&rsquo;, &lsquo;<B>equipment</B>&rsquo;,
&lsquo;<B>fixtures</B>&rsquo;, &lsquo;<B>general intangibles&rsquo;</B>, &lsquo;<B>goods</B>&rsquo;, &lsquo;<B>instruments</B>&rsquo;,
&lsquo;<B>inventory</B>&rsquo;, &lsquo;<B>investment property&rsquo;</B>, <B>&lsquo;letter-of-credit rights</B>&rsquo;, &lsquo;<B>proceeds</B>&rsquo;,
&lsquo;<B>securities</B>&rsquo;, and &lsquo;<B>supporting obligations&rsquo;</B>) shall have the respective meanings given such terms
in Article 9 of the UCC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 41pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<B>Collateral</B>&rdquo; means the collateral in which the Secured Parties are granted a lien and security interest by this Agreement
and which shall include only the following property of the Debtor (as defined below):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<B>All assets of the Debtor</B>, wherever located or deemed located, now owned or at any time hereafter acquired by the Debtor or in
which the Debtor now has or at any time in the future may acquire any right, title or interest including, without limitation, all machinery,
equipment, fixtures, goods, inventory, furnishings, computers, software, motor vehicles, trucks, tanks, boats, ships, appliances, furniture,
special and general tools, fixtures, test and quality control devices and other equipment of every kind and nature, together with all
attachments, components, parts, equipment and accessories installed thereon or affixed thereto, wherever situated, all Intellectual Property,
together with all documents of title and documents representing the same, all additions and accessions thereto, replacements therefor,
all parts therefor, and all substitutes for any of the foregoing and all other items used and useful in connection with Debtor&rsquo;s
businesses and all improvements thereto; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 94.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
All accounts of the Debtor; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 94pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
All chattel paper of the Debtor; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 94pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
All commercial tort claims of the Debtor; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 94pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 94pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
All, general intangibles, including: (A) all rights of the Debtor to receive moneys due and to become due to it thereunder or in connection
therewith; (B) all rights of the Debtor to receive proceeds of any insurance, indemnity, warranty or guarantee with respect thereto;
(C) all claims of the Debtor for damages arising out of any breach of or default thereunder; and (D) all rights of the Debtor to terminate,
amend, supplement, modify or exercise rights or options thereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 94pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
All documents, deposit accounts, goods, instruments, investment property (including all securities, security entitlements and commodity
contracts), and letter of credit rights,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 94pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
All deposits and all money; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 94pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
All books and records pertaining to the Collateral;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 94pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
All Intellectual Property of the Debtor, including, but not limited to those set forth on <U>Schedule F</U> hereto; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 94pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
All Proceeds and products of any of the foregoing, and all substitutions or replacements of any Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 94pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, nothing herein shall be deemed to constitute an assignment of any asset which, in the event of an assignment, becomes
void by operation of applicable law or the assignment of which is otherwise prohibited by applicable law (in each case to the extent
that such applicable law is not overridden by Sections 9-406, 9-407 and/or 9-408 of the UCC or other similar applicable law); <U>provided</U>,
<U>however</U>, that to the extent permitted by applicable law, this Agreement shall create a valid lien security interest in such asset
and, to the extent permitted by applicable law, this Agreement shall create a valid lien security interest in the proceeds of such asset
(subject, in each case, to Permitted Liens).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<B>Intellectual Property</B>&rdquo; means the collective reference to all rights, priorities and privileges relating to the intellectual
property of the Debtor, whether arising under United States, multinational or foreign laws or otherwise, including, without limitation:
(i) all copyrights arising under the laws of the United States, any other country or any political subdivision thereof, whether registered
or unregistered and whether published or unpublished, all registrations and recordings thereof, and all applications in connection therewith,
including, without limitation, all registrations, recordings and applications in the United States Copyright Office; (ii) all letters
patent of the United States, any other country or any political subdivision thereof, all reissues and extensions thereof, and all applications
for letters patent of the United States or any other country and all divisions, continuations and continuations-in-part thereof (&ldquo;<B>Patent
Rights</B>&rdquo;); (iii) all trademarks, trade names, corporate names, company names, business names, fictitious business names, trade
dress, service marks, logos, domain names, business listings and other source or business identifiers, and all goodwill associated therewith,
now existing or hereafter adopted or acquired, all registrations and recordings thereof, and all applications in connection therewith,
whether in the United States Patent and Trademark Office or in any similar office or agency of the United States, any State thereof or
any other country or any political subdivision thereof, or otherwise, and all common law rights related thereto (&ldquo;<B>Trademark
Rights</B>&rdquo;); (iv) all trade secrets arising under the laws of the United States, any other country or any political subdivision
thereof; (v) all rights to obtain any reissues, renewals or extensions of the foregoing; (vi) all licenses for any of the foregoing;
and (vii) all causes of action for infringement of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<B>Obligations</B>&rdquo; means all of the liabilities and obligations (primary, secondary, direct, contingent, sole, joint or
several) of any Debtor due or to become due, or that are now or may be hereafter contracted or acquired, or owing to, the Secured Parties,
including, without limitation, all obligations under this Agreement, the Purchase Agreement, the Notes and the other Transaction Documents
(as defined in the Purchase Agreement) and any other instruments, agreements or other documents executed and/or delivered in connection
herewith or therewith, in each case, whether now or hereafter existing, voluntary or involuntary, direct or indirect, absolute or contingent,
liquidated or unliquidated, whether or not jointly owed with others, and whether or not from time to time decreased or extinguished and
later increased, created or incurred, and all or any portion of such obligations or liabilities that are paid, to the extent all or any
part of such payment is avoided or recovered directly or indirectly from any of the Secured Parties as a preference, fraudulent transfer
or otherwise as such obligations may be amended, supplemented, converted, extended or modified from time to time. Without limiting the
generality of the foregoing, the term &ldquo;<B>Obligations</B>&rdquo; shall include, without limitation: (i) principal of, and interest
on and all expenses related to, the Notes and the loans extended pursuant thereto; (ii) any and all other fees, indemnities, costs, obligations,
liquidated damages and liabilities of the Debtor from time to time under or in connection with this Agreement, the Purchase Agreement,
the Notes, the other Transaction Documents and any other instruments, agreements or other documents executed and/or delivered in connection
herewith or therewith; and (iii) all amounts (including but not limited to post-petition interest) in respect of the foregoing that would
be payable but for the fact that the obligations to pay such amounts are unenforceable or not allowable due to the existence of a bankruptcy,
reorganization or similar proceeding involving any Debtor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<B>Permitted Liens</B>&rdquo; shall mean, with respect to any Person: (i) pledges or deposits by such Person under workmen&rsquo;s
compensation laws, unemployment insurance laws, or similar legislation, or good faith deposits in connection with bids, tenders, contracts
(other than for the payment of Indebtedness), or leases to which such Person is a party, or deposits to secure public or statutory obligations
of such Person or deposits of cash or U.S. government bonds to secure surety or appeal bonds to which such Person is a party, or deposits
as security for the payment of rent or deposits made to secure obligations arising from contractual or warranty refunds, in each case,
incurred in the ordinary course of business; (ii) liens imposed by law, such as carriers&rsquo;, warehousemen&rsquo;s, materialmen&rsquo;s,
repairmen&rsquo;s, and mechanics&rsquo; liens, in each case, incurred in the ordinary course of business and for sums not yet overdue
for a period of more than thirty (30) days or, if more than thirty (30) days overdue, are unfiled and no other action has been taken
to enforce such lien or that are being contested in good faith by appropriate proceedings or other liens arising out of judgments or
awards against such Person with respect to which such Person shall then be proceeding with an appeal or other proceedings for review
if adequate reserves with respect thereto are maintained on the books of such Person in accordance with generally accepted accounting
principles (&ldquo;<B>GAAP</B>&rdquo;); (iii) liens for taxes, assessments, or other governmental charges, not yet overdue for a period
of more than thirty (30) days or which are being contested in good faith by appropriate proceedings if adequate reserves with respect
thereto are maintained on the books of such Person in accordance with GAAP; (iv) liens in favor of issuers of performance, surety, bid,
indemnity, warranty, release, appeal, or similar bonds or with respect to other regulatory requirements or letters of credit or bankers&rsquo;
acceptances issued, and completion guarantees provided for, in each case pursuant to the request of and for the account of such Person
in the ordinary course of its business; (v) minor survey exceptions, minor encumbrances, ground leases, easements, or reservations of,
or rights of others for, licenses, rights-of-way, servitudes, sewers, electric lines, drains, telegraph and telephone and cable television
lines, gas and oil pipelines, and other similar purposes, or zoning, building codes, or other restrictions (including, without limitation,
minor defects or irregularities in title and similar encumbrances) as to the use of real properties or liens incidental, to the conduct
of the business of such Person or to the ownership of its properties in each case which were not incurred in connection with the Notes
and which do not materially interfere with the business of the Debtor; (vi) leases, subleases, licenses, or sublicenses (including of
Intellectual Property) granted to others in the ordinary course of business and which do not materially interfere with the business of
the Debtor; (vii) deposits made or other security provided to secure liabilities to insurance carriers under insurance or self-insurance
arrangements in the ordinary course of business; (viii) restrictive covenants affecting the use to which real property may be put; provided
that the covenants are complied with in all material respects; (ix) security given to a public utility or any municipality or governmental
authority when required by such utility or authority in connection with the operations of that Person in the ordinary course of business;
(x) zoning by-laws and other land use restrictions, including, without limitation, site plan agreements, development agreements, and
contract zoning agreements; (xi) liens arising out of conditional sale, title retention, consignment, or similar arrangements for sale
of goods entered into by the in the ordinary course of business; (xii) liens arising under this Agreement or documents or instruments
related to the Notes; (xiii) Liens to secure other Permitted Indebtedness (as defined in the Purchase Agreement); and (xiv) with respect
to any mortgaged property, the matters listed as exceptions to title on Schedule B of a standard title policy covering such mortgaged
property and the matters disclosed in any survey delivered to the lender with respect to such mortgaged property to the extent such matters
are reasonably acceptable to the lender. For purposes of this definition, the term &ldquo;<B>indebtedness</B>&rdquo; shall be deemed
to include interest on, and fees, expenses, liquidated damages and other obligations payable with respect to, such indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<B>Proceeds</B>&rdquo; shall mean all &ldquo;<B>proceeds</B>&rdquo; as such term is defined in Article 9 of the UCC and, in any
event, shall include with respect to the Debtor, any consideration received from the sale, exchange, license, lease or other disposition
of any asset or property that constitutes Collateral, any value received as a consequence of the possession of any Collateral and any
payment received from any insurer or other Person as a result of the destruction, loss, theft, damage or other involuntary conversion
of whatever nature of any asset or property that constitutes Collateral, and shall include: (i) all cash and negotiable instruments received
by or held (by the Debtor or any other Person) on behalf of the Secured Parties; (ii) any claim of any Debtor against any third party
for (and the right to sue and recover for and the rights to damages or profits due or accrued arising out of or in connection with) (A)
past, present or future infringement or other violation of any patent now or hereafter owned by any Debtor; (B) past, present or future
infringement or dilution or other violation of any trademark now or hereafter owned by any Debtor or injury to the goodwill of the business
connected with the use thereof or symbolized thereby, (C) past, present or future infringement or other violation of any copyright now
or hereafter owned by any Debtor, (D) past, present or future infringement, misappropriation or misuse or other violation or impairment
of any other Intellectual Property now or hereafter owned by any Debtor; and (iii) any and all other amounts from time to time paid or
payable under or in connection with any of the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<B>UCC</B>&rdquo; means the Uniform Commercial Code of the State of Delaware, or any other applicable law of any state or states
which has jurisdiction with respect to all, or any portion of, the Collateral or this Agreement, from time to time. It is the intent
of the parties that defined terms in the UCC should be construed in their broadest sense so that the term &ldquo;Collateral&rdquo; will
be construed in its broadest sense. Accordingly, if there are from time to time, changes to defined terms in the UCC that broaden the
definitions, they are incorporated herein and if existing definitions in the UCC are broader than the amended definitions, the existing
ones shall be controlling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2 <U>Grant of Security Interest in Collateral.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
As an inducement for the Secured Parties to extend the loans as evidenced by the Notes and to secure the complete and timely payment,
performance and discharge in full of all of the Obligations as set forth in the Purchase Agreement and the Notes, as the case may be,
of all of the other Obligations, Debtor hereby unconditionally and irrevocably pledges, grants and hypothecates to the Secured Parties
(subject in each case to Permitted Liens) a priority security interest in and to, and lien upon and a right of set-off against all of
their respective right, title and interest of whatsoever kind and nature in and to, the Collateral as defined above (&ldquo;<B>Security
Interest</B>&rdquo; and, collectively, the &ldquo;<B>Collateral</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Debtor hereby agrees to provide to the Secured Parties or the Collateral Agent (defined as the party appointed by a majority of the Secured
Parties) promptly upon request, any information reasonably necessary to effectuate the filings or recordings authorized by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 41.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 41.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Secured Parties or the Collateral Agent are further authorized to file with the United States Patent and Trademark Office, the United
States Copyright Office or any similar office in any state of the United States (or any successor office), with the signature of each
applicable Debtor, such documents as may be necessary or advisable for the purpose of perfecting, confirming, continuing, enforcing or
protecting the Security Interest granted hereunder to the Patent Rights and Trademark Rights, all right, title and interest to which
have been assigned or will be assigned to the Debtor, by Debtor and naming any Debtor or the Debtor as debtors and the Secured Parties,
as the case may be, as secured party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Security Interest is granted as security only and shall not subject the Secured Parties to, or in any way alter or modify, any obligation
or liability of any Debtor with respect to or arising out of the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3 <U>Delivery of Certain Collateral.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto agree that Debtor is not obligated to deliver any certificates representing shares of capital stock of any Subsidiary
that have not been created to date, and that Debtor is not required to create such certificates for any Subsidiaries. If Debtor creates
a new Subsidiary while the Notes are outstanding, Debtor will notify Secured Party and cause such Subsidiary to become an addition &ldquo;Debtor&rdquo;
party to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4 <U>Representations, Warranties, Covenants and Agreements of the Debtor</U></B><U>.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Debtor represents and warrants to, and covenants and agrees with, the Secured Parties as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Debtor has the requisite corporate, partnership, limited liability company or other power and authority to enter into this Agreement
and otherwise to carry out its obligations hereunder. The execution, delivery and performance by Debtor of this Agreement and the filings
contemplated therein have been duly authorized by all necessary action on the part of Debtor and no further action is required by Debtor.
This Agreement has been duly executed by Debtor. This Agreement constitutes the legal, valid and binding obligation of Debtor, enforceable
against Debtor in accordance with its terms except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization
and similar laws of general application relating to or affecting the rights and remedies of creditors and by general principles of equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Except for the Security Interest granted to the Secured Parties pursuant to this Agreement, and Permitted Liens, Debtor owns, or has
valid leaseholds in or the right to use, each item of the Collateral free and clear of any and all liens or other encumbrances. No security
agreement, financing statement or other public notice with respect to all or any part of the Collateral that evidences a lien securing
any indebtedness is on file or of record in any public office, except such as: (i) have been filed in favor of and for the benefit of
the Secured Parties pursuant to this Agreement; (ii) relate to obligations no longer outstanding or are in respect of commitments to
lend which have been terminated. No written claim has been received that any Collateral or any Debtor&rsquo;s use of any Collateral violates
the rights of any third party. There has been no adverse decision to any Debtor&rsquo;s claim of ownership rights in or exclusive rights
to use the Collateral in any jurisdiction or to any Debtor&rsquo;s right to keep and maintain such Collateral in full force and effect,
and there is no proceeding involving said rights pending or, to the best knowledge of any Debtor, threatened before any court, judicial
body, administrative or regulatory agency, arbitrator or other governmental authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Debtor shall at all times maintain its books of account and records relating to the Collateral at its principal place of business and
its Collateral at the locations set forth on Schedule A attached hereto and may not relocate such books of account and records or tangible
Collateral unless it delivers to the Secured Parties at least thirty (30) days prior to such relocation: (i) written notice of such relocation
and the new location thereof (which must be within the United States); and (ii) evidence that appropriate financing statements under
the UCC and other necessary documents have been filed and recorded and other steps have been taken to perfect the Collateral to create
in favor of the Secured Parties a valid, perfected and continuing perfected lien in the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
This Agreement is effective to create in favor of the Secured Parties a valid and perfected lien and security interest in the Collateral,
subject only to Permitted Liens, securing the payment and performance of the Obligations. Upon making the filings described in the immediately
following paragraph, all security interests created hereunder in any Collateral which may be perfected by filing Uniform Commercial Code
financing statements shall have been duly perfected. Except for the filing of the Uniform Commercial Code financing statements referred
to in the immediately following paragraph, the recordation of the Intellectual Property Security Agreement with respect to copyrights
and copyright applications in the United States Copyright Office, the execution and delivery of deposit account control agreements satisfying
the requirements of Section 9-104(a)(2) of the UCC with respect to each deposit account of the Debtor, and the delivery of the certificates
and other instruments provided in section 3, no action is necessary to create, perfect or protect the security interests created hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Debtor hereby authorizes the Collateral Agent to file one or more financing statements under the UCC, with respect to the Collateral,
with the proper filing and recording agencies in any jurisdiction deemed proper by it. Debtor agrees that at any time and from time to
time, at the expense of the Debtor, it will execute any and all further documents, financing statements, agreements and instruments,
and take all such further actions (including the filing and recording of financing statements and other documents), which may be required
under any applicable law, or which the Collateral Agent may reasonably request, in order: (i) to grant, preserve, protect and perfect
the validity and priority of the Security Interest created or intended to be created hereby; or (ii) to enable the Collateral Agent to
exercise and enforce its rights and remedies hereunder with respect to any Collateral, including the filing of any financing or continuation
statements under the UCC in effect in any jurisdiction with respect to the Security Interest created hereby, all at the expense of such
Debtor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The execution, delivery and performance of this Agreement by the Debtor does not: (i) violate any of the provisions of any articles or
certificate of incorporation or bylaws or other organizational documents (&ldquo;<B>Organizational Documents</B>&rdquo;) of any Debtor
or any judgment, decree, order or award of any court, governmental body or arbitrator or any applicable law, rule or regulation applicable
to any Debtor; or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or
both) of, any agreement, credit facility, debt or other instrument (evidencing any Debtor&rsquo;s debt or otherwise) or other understanding
to which any Debtor is a party or by which any property or asset of any Debtor is bound or affected. If any, all required consents (including,
without limitation, from stockholders or creditors of any Debtor) necessary for any Debtor to enter into and perform its obligations
hereunder have been obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Debtor shall at all times maintain the liens and Collateral provided for hereunder as valid and perfected liens and security interests
in the Collateral in favor of the Secured Parties until this Agreement and the Security Interest hereunder shall be terminated pursuant
to section 14 hereof. Debtor hereby agrees to defend the same against the claims of any and all Persons and entities. Debtor shall safeguard
and protect all Collateral and hold it in trust for the account of the Secured Parties. At the request of the Collateral Agent, Debtor
will sign and deliver to the Collateral Agent on behalf of the Secured Parties at any time or from time to time one or more financing
statements pursuant to the UCC in form reasonably satisfactory to the Collateral Agent and will pay the cost of filing the same in all
public offices wherever filing is, or is deemed by the Collateral Agent to be, necessary or desirable to effect the rights and obligations
provided for herein. Without limiting the generality of the foregoing, Debtor shall pay all fees, taxes and other amounts necessary to
maintain the Collateral and the Collateral hereunder, and Debtor shall obtain and furnish to the Collateral Agent from time to time,
upon demand, such releases and/or subordinations of claims and liens which may be required to maintain the priority of the Collateral
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Debtor will not transfer, pledge, hypothecate, encumber, license, sell or otherwise dispose of any of the Collateral (except for non-exclusive
licenses granted by a Debtor in its ordinary course of business and sales of inventory by a Debtor in its ordinary course of business)
without the prior written consent of a Majority in Interest (defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Debtor shall keep and preserve its equipment, inventory and other tangible Collateral in good condition, repair and order and shall not
operate or locate any such Collateral (or cause to be operated or located) in any area excluded from insurance coverage or outside the
reach of the Collateral Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Debtor shall maintain with financially sound and reputable insurers, insurance with respect to the Collateral, including Collateral hereafter
acquired, against loss or damage of the kinds and in the amounts customarily insured against by entities of established reputation having
similar properties similarly situated and in such amounts as are customarily carried under similar circumstances by other such entities
and otherwise as is prudent for entities engaged in similar businesses but in any event sufficient to cover the full replacement cost
thereof. Debtor shall cause each insurance policy issued in connection herewith to provide, and the insurer issuing such policy to certify
to the Collateral Agent, that: (i) the Collateral Agent or the Secured Parties will be named as lender loss payee and additional insured
under each such insurance policy; (ii) if such insurance be proposed to be cancelled or materially changed for any reason whatsoever,
such insurer will promptly notify the Collateral Agent and such cancellation or change shall not be effective as to the Collateral Agent
for at least thirty (30) days after receipt by the Collateral Agent of such notice, unless the effect of such change is to extend or
increase coverage under the policy; and (iii) the Collateral Agent will have the right (but no obligation) at its election to remedy
any default in the payment of premiums within thirty (30) days of notice from the insurer of such default at the expense of the Debtor.
If no Event of Default (as defined in the Notes) exists and if the proceeds arising out of any claim or series of related claims do not
exceed $100,000, loss payments in each instance will be applied by the applicable Debtor to the repair and/or replacement of property
with respect to which the loss was incurred to the extent reasonably feasible, and any loss payments or the balance thereof remaining,
to the extent not so applied, shall be payable to the applicable Debtor; provided, however, that payments received by any Debtor after
an Event of Default occurs and is continuing or in excess of$100,000 for any occurrence or series of related occurrences shall be paid
to the Collateral Agent on behalf of the Secured Parties and, if received by Debtor, shall be held in trust for the Secured Parties and
immediately paid over to the Collateral Agent unless otherwise directed in writing by the Collateral Agent. Copies of such policies or
the related certificates, in each case, naming the Collateral Agent as lender loss payee and additional insured shall be delivered to
the Collateral Agent upon the execution of this Agreement and at least annually and at the time any new policy of insurance is issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Debtor shall, within ten (10) days of obtaining knowledge thereof, advise the Secured Parties promptly, in sufficient detail, of any
material adverse change in the Collateral, and of the occurrence of any event which would have a material adverse effect on the value
of the Collateral or on the Secured Parties&rsquo; security interest, through the Collateral Agent, therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
Debtor shall permit the Collateral Agent and its representatives and agents to inspect the Collateral during normal business hours and
upon reasonable prior notice, and to make copies of records pertaining to the Collateral as may be reasonably requested by the Collateral
Agent from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
Debtor shall, <I>sua sponte</I>, take all steps reasonably necessary to diligently pursue and seek to preserve, enforce and collect any
rights, claims, causes of action and accounts receivable in respect of the Collateral without the need for a request therefore from the
Collateral Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
Debtor shall promptly notify the Secured Parties in sufficient detail upon becoming aware of any attachment, garnishment, execution or
other legal process levied against any Collateral and of any other information received by Debtor that may materially affect the value
of the Collateral, the Security Interest or the rights and remedies of the Secured Parties hereunder and shall promptly take all necessary
or appropriate action to remediate, mitigate or eliminate such adverse action at its own expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
All information heretofore, herein or hereafter supplied to the Secured Parties by or on behalf of Debtor with respect to the Collateral
is accurate and complete in all material respects as of the date furnished.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
The Debtor shall at all times preserve and keep in full force and effect their respective valid existence and good standing and any rights
and franchises material to its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
At any time and from time to time that any Collateral consists of instruments, certificated securities or other items that require or
permit possession by the Secured Parties to perfect the security interest created hereby, the applicable Debtor shall deliver such Collateral
to the Collateral Agent upon demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
Debtor, in its capacity as issuer, hereby agrees to comply with any and all orders and instructions of Collateral Agent regarding the
Collateral consistent with the terms of this Agreement without the further consent of any Debtor as contemplated by Section 8-106 (or
any successor Section) of the UCC. Further, Debtor agrees that it shall not enter into a similar agreement (or one that would confer
&ldquo;<B>control</B>&rdquo; within the meaning of Article 8 of the UCC) with any other Person or entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
Debtor shall cause all tangible chattel paper constituting Collateral to be delivered to the Collateral Agent, or, if such delivery is
not possible, then to cause such tangible chattel paper to contain a legend noting that it is subject to the security interest created
by this Agreement. To the extent that any Collateral consists of electronic chattel paper, the applicable Debtor shall cause the underlying
chattel paper to be &lsquo;marked&rsquo; within the meaning of Section 9-105 of the UCC (or successor Section thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
Debtor shall immediately provide written notice to the Secured Parties of any and all accounts which arise out of contracts with any
governmental authority and, to the extent necessary to perfect or continue the perfected status of the Collateral in such accounts and
proceeds thereof, shall execute and deliver to the Collateral Agent an assignment of claims for such accounts and cooperate with the
Collateral Agent in taking any other steps required, in its judgment, under the Federal Assignment of Claims Act or any similar federal,
state or local statute or rule to perfect or continue the perfected status of the Collateral in such accounts and proceeds thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
Debtor will from time to time, at the joint and several expense of the Debtor, promptly execute and deliver all such further instruments
and documents, and take all such further action as may be necessary or desirable, or as the Collateral Agent may reasonably request,
in order to perfect and protect any security interest granted or purported to be granted hereby or to enable the Secured Parties to exercise
and enforce their rights and remedies hereunder and with respect to any Collateral or to otherwise carry out the purposes of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5 <U>Effect of Pledge on Certain Rights.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the Collateral subject to this Agreement consists of nonvoting equity or ownership interests (regardless of class, designation,
preference or rights) that may be converted into voting equity or ownership interests upon the occurrence of certain events (including,
without limitation, upon the transfer of all or any of the other stock or assets of the issuer), it is agreed that the pledge of such
equity or ownership interests pursuant to this Agreement or the enforcement of any of Collateral Agent&rsquo;s rights hereunder shall
not be deemed to be the type of event that would trigger such conversion rights notwithstanding any provisions in the Organizational
Documents or agreements to which any Debtor is subject or to which any Debtor is party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6 <U>Defaults.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; text-indent: 0.75in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following events shall be &ldquo;<B>Events of Default</B>&rdquo;:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The occurrence of an Event of Default (as defined in the Notes) under the Notes;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any representation or warranty of any Debtor in this Agreement shall prove to have been incorrect in any material respect when made;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The failure by any Debtor to observe or perform any of its obligations hereunder for ten (10) days after receipt by Debtor of notice
of such failure by or on behalf of a Secured Party unless such default is capable of cure but cannot be cured within such time frame
and Debtor is using best efforts to cure same in a timely fashion, provided that if no cure is provided to the satisfaction of the Secured
Parties within twenty (20) days after such notice, then the failure shall be deemed an Event of Default; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If any provision of this Agreement shall at any time for any reason be declared to be null and void, or the validity or enforceability
thereof shall be contested by any Debtor, or a proceeding shall be commenced by any Debtor, or by any governmental authority having jurisdiction
over any Debtor, seeking to establish the invalidity or unenforceability thereof, or any Debtor shall deny that any Debtor has any liability
or obligation purported to be created under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7 <U>Duty to Hold in Trust.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Upon the occurrence of any Event of Default and at any time thereafter, Debtor shall, upon receipt of any revenue, income, dividend,
interest or other sums subject to the Collateral, whether payable pursuant to the Notes or otherwise, or of any check, draft, note, trade
acceptance or other instrument evidencing an obligation to pay any such sum, hold the same in trust for the Secured Parties and shall
forthwith endorse and transfer any such sums or instruments, or both, to the Secured Parties, pro-rata in proportion to their respective
then-currently outstanding principal amount of Notes for application to the satisfaction of the Obligations (and if any Note is not outstanding,
pro-rata in proportion to the initial purchases of the remaining Notes).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If any Debtor shall become entitled to receive or shall receive any securities or other property (including, without limitation, shares
of pledged securities or instruments representing pledged securities acquired after the date hereof, or any options, warrants, rights
or other similar property or certificates representing a dividend, or any distribution in connection with any recapitalization, reclassification
or increase or reduction of capital, or issued in connection with any reorganization of Debtor or any of its direct or indirect subsidiaries)
in respect of the pledged securities (whether as an addition to, in substitution of, or in exchange for, such pledged securities or otherwise),
Debtor agrees to: (i) accept the same as the Collateral Agent of the Secured Parties; and (ii) hold the same in trust on behalf of and
for the benefit of the Secured Parties; and (iii) to deliver any and all certificates or instruments evidencing the same to Collateral
Agent on or before the close of business on the fifth business day following the receipt thereof by Debtor, in the exact form received
together with the necessary endorsements, to be held by Collateral Agent subject to the terms of this Agreement as Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8 <U>Rights and Remedies Upon Default.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Upon the occurrence of any Event of Default and at any time thereafter, the Secured Parties, acting through the Collateral Agent, shall
have the right to exercise all of the remedies conferred hereunder and under the Purchase Agreement and the Notes, and the Secured Parties
shall have all the rights and remedies of a secured party under the UCC. Without limitation, the Collateral Agent, for the benefit of
the Secured Parties, shall have the following rights and powers:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">The Collateral Agent shall have the right to take possession of the Collateral
and, for that purpose, enter, with the aid and assistance of any Person, any premises where the Collateral, or any part thereof, is or
may be placed and remove the same, or to appoint a receiver for such purpose (without the requirement to post a bond or other surety)
and Debtor shall assemble the Collateral and make it available to the Collateral Agent at places which the Collateral Agent shall reasonably
select, whether at Debtor&rsquo;s premises or elsewhere, and make available to the Collateral Agent, without rent, all of Debtor&rsquo;s
respective premises and facilities for the purpose of the Collateral Agent taking possession of, removing or putting the Collateral in
saleable or disposable form.</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>(ii)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">Upon notice to the Debtor by Collateral Agent, all rights
of Debtor to exercise the voting and other consensual rights which it would otherwise be entitled to exercise and all rights of Debtor
to receive the dividends and interest which it would otherwise be authorized to receive and retain, shall cease. Upon such notice, Collateral
Agent shall have the right to receive, for the benefit of the Secured Parties, any interest, cash dividends or other payments on the
Collateral and, at the option of Collateral Agent, to exercise in such Collateral Agent&rsquo;s discretion all voting rights pertaining
thereto. Without limiting the generality of the foregoing, Collateral Agent shall have the right (but not the obligation) to exercise
all rights with respect to the Collateral as it were the sole and absolute owner thereof, including, without limitation, to vote and/or
to exchange, at its sole discretion, any or all of the Collateral in connection with a merger, reorganization, consolidation, recapitalization
or other readjustment concerning or involving the Collateral or any Debtor or any of its direct or indirect subsidiaries.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>(iii)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">The Collateral Agent shall have the right to operate the
business of Debtor using the Collateral and shall have the right to assign, sell, lease or otherwise dispose of and deliver all or any
part of the Collateral, at public or private sale or otherwise, either with or without special conditions or stipulations, for cash or
on credit or for future delivery, in such parcel or parcels and at such time or times and at such place or places, and upon such terms
and conditions as the Collateral Agent may deem commercially reasonable, all without (except as shall be required by applicable statute
and cannot be waived) advertisement or demand upon or notice to any Debtor or right of redemption of a Debtor, which are hereby expressly
waived. Upon each such sale, lease, assignment or other transfer of Collateral, the Collateral Agent, for the benefit of the Secured
Parties, may, unless prohibited by applicable law which cannot be waived, purchase all or any part of the Collateral being sold, free
from and discharged of all trusts, claims, right of redemption and equities of any Debtor, which are hereby waived and released.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">The Collateral Agent shall have the right (but not the
obligation) to notify any account debtors and any obligors under instruments or accounts to make payments directly to the Collateral
Agent, on behalf of the Secured Parties, and to enforce the Debtor&rsquo;s rights against such account debtors and obligors. Anything
herein to the contrary notwithstanding, Debtor shall remain liable under each of the accounts to observe and perform all the conditions
and obligations to be observed and performed by it thereunder, all in accordance with the terms of any agreement giving rise thereto.
Unless the Collateral Agent has expressly in writing assumed the obligations and liabilities with respect thereto, and released the Debtor
therefrom, neither the Collateral Agent nor any Secured Party shall have any obligation or liability under any account (or any agreement
giving rise thereto) by reason of or arising out of this Agreement or the receipt by the Collateral Agent or any Secured Party of any
payment relating thereto, nor shall the Collateral Agent or any Secured Party be obligated in any manner to perform any of the obligations
of any Debtor under or pursuant to any account (or any agreement giving rise thereto), to make any payment, to make any inquiry as to
the nature or the sufficiency of any payment received by it or as to the sufficiency of any performance by any party thereunder, to present
or file any claim, to take any action to enforce any performance or to collect the payment of any amounts which may have been assigned
to it or to which it may be entitled at any time or times.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Collateral Agent, for the benefit of the Secured Parties, may (but is not obligated to) direct any financial intermediary or any
    other Person or entity holding any investment property to transfer the same to the Collateral Agent, on behalf of the Secured Parties,
    or its designee and all Proceeds received by any Debtor consisting of cash, checks and other near cash items shall be held by such
    Debtor in trust for the Collateral Agent and the Secured Parties, segregated from other funds of such Debtor, and shall, forthwith
    upon receipt by such Debtor, be turned over to the Collateral Agent in the exact form received by such Debtor (duly endorsed by such
    Debtor to the Collateral Agent, if required). All Proceeds received by the Collateral Agent hereunder shall be held by the Collateral
    Agent in a Collateral Account maintained under its dominion and control and on terms and conditions reasonably satisfactory to the
    Collateral Agent. All Proceeds while held by the Collateral Agent in a Collateral Account (or by such Debtor in trust for the Collateral
    Agent and the Secured Parties) shall continue to be held as collateral security for all the Obligations and shall not constitute
    payment thereof until applied.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">The Collateral Agent may (but is not obligated to) transfer any or all Intellectual
Property registered in the name of any Debtor at the United States Patent and Trademark Office and/or Copyright Office into the name
of the Secured Parties or any designee or any purchaser of any Collateral.</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Collateral Agent shall comply with any applicable law in connection with a disposition of Collateral and such compliance will not
be considered adversely to affect the commercial reasonableness of any sale of the Collateral. The Collateral Agent may sell the Collateral
without giving any warranties and may specifically disclaim such warranties. If the Collateral Agent sells any of the Collateral on credit,
the Debtor will only be credited with payments actually made by the purchaser. In addition, Debtor waives any and all rights that it
may have to a judicial hearing in advance of the enforcement of any of the Collateral Agent&rsquo;s rights and remedies hereunder, including,
without limitation, its right following an Event of Default to take immediate possession of the Collateral and to exercise its rights
and remedies with respect thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
For the purpose of enabling the Collateral Agent to further exercise rights and remedies under this section 8 or elsewhere provided by
agreement or applicable law, Debtor hereby grants to the Collateral Agent, for the benefit of the Collateral Agent and the Secured Parties,
an irrevocable, nonexclusive license (exercisable without payment of royalty or other compensation to Debtor) to use, license or sublicense
following an Event of Default, any Intellectual Property now owned or hereafter acquired by Debtor, and wherever the same may be located,
and including in such license access to all media in which any of the licensed items may be recorded or stored and to all computer software
and programs used for the compilation or printout thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9 <U>Application of Proceeds.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proceeds of any such sale, lease or other disposition of the Collateral hereunder or from payments made on account of any insurance policy
insuring any portion of the Collateral shall be applied first, to the expenses of retaking, holding, storing, processing and preparing
for sale, selling, and the like (including, without limitation, any taxes, fees and other costs incurred in connection therewith) of
the Collateral, to the reasonable attorneys&rsquo; fees and expenses incurred by the Collateral Agent in enforcing the Secured Parties&rsquo;
rights hereunder and in connection with collecting, storing and disposing of the Collateral, and then to satisfaction of the Obligations
<I>pro rata</I> among the Secured Parties (based on then-outstanding principal amounts of Notes at the time of any such determination),
and to the payment of any other amounts required by applicable law, after which the Secured Parties shall pay to the applicable Debtor
any surplus proceeds. If, upon the sale, license or other disposition of the Collateral, the proceeds thereof are insufficient to pay
all amounts to which the Secured Parties are legally entitled, the Debtor will be personally liable, jointly and severally, for the deficiency,
together with interest thereon, at the rate of 15% per annum or the lesser amount permitted by applicable law (&ldquo;<B>Default Rate</B>&rdquo;),
and the reasonable fees and expenses of any attorneys employed by the Secured Parties to collect such deficiency. To the extent permitted
by applicable law, Debtor waives all claims, damages and demands against the Secured Parties arising out of the repossession, removal,
retention or sale of the Collateral, unless due solely to the gross negligence or willful misconduct of the Secured Parties as determined
by a final judgment (not subject to further appeal) of a court of competent jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10 <U>Securities Law Provision.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debtor
recognizes that Collateral Agent may be limited in its ability to effect a sale to the public of all or part of the Pledged Securities
by reason of certain prohibitions in the Securities Act of 1933, as amended, or other federal or state securities laws (collectively,
the &ldquo;<B>Securities Laws</B>&rdquo;), and may be compelled to resort to one or more sales to a restricted group of purchasers who
may be required to agree to acquire the pledged securities set forth in Schedule A (&ldquo;<B>Pledged Securities</B>&rdquo;) for their
own account, for investment and not with a view to the distribution or resale thereof. Debtor agrees that sales so made may be at prices
and on terms less favorable than if the Pledged Securities were sold to the public, and that Collateral Agent has no obligation to delay
the sale of any Pledged Securities for the period of time necessary to register the Pledged Securities for sale to the public under the
Securities Laws. Debtor shall cooperate with Collateral Agent in its attempt to satisfy any requirements under the Securities Laws (including,
without limitation, registration thereunder if requested by Collateral Agent) applicable to the sale of the Pledged Securities by Collateral
Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
11 <U>Costs and Expenses.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debtor
agrees to pay all reasonable out-of-pocket fees, costs and expenses incurred in connection with any filing required hereunder, including
without limitation, any financing statements pursuant to the UCC, continuation statements, partial releases and/or termination statements
related thereto or any expenses of any searches reasonably required by the Collateral Agent. The Debtor shall also pay all other claims
and charges which in the reasonable opinion of the Collateral Agent is reasonably likely to prejudice, imperil or otherwise affect the
Collateral or the Collateral therein. The Debtor will also, upon demand, pay to the Collateral Agent the amount of any and all reasonable
expenses, including the reasonable fees and expenses of its counsel and of any experts and Collateral Agents, which the Collateral Agent,
for the benefit of the Secured Parties, may incur in connection with the creation, perfection, protection, satisfaction, foreclosure,
collection or enforcement of the Security Interest and the preparation, administration, continuance, amendment or enforcement of this
Agreement and pay to the Collateral Agent the amount of any and all reasonable expenses, including the reasonable fees and expenses of
its counsel and of any experts and Collateral Agents, which the Collateral Agent, for the benefit of the Secured Parties, and the Secured
Parties may incur in connection with: (i) the enforcement of this Agreement; (ii) the custody or preservation of, or the sale of, collection
from, or other realization upon, any of the Collateral; or (iii) the exercise or enforcement of any of the rights of the Secured Parties
under the Notes. Until so paid, any fees payable hereunder shall be added to the principal amount of the Notes and shall bear interest
at the Default Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
12 <U>Responsibility for Collateral.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Debtor assumes all liabilities and responsibility in connection with all Collateral, and the Obligations shall in no way be affected
or diminished by reason of the loss, destruction, damage or theft of any of the Collateral or its unavailability for any reason. Without
limiting the generality of the foregoing, (a) neither the Collateral Agent nor any Secured Party (i) has any duty (either before or after
an Event of Default) to collect any amounts in respect of the Collateral or to preserve any rights relating to the Collateral, or (ii)
has any obligation to clean-up or otherwise prepare the Collateral for sale, and (b) Debtor shall remain obligated and liable under each
contract or agreement included in the Collateral to be observed or performed by Debtor thereunder. Neither the Collateral Agent nor any
Secured Party shall have any obligation or liability under any such contract or agreement by reason of or arising out of this Agreement
or the receipt by the Collateral Agent or any Secured Party of any payment relating to any of the Collateral, nor shall the Collateral
Agent or any Secured Party be obligated in any manner to perform any of the obligations of any Debtor under or pursuant to any such contract
or agreement, to make inquiry as to the nature or sufficiency of any payment received by the Collateral Agent or any Secured Party in
respect of the Collateral or as to the sufficiency of any performance by any party under any such contract or agreement, to present or
file any claim, to take any action to enforce any performance or to collect the payment of any amounts which may have been assigned to
the Collateral Agent or to which the Collateral Agent or any Secured Party may be entitled at any time or times.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
13 <U>Collateral Absolute.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
rights of the Secured Parties and all obligations of the Debtor hereunder, shall be absolute and unconditional, irrespective of: (i)
any lack of validity or enforceability of this Agreement, the Purchase Agreement, the Notes or any agreement entered into in connection
with the foregoing, or any portion hereof or thereof; (ii) any change in the time, manner or place of payment or performance of, or in
any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to any departure from the Purchase
Agreement, the Notes or any other agreement entered into in connection with the foregoing; (iii) any exchange, release or non-perfection
of any of the Collateral, or any release or amendment or waiver of or consent to departure from any other collateral for, or any guarantee,
or any other security, for all or any of the Obligations; (iv) any action by the Secured Parties to obtain, adjust, settle and cancel
in its sole discretion any insurance claims or matters made or arising in connection with the Collateral; or (v) any other circumstance
which might otherwise constitute any legal or equitable defense available to a Debtor, or a discharge of all or any part of the Collateral
granted hereby. Until the Obligations shall have been paid and performed in full, the rights of the Secured Parties shall continue even
if the Obligations are barred for any reason, including, without limitation, the running of the statute of limitations or bankruptcy.
Debtor expressly waives presentment, protest, notice of protest, demand, notice of nonpayment and demand for performance. In the event
that at any time any transfer of any Collateral or any payment received by the Secured Parties hereunder shall be deemed by final order
of a court of competent jurisdiction to have been a voidable preference or fraudulent conveyance under the bankruptcy or insolvency laws
of the United States, or shall be deemed to be otherwise due to any party other than the Secured Parties, then, in any such event, Debtor&rsquo;s
obligations hereunder shall survive cancellation of this Agreement, and shall not be discharged or satisfied by any prior payment thereof
and/or cancellation of this Agreement, but shall remain a valid and binding obligation enforceable in accordance with the terms and provisions
hereof. Debtor waives all right to require the Secured Parties to proceed against any other person or entity or to apply any Collateral
which the Secured Parties may hold at any time, or to marshal assets, or to pursue any other remedy. Debtor waives any defense arising
by reason of the application of the statute of limitations to any obligation secured hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
14 <U>Term of Agreement.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement and the Collateral shall terminate on the date on which all payments under the Notes have been indefeasibly paid in full and
all other Obligations under the Purchase Agreement have been paid or discharged; provided, however, that all indemnities of the Debtor
contained in this Agreement shall survive and remain operative and in full force and effect regardless of the termination of this Agreement.
Upon such termination, the Collateral Agent shall, within two (2) business days following written request by the Debtor, execute and
deliver all documents and take all actions necessary to evidence the release or termination of the Security Interest, including but not
limited to the prompt filing (or authorization to file) of UCC-3 Termination Statements and any similar documents with the appropriate
filing offices. If the Secured Party fails to execute or authorize the delivery or filing of any UCC-3 termination statement or other
release documentation within the time period set forth in Section (a), then the Company shall have the right, upon five (5) Business
Days&rsquo; prior written notice to the Secured Party, to execute and file such UCC-3 termination statement(s) on behalf of the Secured
Party, and the Secured Party hereby irrevocably appoints the Company as its attorney-in-fact for the limited purpose of effecting such
filings, which appointment shall be coupled with an interest and shall survive the termination of this Note. Failure to comply with this
Section shall constitute a material breach of the Secured Party&rsquo;s obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
15 <U>Power of Attorney; Further Assurances.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Debtor authorizes the Collateral Agent, and does hereby make, constitute and appoint the Collateral Agent and its officers, Collateral
Agents, successors or assigns with full power of substitution, as Debtor&rsquo;s true and lawful attorney-in-fact, with power, in the
name of the Collateral Agent or Debtor, to, after the occurrence and during the continuance of an Event of Default: (i) endorse any note,
checks, drafts, money orders or other instruments of payment (including payments payable under or in respect of any policy of insurance)
in respect of the Collateral that may come into possession of the Collateral Agent; (ii) to sign and endorse any financing statement
pursuant to the UCC or any invoice, freight or express bill, bill of lading, storage or warehouse receipts, drafts against debtors, assignments,
verifications and notices in connection with accounts, and other documents relating to the Collateral; (iii) to pay or discharge taxes,
liens, security interests or other encumbrances at any time levied or placed on or threatened against the Collateral; (iv) to demand,
collect, receipt for, compromise, settle and sue for monies due in respect of the Collateral; (v) to transfer any Intellectual Property
or provide licenses respecting any Intellectual Property; and (vi) generally, at the option of the Collateral Agent, and at the expense
of the Debtor, at any time, or from time to time, to execute and deliver any and all documents and instruments and to do all acts and
things which the Collateral Agent deems necessary to protect, preserve and realize upon the Collateral and the Collateral granted therein
in order to effect the intent of this Agreement and the Notes all as fully and effectually as the Debtor might or could do; and Debtor
hereby ratifies all that said attorney shall lawfully do or cause to be done by virtue hereof. This power of attorney is coupled with
an interest and shall be irrevocable for the term of this Agreement and thereafter as long as any of the Obligations shall be outstanding.
The designation set forth herein shall be deemed to amend and supersede any inconsistent provision in the Organizational Documents or
other documents or agreements to which any Debtor is subject or to which any Debtor is a party. Without limiting the generality of the
foregoing, after the occurrence and during the continuance of an Event of Default, each Secured Party is specifically authorized to execute
and file any applications for or instruments of transfer and assignment of any patents, trademarks, copyrights or other Intellectual
Property with the United States Patent and Trademark Office and the United States Copyright Office.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On a continuing basis, Debtor will make, execute, acknowledge, deliver, file and record, as the case may be, with the proper filing and
recording agencies in any jurisdiction, including, without limitation, the jurisdictions indicated on Schedule C attached hereto, all
such instruments, and take all such action as may reasonably be deemed necessary or advisable, or as reasonably requested by the Collateral
Agent, to perfect the Collateral granted hereunder and otherwise to carry out the intent and purposes of this Agreement, or for assuring
and confirming to the Collateral Agent the grant or perfection of a perfected security interest in all the Collateral under the UCC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Debtor hereby irrevocably appoints the Collateral Agent as Debtor&rsquo;s attorney-in-fact, with full authority in the place and instead
of Debtor and in the name of Debtor, from time to time in the Collateral Agent&rsquo;s discretion, to take any action and to execute
any instrument which the Collateral Agent may deem necessary or advisable to accomplish the purposes of this Agreement, including the
filing, in its sole discretion, of one or more financing or continuation statements and amendments thereto, relative to any of the Collateral
without the signature of Debtor where permitted by law, which financing statements may (but need not) describe the Collateral as &lsquo;all
assets&rsquo;, &lsquo;all assets now owned or hereafter acquired&rsquo; or &lsquo;all personal property&rsquo; or words of like import,
and ratifies all such actions taken by the Collateral Agent. Debtor hereby also authorizes the Collateral Agent, at any time and from
time to time, to file continuation statements with respect to previously filed financing statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
This power of attorney is coupled with an interest and shall be irrevocable for the term of this Agreement and thereafter as long as
any of the Obligations shall be outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
16 <U>Notices.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
notices, requests, demands and other communications hereunder shall be subject to the notice provision of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
17 <U>Power of Attorney; Further Assurances.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that the Obligations are now or hereafter secured by property other than the Collateral or by the guarantee, endorsement or
property of any other Person, firm, corporation or other entity, then the Collateral Agent shall have the right, in its sole discretion,
to pursue, relinquish, subordinate, modify or take any other action with respect thereto, without in any way modifying or affecting any
of the Secured Parties&rsquo; rights and remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
18 <U>Appointment of Collateral Agent.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Secured Parties may appoint a person or entity to act on their behalf with respect to the Collateral pledged hereby (&ldquo;<B>Collateral
Agent</B>&rdquo;) and any action to be taken hereunder by the Secured Parties may be taken by the Collateral Agent on their behalf and
in their place and stead without further action on the part of the Secured Parties. <B>The initial Collateral Agent shall be the Lead
Investor.</B> The name and contact information of the Collateral Agent and any replacement Collateral Agent shall be provided in writing
to the Debtor at any time or from time to time and shall be binding upon the parties hereto without more. Any reference herein to the
Collateral Agent or to the Secured Parties may apply to either or both as the context may require. The fees and reasonable expenses of
the Collateral Agent shall be the obligation of the Debtor which hereby agrees to pay such fees and expenses upon demand. Any such appointment
shall continue until revoked in writing by a majority of the then outstanding principal balance in interest of the Notes (&ldquo;<B>Majority
in Interest</B>&rdquo;), at which time a Majority in Interest shall appoint a new Collateral Agent. The Collateral Agent, if any, shall
have the rights, responsibilities and immunities set forth in Schedule B hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
19 <U>Miscellaneous.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
No course of dealing between the Debtor and the Secured Parties or the Collateral Agent, nor any failure to exercise, nor any delay in
exercising, on the part of the Secured Parties or the Collateral Agent, any right, power or privilege hereunder or under the Purchase
Agreement or the Notes shall operate as a waiver thereof; nor shall any single or partial exercise of any right, power or privilege hereunder
or thereunder preclude any other or further exercise thereof or the exercise of any other right, power or privilege.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All of the rights and remedies of the Secured Parties with respect to the Collateral, whether established hereby or by the Notes or by
any other agreements, instruments or documents or by law shall be cumulative and may be exercised singly or concurrently.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
This Agreement, the Purchase Agreement and the Notes, together with the exhibits and schedules hereto and thereto, contain the entire
understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or
written, with respect to such matters, which the parties acknowledge have been merged into this Agreement and the exhibits and schedules
hereto. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the
case of an amendment, by the Debtor and the Secured Parties holding 67% or more of the principal amount of Notes then outstanding, or,
in the case of a waiver, by the party against whom enforcement of any such waived provision is sought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall
any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Debtor may
not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Secured Party (other than
by merger). Any Secured Party may assign any or all of its rights under this Agreement to any Person (as defined in the Purchase Agreement)
to whom such Secured Party assigns or transfers any Obligations, provided such transferee agrees in writing to be bound, with respect
to the transferred Obligations, by the provisions of this Agreement that apply to the &ldquo;Secured Parties.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Each party shall take such further action and execute and deliver such further documents as may be necessary or appropriate in order
to carry out the provisions and purposes of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Except to the extent mandatorily governed by the jurisdiction or situs where the Collateral is located, all questions concerning the
construction, validity, enforcement, and interpretation of this Agreement shall be governed by and construed and enforced in accordance
with the internal laws of the State of Delaware, without regard to the principles of conflicts of law thereof. Except to the extent mandatorily
governed by the jurisdiction or situs where the Collateral is located, Debtor agrees that all proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement, the Purchase Agreement and the Notes (whether brought against
a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or Collateral Agents) shall
be governed by Section 5.08 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and, all
of which taken together shall constitute one and the same Agreement. In the event that any signature is delivered by facsimile or electronic
transmission, such signature shall create a valid binding obligation of the party executing (or on whose behalf such signature is executed)
the same with the same force and effect as if such facsimile signature were the original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Debtor shall indemnify, reimburse and hold harmless the Collateral Agent and the Secured Parties and their respective partners, members,
shareholders, officers, directors, employees and agents (collectively, &ldquo;<B>Indemnitees</B>&rdquo;) from and against any and all
losses, claims, liabilities, damages, penalties, suits, costs and expenses, of any kind or nature, (including fees relating to the cost
of investigating and defending any of the foregoing) imposed on, incurred by or asserted against such Indemnitee in any way related to
or arising from or alleged to arise from the Purchase Agreement, the Notes, this Agreement or the Collateral, except any such losses,
claims, liabilities, damages, penalties, suits, costs and expenses which result from the gross negligence or willful misconduct of the
Indemnitee as determined by a final, non-appealable decision of a court of competent jurisdiction. This indemnification provision is
in addition to, and not in limitation of, any other indemnification provision in the Notes, the Purchase Agreement or any other agreement,
instrument or other document executed or delivered in connection herewith or therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Nothing in this Agreement shall be construed to subject Collateral Agent or any Secured Party to liability as a fiduciary, joint-venturer,
agent or partner in any Debtor or any if its direct or indirect subsidiaries that is a partnership or as a member or manager in any Debtor
or any of its direct or indirect subsidiaries that is a limited liability company, nor shall Collateral Agent or any Secured Party be
deemed to have assumed any obligations under any partnership agreement or limited liability company agreement, as applicable, of any
Debtor or any of its direct or indirect subsidiaries or otherwise, unless and until any such Secured Party exercises its right to be
substituted for Debtor as a partner or member, as applicable, pursuant hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
To the extent that the grant of the security interest in the Collateral and the enforcement of the terms hereof require the consent,
approval or action of any partner or member, as applicable, of any Debtor or any direct or indirect subsidiary of any Debtor or compliance
with any provisions of any of the Organizational Documents, the Debtor hereby grants such consent and approval and waives any such noncompliance
with the terms of said documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
Debtor further agrees that, if any payment made by the Debtor or other Person and applied to the Obligations is at any time annulled,
avoided, set aside, rescinded, invalidated, declared to be fraudulent or preferential or otherwise required to be refunded or repaid,
or the proceeds of Collateral are required to be returned by any Secured Party to the Debtor, its estate, trustee, receiver or any other
Person, including any Debtor, under any bankruptcy law, state or federal law, common law or equitable cause, then, to the extent of such
payment or repayment, any lien or other Collateral securing such liability shall be and remain in full force and effect, as fully as
if such payment had never been made or, if prior thereto the lien granted hereby or other Collateral securing such liability hereunder
shall have been released or terminated by virtue of such cancellation or surrender, such lien or other Collateral shall be reinstated
in full force and effect, and such prior cancellation or surrender shall not diminish, release, discharge, impair or otherwise affect
any lien or other Collateral securing the obligations of any Debtor in respect of the amount of such payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
Notwithstanding anything to the contrary in this Agreement and the Transaction Documents, the Debtor shall, from the day it becomes aware
of an Event of Default (either via notification by a Secured Party, or otherwise) have (30) days (&ldquo;Enforcement Period&rdquo;) until
which the Collateral Agent may take any action to foreclose on and sell the Collateral hereunder. If such circumstances pose immediate
or imminent harm to the Secured Parties, the Enforcement Period will be shortened to (1) day. If the Debtor does not cure the Event of
Default within such Enforcement Period, the Collateral Agent may exercise the rights and remedies available to it under this Agreement
and applicable law. The Collateral Agent may exercise remedies related to the Collateral only following expiration of the Enforcement
Period. The Debtor and Secured Parties shall each notify the other within one (1) day of becoming aware of the occurrence or existence
of an Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
Any sale or other disposition of the Collateral shall be conducted in a commercially reasonable public manner and in accordance with
applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>Signature
Page Follows</I>)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the parties hereto have caused this Security Agreement to be duly executed on the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPHASE
                                            LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
                                            Karkus</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                            Executive Officer</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPHASE
                                            BIOPHARMA, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
                                            Karkus</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
                                            Officer</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEBULA GENOMICS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
                                            Karkus</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
                                            Officer</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TK SUPPLEMENTS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
                                            Karkus</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
                                            Officer</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DNA COMPLETE, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
                                            Karkus</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
                                            Officer</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[SIGNATURE
PAGE OF HOLDER(S) FOLLOWS]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURE
PAGE OF HOLDERS OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>20%
OID SENIOR SECURED CONVERTIBLE NOTES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing entity</I>: _____________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: __________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing entity</I>: _______________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: __________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ___________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Investor/Holder
Signature Page to Security Agreement]</I></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
A</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
Place(s) of Business of Debtor and where Collateral is Located and Stored:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Name and Organizational Identification Numbers</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
Labs, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EIN:
23-2577138</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TK
Supplements, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EIN:
47-4603042</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nebula
Genomics Holdings, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EIN:
87-1110117</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
BioPharma, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EIN:
88-3027733</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DNA
Complete, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EIN:
99-5143645</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
and Privileges of the Collateral Agent</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
C</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing
Jurisdictions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
F</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
Property</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
H</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pledged
Securities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rights
and Privileges of the Collateral Agent</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B><U>Collateral Agent&rsquo;s Appointment as Attorney-in-Fact, etc.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Secured Parties shall appoint, and the Debtor hereby consents to and approves such appointment, which appointment is coupled with
an interest, and shall automatically terminate on the date that all Obligations under the Purchase Agreement, this Agreement and the
Notes (subject to the reinstatement provision of section 6 hereof) (&ldquo;<B>Termination Date</B>&rdquo;), the Collateral Agent and
any officer or agent thereof, with full power of substitution, as Debtor&rsquo;s true and lawful attorney-in-fact with full irrevocable
power and authority in the place and stead of such Debtor and in the name of such Debtor or otherwise, for the purpose of carrying out
the terms of this Agreement, to take any and all appropriate action and to execute any and all documents and instruments that may be
necessary or advisable to accomplish the purposes of this Agreement, and, without limiting the generality of the foregoing, Debtor hereby
gives the Collateral Agent the power and right, on behalf of such Debtor, either in the Collateral Agent&rsquo;s name or in the name
of such Debtor or otherwise, without assent by such Debtor, to do any or all of the following, in each case after the occurrence and
during the continuance of an Event of Default all without prior notice to the Debtor (provided that the Collateral Agent shall provide
prompt notice to the Debtor thereafter of the initial exercise of any such rights): (i) take possession of and endorse and collect any
checks, drafts, notes, acceptances or other instruments for the payment of moneys due under any account constituting Collateral or with
respect to any other Collateral and file any claim or take any other action or proceeding in any court of law or equity or otherwise
deemed appropriate by the Collateral Agent for the purpose of collecting any and all such moneys due under any account constituting Collateral
or with respect to any other Collateral whenever payable; (ii) in the case of any Intellectual Property, execute and deliver, and have
recorded, any and all agreements, instruments, documents and papers as the Collateral Agent may reasonably request to evidence the Security
Interest in such Intellectual Property and the goodwill and general intangibles of such Debtor relating thereto or represented thereby;
(iii) pay or discharge taxes and liens levied or placed on or threatened against any of the Collateral (other than taxes not required
to be discharged under this Agreement and other than Permitted Liens); (iv) execute, in connection with any sale provided for in this
Agreement, any endorsements, assignments or other instruments of conveyance or transfer with respect to any of the Collateral; (v) obtain
and adjust insurance required to be maintained by such Debtor pursuant to this Agreement; (vi) direct any party liable for any payment
under any of the Collateral to make payment of any and all moneys due or to become due thereunder directly to the Collateral Agent or
as the Collateral Agent shall direct; (vii) ask or demand for, collect and receive payment of and receipt for, any and all moneys, claims
and other amounts due or to become due at any time in respect of or arising out of any of the Collateral; (viii) sign and endorse any
invoices, freight or express bills, bills of lading, storage or warehouse receipts, drafts against debtors, assignments, verifications,
notices and other documents in connection with any of the Collateral; (ix) commence and prosecute any suits, actions or proceedings at
law or in equity in any court of competent jurisdiction to collect the Collateral or any portion thereof and to enforce any other right
in respect of any of the Collateral; (x) defend any suit, action or proceeding brought against such Debtor with respect to any of the
Collateral; (xi) settle, compromise or adjust any such suit, action or proceeding with respect to any of the Collateral and, in connection
therewith, give such discharges or releases as the Collateral Agent may deem appropriate; and (xii) generally, sell, transfer, pledge
and make any agreement with respect to or otherwise deal with any of the Collateral as fully and completely as though the Collateral
Agent were the absolute owner thereof for all purposes, and do, at the Collateral Agent&rsquo;s option and such Debtor&rsquo;s expense,
at any time, or from time to time, all acts and things that the Collateral Agent deems necessary to protect, preserve or realize upon
the Collateral and the Security Interest therein and to effect the intent of this Agreement, all as fully and effectively as such Debtor
might do.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Subject to any limitations of the Collateral Agent to take actions as set forth in clause (a) above, if any Debtor fails to perform or
comply with any of its agreements contained herein within a reasonable period of time after the Collateral Agent has requested it to
do so, the Collateral Agent, at its option, but without any obligation so to do, may perform or comply, or otherwise cause performance
or compliance, with such agreement at Debtor&rsquo;s sole expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">DB-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Debtor hereby ratifies all that said attorneys shall lawfully do or cause to be done by virtue hereof. All powers, authorizations and
agencies contained in this Agreement are coupled with an interest and are irrevocable until this Agreement is terminated and the Security
Interest created hereby is released.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B><U>Duty of Collateral Agent</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Collateral Agent&rsquo;s sole duty with respect to the custody, safekeeping and physical preservation of the Collateral in its possession,
under Section 9-207 of the UCC or otherwise, shall be to deal with it in the same manner as the Collateral Agent deals with similar property
for its own account. The Collateral Agent shall be deemed to have exercised reasonable care in the custody and preservation of any Collateral
in its possession if such Collateral is accorded treatment substantially equal to that which the Collateral Agent accords its own property.
Neither the Collateral Agent, any Secured Party nor any of their respective officers, directors, employees, attorneys in fact or agents
shall be liable for failure to demand, collect or realize upon any of the Collateral or for any delay in doing so or shall be under any
obligation to sell or otherwise dispose of any Collateral upon the request of any Debtor or any other Person or to take any other action
whatsoever with regard to the Collateral or any part thereof. The powers conferred on the Collateral Agent and the Secured Parties hereunder
are solely to protect the Collateral Agent&rsquo;s and the Secured Parties&rsquo; interests in the Collateral and shall not impose any
duty upon the Collateral Agent or any Secured Party to exercise any such powers. The Collateral Agent and the Secured Parties shall be
accountable only for amounts that they actually receive as a result of the exercise of such powers, and neither they nor any of their
officers, directors, employees or agents shall be responsible to any Debtor for any act or failure to act hereunder, except for their
own respective gross negligence or willful gross misconduct as determined in a final non-appealable judgment of a court of competent
jurisdiction. The Collateral Agent shall not be responsible for or have any duty to ascertain or inquire into any representation or warranty
regarding the existence, value or collectability of the Collateral, the existence, priority or perfection of the Collateral Agent&rsquo;s
lien thereon, or any certificate prepared by the Debtor in connection therewith, nor shall the Collateral Agent be responsible or liable
to the Secured Parties for any failure to monitor or maintain any portion of the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><U>Authority of Collateral Agent</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debtor
acknowledges that the rights and responsibilities of the Collateral Agent under this Agreement with respect to any action taken by the
Collateral Agent or the exercise or non-exercise by the Collateral Agent of any option, voting right, request, judgment or other right
or remedy provided for herein or resulting or arising out of this Security Agreement shall, as between the Collateral Agent and the Secured
Parties, be governed by this Agreement, and by such other agreements with respect thereto as may exist from time to time among them,
but, as between the Collateral Agent and the Debtor, the Collateral Agent shall be conclusively presumed to be acting as agent for the
applicable Secured Parties with full and valid authority so to act or refrain from acting, and no Debtor shall be under any obligation,
or entitlement, to make any inquiry respecting such authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B><U>Security Interest Absolute</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
rights of the Collateral Agent hereunder, the Security Interest and all Obligations of the Debtor hereunder shall be absolute and unconditional.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">DB-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B><U>Continuing Security Interest; Assignments Under this Agreement; Release</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
This Agreement shall remain in full force and effect and be binding in accordance with and to the extent of its terms upon Debtor and
the successors and assigns thereof and shall inure to the benefit of the Collateral Agent and the Secured Parties and their respective
successors, endorsees, transferees and assigns permitted under this Agreement until the Termination Date (subject to the reinstatement
provision of section 6 below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Security Interest granted hereby in any Collateral shall automatically be released as it relates to the Obligations upon the effectiveness
of any written consent to the release of the Security Interest granted hereby by the Secured Parties or the Collateral Agent. Any such
release in connection with any sale, transfer or other disposition of such Collateral permitted under this Agreement to a Person that
is not a Debtor shall result in such Collateral being sold, transferred or disposed of, as applicable, free and clear of the lien and
Security Interest created hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
In connection with any termination or release pursuant to clause (a) or clause (b) above, the Collateral Agent shall execute and deliver
to any Debtor, at such Debtor&rsquo;s expense, all documents that such Debtor shall reasonably request to evidence such termination or
release subject to, if reasonably requested by the Collateral Agent, the Collateral Agent&rsquo;s receipt of a certification by the Company
stating that such transaction is in compliance with this Agreement, the Purchase Agreement and Notes. Any execution and delivery of documents
pursuant to this section 5 shall be without recourse to or warranty by the Collateral Agent. In connection with any termination or release
of the Security Interest, the Collateral Agent shall, within two (2) business days following written request by the Debtor, execute and
deliver to the Debtor, at such Debtor&rsquo;s expense, all documents and take all actions reasonably necessary to evidence such termination
or release, including but not limited to the prompt filing (or authorization to file) of UCC-3 Termination Statements and any similar
documents with the appropriate filing offices. If the Secured Party fails to execute or authorize the delivery or filing of any UCC-3
termination statement or other release documentation within the time period set forth herein, then the Company shall have the right,
upon five (5) Business Days&rsquo; prior written notice to the Secured Party, to execute and file such UCC-3 termination statement(s)
on behalf of the Secured Party, and the Secured Party hereby irrevocably appoints the Company as its attorney-in-fact for the limited
purpose of effecting such filings, which appointment shall be coupled with an interest and shall survive the termination of this Note.
Failure to comply with this Section shall constitute a material breach of the Secured Party&rsquo;s obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<B><U>Reinstatement</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debtor
further agrees that, if any payment made by the Debtor or other Person and applied to the Obligations is at any time annulled, avoided,
set aside, rescinded, invalidated, declared to be fraudulent or preferential or otherwise required to be refunded or repaid, or the proceeds
of Collateral are required to be returned by any Secured Party to the Debtor, its estate, trustee, receiver or any other Person, including
any Debtor, under any bankruptcy law, state or federal law, common law or equitable cause, then, to the extent of such payment or repayment,
any lien or other Collateral securing such liability shall be and remain in full force and effect, as fully as if such payment had never
been made or, if prior thereto the lien granted hereby or other Collateral securing such liability hereunder shall have been released
or terminated by virtue of such cancellation or surrender, such lien or other Collateral shall be reinstated in full force and effect,
and such prior cancellation or surrender shall not diminish, release, discharge, impair or otherwise affect any lien or other Collateral
securing the obligations of any Debtor in respect of the amount of such payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<B><U>Liability</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Collateral Agent nor any of its managers, members, officers, directors, employees, agents, attorneys in fact or affiliates shall
be liable to any party for any action taken or omitted to be taken by any of them under or in connection with this Agreement or any other
agreement, document or instrument except for its or such other Person&rsquo;s own gross negligence or willful gross misconduct, as determined
in a final non-appealable judgment of a court of competent jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">DB-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing
Jurisdictions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
F</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method
&amp; composition for topical treatment of diabetic neuropathy</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US&#8239;7,914,823</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nutritional
product for enhancing physical performance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US&#8239;11,426,439</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Be-Smart
Patent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US-11874277-B2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equivir
licensed patents</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US
Pat. No. 10,383,842 Method and composition for preventing and treating viral infections 12</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US
Pat. No. 11,033,528 Method and composition for preventing and treating viral infections 13</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US
appln 17/346,569 Method and composition for preventing and treating viral infections 14</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US
appln 17/346,602 Method and composition for preventing and treating viral infections</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Linebacker
licensed patents</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US
10,123,991</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US
10,966,954</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
H</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pledged
Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>None</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 25; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>ex10-6.htm
<DESCRIPTION>EX-10.6
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.6</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-6_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
<U>22</U>, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equiniti
Trust Company LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28
Liberty Street, Floor 53</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10005</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
REDACTED, Team Lead<BR>
Team Email: REDACTED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Instruction
to Reserve Shares</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned ProPhase Labs, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), and certain investors identified therein (the &ldquo;Investors&rdquo;),
including the undersigned REDACTED (&ldquo;<B>Lead Investor</B>&rdquo;) have entered into a Securities Purchase Agreement dated as of
the date hereof (the &ldquo;Agreement&rdquo;) providing for the issuance of the Company&rsquo;s Senior Secured Convertible Note(s) (&ldquo;<B>Note</B>s&rdquo;)
and Warrants (&ldquo;<B>Warrants</B>&rdquo;; and collectively with the Notes, &ldquo;<B>Securities</B>&rdquo;) to purchase Common Stock,
par value $0.0005 per share, of the Company (&ldquo;<B>Common Stock</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
as the Company&rsquo;s duly appointed and acting transfer agent for the Common Stock (&ldquo;<B>Transfer Agent</B>&rdquo;) are hereby
irrevocably authorized and instructed to reserve a specified number of shares of Common Stock (initially being 1,000,0000 shares of Common
Stock) for issuance upon any partial or full conversion of Notes and/or exercise of Warrants in accordance with the terms thereof. In
the event of a stock split, the reserve amount will be automatically adjusted with the same ratio as the stock split. <B>The amount of
Common Stock so reserved may be increased, from time to time, only upon the written instructions of the Company or the Lead Investor.</B>
Without limiting the generality of foregoing, upon the Company&rsquo;s obtaining of the Stockholder Approval (as defined and provided
in Section 4.03 of the Agreement) the Company shall and the Lead Investor may instruct the Transfer Agent to increase such amount reserved
to 226,310,704 shares. The Company and Lead Investor understand that the Transfer Agent will only increase the reserve if authorized
unissued shares of Common Stock are available and have not been previously reserved. Further, conversions and exercises will only be
processed should there be sufficient unissued, but authorized shares of Common Stock available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability to convert or exercise the Securities in a timely manner is a material obligation of the Company pursuant to such Securities.
You have the right to rely on each notice of conversion or exercise (&ldquo;<B>Notice</B>&rdquo;) as presented and have no responsibility
to verify the conversion formula used. <B>Provided you are acting as Transfer Agent at the time</B>, your firm is hereby irrevocably
authorized and instructed to within two (2) trading days issue shares of Common Stock to relevant Investors without any further action
or confirmation by the Company upon your receipt from the relevant Investor of: (i) a Notice executed by such Investor; (ii) opinion
of counsel confirming that the shares to be issued have been registered and the relevant registration statement under the Securities
Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), is currently effective or an opinion of counsel of such Investor or
the Company, in form, substance and scope customary for opinions of counsel in comparable transactions (and satisfactory to the Transfer
Agent), to the effect that the applicable shares of Common Stock are not &ldquo;restricted securities&rdquo; as defined in Rule 144 and
otherwise may be issued pursuant to Rule 144 under the Securities Act without any transfer restrictions; and (iii) customary seller representation
letter for sales made under Rule 144 signed by such Investor if applicable. Such shares should be issued and delivered, at the option
of the Investor as specified in the Notice or similar instruction either (i) electronically if the Company is approved by The Depository
Trust Company (&ldquo;DTC&rdquo;) for Deposit Withdrawal at Custodian (&ldquo;DWAC&rdquo;) processing by making the shares available
in book-entry form for further credit to the Investor&rsquo;s account at a participant broker with DTC through its DWAC system, provided
the Investor causes its broker or bank to properly initiate a DWAC deposit, or (ii) in certificated form without any restrictive legend
which would restrict the transfer of the shares; <I>provided, however,</I> that if such shares are not registered for resale under the
Securities Act or are not able to be sold under Rule 144 and you have not received an opinion of counsel that the issuance of the shares
is exempt from registration under the Securities Act, then the issued certificates for such shares shall bear the following restrictive
legend:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY
NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unissued shares of Common Stock shall remain in the created reserve with you, the Transfer Agent, until the Lead Investor <B><U>and</U></B>
an authorized officer of the Company provide written instructions to you that the shares or any part of them shall be taken out of the
reserve and shall no longer be subject to the terms of these instructions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall indemnify you and your officers, directors, principals, partners, agents and representatives, and hold each of them harmless
from and against any and all loss, liability, damage, claim or expense (including the reasonable fees and disbursements of its attorneys)
incurred by or asserted against you or any of them arising out of or in connection with the instructions set forth herein, the performance
of your duties hereunder and otherwise in respect hereof, including the costs and expenses of defending yourself or themselves against
any claim or liability hereunder. Such indemnification includes any claim made by the Company against you with respect to these instructions
or the performance of your duties hereunder. You shall have no liability to the Company in respect of this, and you shall be entitled
to rely in this regard on the advice of counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors of the Company has approved the foregoing IRREVOCABLE INSTRUCTIONS. The Company hereby confirms to you that no instruction
other than as contemplated herein will be given to you by Company with respect to the matters referenced herein. Company hereby authorizes
you, and you shall be obligated, to disregard any contrary instruction received by or on behalf of Company or any other person purporting
to represent Company. At your sole discretion, you are also authorized to release any information you deem necessary for the processing,
clearing, and settlement of the shares arising from this reservation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
any other provision hereof, Company and Lead Investor understand that you shall not be required to perform any issuance or transfer of
shares of Common Stock underlying the Securities if (i) such an issuance or transfer of shares is in violation of any state or federal
securities laws or regulations, or (ii) the issuance or transfer of such shares is prohibited or stopped as required or directed by an
order of a court of competent jurisdiction. The Company is responsible for all fees associated with the conversion of Notes and exercise
of Warrants, including delivery and transfer of shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company agrees that in the event that you resign or are terminated as the Company&rsquo;s Transfer Agent, the Company shall engage a
suitable replacement agent that will agree to serve as agent for the Company within five (5) business days. You reserve the right to
resign as Transfer Agent at any time in accordance with the terms of your agreement(s) with the Company, and upon either voluntary resignation
or termination by the Company, your obligations under this letter shall cease immediately and you shall have no further obligations to
act under these instructions. Notwithstanding the foregoing, the Company acknowledges that you will complete any pending Notice that
is outstanding at the time of termination by either party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
letter is governed by the laws of the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page Follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investor is intended to be and is a third-party beneficiary hereof, and no amendment or modification to the instructions set forth herein
may be made without the consent of the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPHASE LABS, INC</B>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted Karkus</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Acknowledged
and Agreed:</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Lead
Investor:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REDACTED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REDACTED</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Partner</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transfer
Agent:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EQUINITI
TRUST COMPANY LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex10-6_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-6_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !3 24# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
:4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>prph-20250728.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa6KSbP9z5Z8WekhvWBxbbkqnyUr9PyicSRkijn2kY4F -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:PRPH="http://prophaselabs.com/20250728" elementFormDefault="qualified" targetNamespace="http://prophaselabs.com/20250728">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://prophaselabs.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="prph-20250728_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="prph-20250728_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>prph-20250728_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>prph-20250728_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="prph-20250728.xsd#Cover" roleURI="http://prophaselabs.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://prophaselabs.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 28, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 28,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-21617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PROPHASE
LABS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000868278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">23-2577138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">626
                                            RXR Plaza<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">6th
                                            Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Uniondale<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(215)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">345-0919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.0005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRPH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>prph-20250728.xsd</File>
    <File>prph-20250728_lab.xml</File>
    <File>prph-20250728_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "PRPH",
   "nsuri": "http://prophaselabs.com/20250728",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "prph-20250728.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "prph-20250728_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prph-20250728_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://prophaselabs.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-07-28",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-07-28",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001641172-25-021109-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-021109-xbrl.zip
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MU+PNDBJ!GY[4Q?PR*E4PN2B46L)3@U$%%P7_3./_U/E+F"OS#4[7/POZ>!S
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M^(R96B15L$HC27K1F4/QQVB%QXU5#)Q7U>J$<SZSDN(<)I3J3K/[3,FG>5-
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M Y9G$B,N@9?[;QX:N3/N'+?0BMRBV[XQN%:-N_J7>Z_,MC99@4FEEHV"3YT
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M*^F!Q[OT0F6P(]) P=V18)9T4 Z"A*D]IWQ!5MFI9Y!?@@A%]%9"03(<P"C
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MF*1)"CVOE/52MY C4BM)B5&A:V^!9T3WTH;2FC0*%F3I#WE(%-#2V'6NI,=
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M\"#&C>( !E:0&G5K-+H \WC1YW2(& Z<LD2#NG"J-J@K6M8R1*AHD=S9-K)
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M\7L9Q.F$/J&L37L<^^=XVR??/WL6!O *$S!;#V#0([Q0X!'.8.!RT[\%'G@
M_[._?WR*B=-W_PZ#]Y-_!S ', 5PTS?T]O!"9\?OZ&6G)^?!R8?3LP\36-SS
M8QHP7+5_?O@SF/_>8.D5*9O4->R 1GW:O-GDY\GA.\KG^O,0XK4P79, ;G]T
M!C_&;W"<9Q]>_Q<\'WX?TB/<,>"(_N^'PU/?D&\, I<1[TR30$M!JSTY.7EW
MN$]#X<5R?O9N\LL9SO3TY\.#*?SB('C];QC:N^E/DW?!\<GAD:ST_O&'H[/I
M.Y#;8WHRC1WF%"7D.*",',\>#QU>!5-R^Y158^D]>SMY]P[7XG0Z.3L^@N'\
M&T<*RT CD_N"?)V 5/7'Y-TS+7S;PS5ZN,:=P#6^?:APC9W;WCM@;A'AW(>5
M!'?;24G&CG>6_%"767)A-3R\[2BY3J7V%CDAZ6<IL %RGD6S%%Q'@R,LA:NY
MS(W)'3(>H5!SE:R8$QAF"=ZT6)MPKU,[T'J?69%_Q&YR\OCV@ G7D*<Q@4KY
M:J_.KAS[SJ[%P6K6Q7E>,HQ184:T0J@]@6(YDZX=6L<!=CS>5&&>?4/[Z^'
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M]>L!@Q6Q!$7PS[JF5V,UQHX5HKNV29B!JI/F&$1@6\AIZG9#M3GWT*,J!V/
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M\['-11^H&7@G-A?%$;1-< _/5*("&<NSV(S%2G2Z2E*=@"?+G] IE^"$8S0
M;)<YE96@;AV;*@DPY"@R:$L-+6TC.302C"$HLC+_XE^?P."3>NF"0&R.I"NP
M]P=LOWZSW45VUY/S.]UE_@[:8G=PEFK[[1%LVAWUBH2<JN<>+1"!;O;(TQ=;
M;!%3\_ 9>R3XP[9(;W[<$Z,2<HV7R"* /G5YIWO#WO>K;HS?=VSP,&[>$_+/
MCCW1B_\.B7\LAT.1!Z=1%>EUE4V T9VVH#2K5GQYY>(@2CS96NB-LL1;04 E
M6#8F39(XBY3$ OEP:'\Q1XYF'/_R^C('CQ-&A]?-L8F8Q'DZ'_CJ\$=XBZ"
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MU0JM6N2DJ;C@%ITBIIS:!19[N!"6!GZ0,B53.?+J#]*R4&ZB<I%I%L)=C,<
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MZ'2TA+R,N 7CW5*WQ,@2T$%9T/]JSXV0D9?V&>D!,.?4IDTK%2?G) \=D[;
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M^O!#H,3S.5BWI4N*Q'3@LZ6$'GQJQ.!H5B_&3',E_1K_8HH*F*! MP(;6[R
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MU#NG%W#D$MC%^^'CVY+'>M*Q?]+H<J(B(CKS#,:16#$VYX63KIX@UWHB352
M"-[OC8A!ZAJQ*3 DSOIU\37!]&3.$HPXD?F4&2P*RS.JPAJ=GF'(M]]S&5]2
MN+SX*?#BQW<"CY6PE$=883"A;FA@]F63ND#@EA)H(PQF=01,I5** 7ZFXCI6
MGY*2:? 09C@&OI*Q0<@=A$J5B0\:LY@<1M0EYP(4<T/8U,,W2Q#(H,+"NRF9
MRT0W)!"8<5_AJN#,;$GV OGWHSB'CQ*4E9F(_!3SZ3'D,:"ZOBD5]4FBM@#6
MK*STV]#N0UG68#ID5"&@76!>&)GC9O+L.\E _5GF3JK->(71K9!T(XI99!G3
M8P5_ X4DE.1/:E6,Z2E4;43Z*#L]I&1(]":)ZHG&*+XXS/+'!O5NU/GQ;?QC
MI:?9D/Q6J[#?@_]JO1B+U32_XZ^#QK?&5QM-J-2#S1#1N&+X9Y*!V"T[F_XA
MY?I=/ KOW_W> 8QYB24]2'N.+D?IK=B,Q,ZFW4:P,5K@#3:%R0&KE1(BN#HZ
M[X9=Q7G1M)M"K#R4>!K=&\F)L.^W^;VH()!5XEI%T^#[W>>496E"<=WOC6N3
MHX&99'Y<DG ,N)M<=_-$'&OMLKF2.LYIEI=2CDA5X.8<87)3E52*2Q9YO0.,
MN$<<<93OZT(-I2V*%*W?=@[X.GR]$ Q')E%E>WRWZK$RB_F78A84M4$U1,6^
M%N5<=JO\D)> PD#?[^!%HLN$FE._-R#%2*?!:ZVH1,U<E"V-1-IE]0]I:.>=
MG %28.[E9*[B.G4 46U2;:O:;JUJ%PQT[+Z,/M(UFL#PH'MQP3"IDGCGZTSO
M!NY%2" <)A.+-^ J+SX22HY@-AF@A G,6_)X^SW,:-=Z7H[IMUA#,,GK@B^Q
M#JQL%+Z'LBQJ_H69)N22HZZVH/T1AEB,67G)N)8,K$Q#;;7$*Q9C5G+A..7)
M%W&/;]<>*S'\.=3&*F@EQ'36V:;:''1H0G)V//\OEI"@#2%,1GN.+4<<?!HZ
MEBN.RD\.5D/^ER@#*-TQTHDY06/F/)4RA07\NQF9TRY+;INBC^_0'F<JRN!C
MVP^K+4K.M!,<;Q*6%-H K3=-G%XZ!@!([$G2)]V?)M@E.59,QD!A"ZE *Y^
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M.E1$ND<UP:KI]:^2-"1Y@9M*-*I,;7F_1\%:E(8V#6DH>A^[VR>,(Y1?96V
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M, >JY)*7-88Q'IU3#;J/H C.<"49WDFE\56QT2XFS 8&S]4ZN@PT)ANETB#
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MU_T>1I"!V>AL]0RFQ\@<C!G@#K"AJ'M&4=R-^%=%R$@Z?P_YVEP^<I O10'
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M2/&N=0U:NK-_;+'=!W@SWJ&%]=OHZ /:37L'8)ON^Y%^)F*&.I=N('"4<&_
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MD@#Q"AS?) 66'+\RZD 8S/,K+M&@.O4T*DQQ<=B>PYI:]+%7(N5,@"!HNV9
M( KPH6PD8L-AD<,\7RC9P-!\-U?85 ,.\PDUK&A^G^79$VPOP]A#B-V6KY1^
M2M!/1%#8UM+H<"YYI@S"JQOLD'(#4Y0Z*%)#YZL2/6O!N(@R J?7#7FD-(H[
M7KB]S[PB(=X9.+4R[_?2'#4<5J*H?*/(LV028(%(R0U0$=RL7($RNW#[FM'Q
M7"78"E,>*JEOZ6>1R4QEV*,"4>+PG_E2<5< A-:!@YK Y8$#P(W)6/&,[Q"&
MXG%B!]P'GL3F-JK-#D-B_00;M$S,US[8A.Z<ZT,";$3/_3_F?D\;HE;^="O
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M@&L&6NXVH!\&S,WO*TV8*8*#(J#(CDW^,AB,ADTP&/%M$5X)S<+CQGH:R[K
M]K:<1XF?&@Y%61].3G^+2W(]V^#M4+O5=4 L:@$T&!S2&W8E].M>9:-T2I)
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M GC#GSE]XFZ"%'#"UYA'W744=)SDCBCS&LF:AALC'IC;;UCO]Y(;I2/LG*J
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ML!&+^4;6P?T2P;&GYBM3HPD28U(D2PM]C,*I_9Q1UL6GRCJQU[><XD0BB_0
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ME.MPP#"1;#"7&4-^80P0Y*',DG-9KW=BHWT:G/R]D5"6?R\^1]^57;I+0HI
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MP7>_ =_]R9_UW6^]*NOVO8XO?GCU[']@-WWQTZ\_O_C^_P%02P,$%     @
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MO^$)31A^=3CL_=9UYTHKA*D,VZW5TS[S7];YK=,[IF-P]R'$W\)V=0)X?W\
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MTP+;IX1 8W<BQ4<P<\WJ*_$%N/[0C6O(^LL5&R!IU*&[Z.T-N3\W)'%NB*\
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M#IS?\(0F#+\Z'/9^Z[ISI15R&'SUM,_\EW5^Z_2.Z1C<?0CQM[!=G0#>WQ_
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M[>_6 /M.T_<GO@[[N*(Q_$VI=G5LY!;[N,4^/A*_4@_-4,LM8 )(/X,6DI$
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MMENNO6LCCU0Q5GR%PUJTH  E=C%&P]289J;O7>-$B2"MF1+F(VJW./O#\HG
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MVRG"DJ]R4A"4'J&\:O)O\M!8\0W/4^2U74 _*R$L:I58M&!H2OXIN82M<9;
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M6K85:3*9LJZNZ@JP_Y)@7:7"GDS0>WI:P/ 5EE@@HX)]FCH2Y4ZYJ8"1^,7
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MC*UM&F.9]5BEMKM7RZ)'&<M\I/T2=;.Y'P].CGXG0?E^^.'X[?\/4$L#!!0
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M04%6P46^B&4Y0_/919S"38+MO0<.R[3Q>99G]V W8.MAG,,!NC7Y.M:OJ:_
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M8ZPGJOVQFE2%HC[D&B?:/*H>Q&HK@-!X'EMUS:'6RG'\8=:5>N?/;S8H# G
M&BHH"'ZQS,O8Z =,'ISG^"DX/RO\8$2FZDPM6I$0Y/NX*^E8(0;G%531!RE0
MPK@ +F3-L@'AD&G-56U3>+T;*!-C],@/W64R"]+XE7[RI0HE=R+DDT7(!U^$
MH%>^_^A1TPC23S DM5BEYVXU$N:&N\J'2,[0\<52(0V72QU1,(>'L?BI<KBV
MI <[0("V<HB?Q,:7E!SI*399Z@5C%(UT6Z)@8Q"-JC<JO,)*0K=DJ.X3RLU>
MKB9I,G5=!R-@=T=\RZ<T2IM'_-'^XXXCCB&IK3_B# Y6I9+/Y^P\N.<X _,1
M2VZ2;)6O2(+/XC1:XXRB,MEY%)]I2M< 63QX&APO21T_P8%(R/YI\,\H7>''
M?RT,1K,,T7O=-\]?WG,74Y?Q:7"V7L((#L!53J9/@[=PW7BIW^:X@ \\D(+^
M"C_9(3RV >'Q%Q<3MZ?<%IYR ^70CB-^GR6HS2C*5;KZ"WV-0PTC8T05O!OQ
M,,3Q$(U4,3'$EU4<=WSW;W/X#[@2\L3+\>U*(;=^2H1.AXW[&6Y:!&['.FAL
M(1<!B<?![CQG8REUP^9ECA9="7]'6@B!%TQ6! +(<DGZ.' GO/,UJ%<X'!!L
MR&9HP9*$KVX =L$_7N?%(CB]MV_#U%*4&:6,DX !BW7:'K\.@V='3D7;T7-T
MLA1+O.']O!Z:_R:#5]X,#TCCJ&2OSL9I.A)$8 + 2\2?TU#9<- 2*ZOSY6Q
M>LOX4XWRN^N[AYFN35,4*!I7I)-+\*D8NQYX5R@+*67XP2C^.(WA4B1SFR@<
M#K@ZSKH]]4#VN,'.D=(9<W![7K#;QR>\2R-R8U[AY!(XO36<0LFF<(D92,2)
M8QA;EE:"90O8] K622J%,=)5!LPU(12"P0MEFFB[5EA AV"<20S')IYCT(K"
M %1NU7D:AP.[5\&7V*K6XAT.3-"E_31YX%0/M=?(T.7J.>T[7;/E4Z(20[@+
M1^!'98P*A;MSO$@JN--[ =^,KVB^7^,63G4+8W@O2+04\W\@,-Z#Z!)%_+#+
M:J (%64!J(9;5*:OK+NUM*/J'Q+,4X4,B022OB"FHLLH2>F7!@]#0VCH>%NV
MZ \2*\M)!5$^H8[RPF]TR%Y.<!*:@WX%TZV25"C5,,!&B)J-9LS#/C.F>W6&
M@^O55AI &ZP%X896+O=-)007WD)*:?=.O&[YE*B4 N[FJ3(/5<%;8W9*5O'$
M 6KB)3V2<TX*N=50M>>  \PNZKC-VC2\1UQM2H=YLPE>MTCH9VSH]=FW% 8P
M*9._%R6Q/.#KD%@!;1HPH5R45,?;6RI!@@>C\QIQ) L(BISWC@K!#)31*4LD
M91Q31!UM+$&#FZL89+BY'0^1E&9Y 5,0X]+*-KRG<RGUM(83OVD"IE^(!!&1
MD/?1#CC>"+H5W;EXQ[\X*Z(9UW6NO8J8)1)=S51$<5V(9(P%F"MX6%HKW:GZ
M9#V[U0?!;3 A<3/XR&)>V;$CY\F\0A$XVG\\QB+5TBG>R6(,%9&ZDM4+H@))
MP8:#$3X7%!/!BR4W+> #&.(<=C,O$\ML6D-<-NMB^$=45BJ9O=IJ&#^O=350
M1G^KMF[?$1'R#UPSR>N,/8O>/6WCZSH<?&TQW=\RZKYC_X='C14&5FE1N4++
M*7!9D>R)T\()=\JWXW* H='C<Z#:[L%-F J)\)K2M3?.X%+EB-_J"MS@^O)6
M?5H4'TX>^EJA"C/FX< )=]CTXV8:"% 4*2ZSV0A8IMD*;I1"?%CR+U9IE2S3
M-0/$QK[+[]\=3W19DPL>0DB5^WL_W.?S/XW2J:8L&\ 0NV_( 40I&5.OMXAF
M\69P+D%8+'PE1-YQT$",B-8; L./%TLW:]HHUH%;HDK&&S%K(,3L,!6 ,6*%
M6[B(!6;GDP)SB3]A;[HVE1]#)BR(=]QB7 <'3?ZN2& ]6JH=!:#'AJ4\1^<!
MEUB&Y-$/VQ$%&X=TJ)B>S@$8/$](Q .54P[JH T%L>WS+PN3E M*K"Z*?'7.
M0N3, LZ8W*#O[3L#^4]+6C_<Y:=O-3_]<)>?WN6GMU<BW&[1,D;G.6(#&N@U
M*#XD[ .U]!K34:@MCHE*B/[S9XT.'38B0YU^L7C:#%/N,O!08W]:]JK+=:Z$
M+'@T2TJV5[AZ<HWVQXI]W X&A/EX+*3I?X0V ,T\M%'01VOZ(P%G\5D^M"4$
MV;KL];/=#BKR:]D_EXD=UAVI??!3;M-2(9DSF2I)LPZF'J1S_3(U_R+TE&@Y
MR6?5^ ,]*U]BS&&525Q4:)6XD<M"8WWDV$<<$W3Y+37V\' T'4LC#"\$ ;Z(
MVJ.6,1/7ES-$,."2.)1H(QBSC:<.=\'8D^P)M3P'48&!OXRX0VA2X2N:844J
MS.W<SD]+XJ#A&W2QI75L+KI%';LK:^WQ4+F1#-^7]"GO-@ZU$1L:#LQ>\($W
M!W2.E03J=#FAUTVO\&X,NUB, WWP:#1I[;YAKO%#_,+HZB*F1"#&7W*-0[@C
M@(-2Q=.+#'5BNO9.HP&-ML;!KG,&0:K90_CBNH>P+EUEV\=22.O0X<Y64A(>
M'. ^DF3\L8A@+=Z!+(5SX-CK>$K@.Q@CRPRUK@T/U?:>"IRZ?/$HC<M/DLU<
M\(1C46K4KEMP,Z$=L,R>1IG0F)&WZGZQYV7#P6A#/? DYG@0+<K<:L@/<;SL
MG881%:'_0Y@=D?=J4AO#FR)M(SJ2'*R+BC7?$%IP7L*;S S?6J[@I&<*&IO%
M*7Q/0I0C# &ZP\*808K^?%F-#=#>.J0B3&P]T,]1\2&NKDM*Z,&JW8+>9+$D
M(F/MGE)[?@BGI390DSR+ B?\LS%R@P(:3U)4"L$P%CTOF<)XK)3%?8DAXM[#
M(];(#M'_\CFEIWNZF:PF;+0 %[-%AE/4FLO@DYYK)Z]VU$_MG=>80'#-\0N0
M(J&]&GT<^V8"_+;4'V"[&GH['D42?FNQX.CFFWI;K5 !S3[:'V\LP:=PE-UP
M]\D@7 IF3J*J#^_V.&]UU06_EY9Y[<\%LX;$@DFI0\1;(<T 7I1R6B03/M'F
M&0F.'<U84O7,",,JQ?R0N>QA\*L*QFY;\?C* Z?FSHOH#[33EA^8<U_^8.P?
MK)>R%.]X*8[L4K2=,R; $5(#IRE'ME8I;HMO,&RURC213'4X'2+>Q@0-_7=M
MZ8,6^3H<N+M]F:<8T7,9Q%GG9I0+H>9G$<+,TB2>T\GCQ,,"G,M2PY!"3.;?
M<*W.H_(*6,Z0RS9$EV!>+*0,0&13^3191N7"\SC\JCW">,7P@,W63FG?!$OO
M8(HEZD]Y+<LY^FKB1;HQ%15=";\GGM=J'2*FJO<^X(U&.GE,J- F@RQI-4N6
M$4V"#'-9$;Q]7>H9 ZMH_;$>J0'NW-P&1G)73&LTC<H+![!WE>.@IJ2V'_QM
M;"+0C;1D;T5IZT\X9JF*QZ-9E;]I\HU^[AOO8;L9%08MXAAWH_LR#0?FMW4*
M*>'NP!)5D"(HH)(""3,>WA^S@95E"4:0496CRCT:-YT,!RA1^P2]&/C?V5/X
MX1'>WP[3T'U$^Q>\)]$@VE;!>4S;Q^8APLYW]$]\T&8A),^E3+NE\]64AD5Q
M7N-).@1<>33<X!DVW6%1JTW=P)J/F@;$3E.%!NF1R"LW&PL*M:!L.M4(DV&-
M0@>I7F"O,)-#@-FLOOGEV  ,*-E'@J'K4+I1>YK"@[_A75YX?@(.@ ;V\/X]
M/%U+M?*1ODE&R68!?4OEIO?ML=2\773P.1I/=93LQ7L8.UI6/GGT>/-QL^DZ
MVBW./<ETRL PQD2;1929.T+FJB9.,RD=)R >D^(B1BWQ.M1PB]Q.NIZ4>T6J
MX9T,CK"IZJF^]MSC5IRP]VMC1='*8]K*8?P1<P9.;8T*<QDELU9Y5O\I P.,
M<1!-\DM4 IZ^,'EAS>4Q1B)K&<=Y<HG?1A! 6T:^MC#VZBWA&!6J=3<(O(YY
M4$:L1>/XJ^DG'V6%\(5PY!\6<));^+4Y9P@O:0'W^ 8L3&"!8#P_VE6?-%9J
MBE\$2C<C"Z^UY:>SX$V7K/94G5B$3T,X4EEIN@_O,,-UZGH5_A& +P.O&_D2
M26XY?5;JY:1#)7G&/<Q1XD"=))\W8!",S>$.!XWQ!OE5+&E?&_4;.0&)!E=K
MJQYA"Y0*9 LB>>QW4K%#=8>7JMNZT4EMIY$5^2EA%)%)'-3HL$<ZI)14%9=(
MVJ*1([- GV8A!YL,9%;"^FV&^,B1Z':1O "7[Y-1/,#W-NKXJEV*]T]+\3[:
MI7AO-<7[:)?BW:5XMU<BW"Z1[;/WSX^%AH*SL75[ )0AV%4<""!_!1Y3H EG
M(X@4V?4+H1!>6&L7KRY++2W0:ENU!_)C"@[6++>2$*4.Q\:H\BO=\',O+R8Q
M(OQN&<<?& I\$2&.,L;>>J@]UY:<PQU+9P2VK4[,R_A&%'*%?:U6E21FS!O0
MIK &PV0=,F\3.DE@7>'DO'!.* $B&TIB\U.L2X,T8ZRM,]L99Z-<X&U7_JX5
M= HV!37EM-A&L8+%_*4WS_*8 \EFNK$)A)H9&T0<CZ4T)TM83VRA*'ZPX&0"
M)P&& QN*9%\*;#GU;2B03<F+TJ%156*7*19.:N#2RT^/C;'$^=(L6CB1<8SL
MF-0KF6?8>P<67(X4A76SEH@;11,[L*-^VBM(^K->V-H8'FBGWBRAD3)#VG0-
M+=,9IZ&4^2?N.\T>U5@);@-Y3@N&@W,.5..EK<GX&\R_,4$BP@%O!MV>B+EO
M@A'\#])Q+L64MP_M*OVQAZ CWV@#)_8LK#+!X,K7E&Y-1HY#==UX8\U3+LKY
M /UQ^)F9$T,^K8LCLJQ^3TU45$[<9"T\;D8<N&MM6G :>26(?)*5[+@XTI*F
M,!Q<Q&WN2-X<LW7P",*1I6M=!D>\VPPLQ9O ,Z U:CRK94\)*>&-0EGKZ(\L
MWWCWX2!>Y:MTIFD*504?G2W"/W U1^/ R0GSWS5^&FCI6\BU[6'#'>2PH8Y:
MZF:<2AKQ&/6986U14?I0$U*&@*?:V=2XDO5'PS%9Y.*)=Q7\U;Q0NI?:4:2A
M)+OT@5R)TAL^Z40"!;>PK&V XF_4@GSW-&-!L KDR);^9EURUHA9Q",7,Z;$
M_S1I%EJ@A9FPI[',[TC$Y:()>&3.D*32O2>_SBDJ#1<+7KV,VQ(SCIBDV/%&
MN2;K:'L+$&K"B@=O?F%;N66'?2 +(0=#, BR07IJ"_=Y9A%9N992$E+[C:HC
M8R<0?FLO..A$;]"Y 5$:G1?1\H(+AN9)45:Z6&ZY:?URX/--W!VQ%$(0OYGV
MLQ89E'R='2(F73?7R?F#)Y8(!,8Q08.]9[56Z=AFA(4I+7[(:@XC7I0^(E "
M'KXJYE -1@;]2MZ .J TY7K(=I-#C4A\(IWTV"@ 481<P3_6P>B!Y"S,R=*W
MC]Q>B;1.3IMG![IA^/DP8.=&F=I.X=AE"FEH*-?<].VYVHP[DNL:M9=SJC-A
M$(^"K&8,W[$FD'RW=;$2![.H W.-3[1JL5TVJ8J&IZ2%0NUDY'A/2.CX58 M
M%_H)0VB[+T6[PJ?3A_@&W!<5)BPB,5[IN3Z9LR!=.)3K[8Z 6OK&.QR8_ES7
MCYQ>,U3J (S&'5D^O^+1='G84/(HF@N^DZ2(HC3T*/"VE=0!_8&@['!PXZBL
MA0_5I#6>/U4C'2I.7<R&EG-QO]?=<2ZXO?'Y-'XB'52B2F;Z&'1(T#\F6@'K
M0G5:)JW=F[K1SW2CT4H!93R+%X3X)OGL/$<+X<Q158IE=F:<-(A4Z\5T64MS
M#-RC0V<2=X%0#V6/ZF^Q@2H#BR<?D*H]FTM9^J*(4X2[L/V?%K9_O O;WVK8
M_O$N;+\+VV^O1+C=)ES/WC]_EYR?KR=X_UV=5W(4_Y<Z\(."Q6!=G)O8@X=U
M54.3W3NM5V]KUL"%082WXJ*.ZQB&IH)K<UW IT"5V8I>2<>LIMEOBN=):5J&
MQJ"%5[&G9Y#EZW;HXBQ,,B+0J'P%!X2![?PJL\09P@)@>33(32@["<H-8'1.
MSV)$J!N/<0$6EBCI$<'BY1_?!R-R'(@JPM*C=[U2TR-)P4@<?.<E-K>O?$QH
M<RP25V57&]11G%)',MR^3%(XM-+4I'<*/Q<K6N88<S\QA$\K= <CLXW7F"8>
M+8_VPJ(21*7F9; @2XU>\)*A'92O8_1^LG@.1A28109:W'J$R ]O9 X<IQR.
M));AJY?L-64A/E!8CKDZUWU\+"YMC.O_,W\(O26TIGDMH%#FQJO%^&]!U[\U
M.B^&LTD]W.C@TT6VB+9&G\<Z5L\;J0R0"56\0)83C@TN\BM$SK9%S 19[<;T
M;>%'=_/7+GP@5G:>:]<6$ W,X"8E$!**:'44_X 7Z@%V7->0\SB?';##]UPF
M3/Z.!',HT(2WX)Z3^^N*<CH1H'HO4>?.IM%5*66SVA5AU\A@VZ=$3?? SCCP
M,A9=/3^5UU"1L!M#V)[;WLV<1F!N:O*93;%X(]: V_5?H%:#R60Y)&B:>K$9
M%YN&XF2CEVJD2-"&"$9-/0A[#(;I^G(5QD+RR&ROD> L[,JH[Y^4_4R'#?PK
M$1VY&: T+?U.I-IKNU1[Y$8@R) 7I:-A=SOM%0Y*"ZF\P35W,6I)H8GZ)#G&
M5#:4U[_)J>S;+E.=K'.2]&]M3L.!.RE.>'14(%XKC$5J0@N-B'FAGH5\!WMD
M&->F>"Q*ZE]CF@9V3/R:M((MJR\Y"+O(Y@:%7JY7LE37NKMDA+6&!$O%XA;7
MI4+<*9HMGQ+UX 1%\S:'779R^<=DJ+<I&=\8=&GLU*:E3VLI07:3NBETR33N
MS6S[^'Z4MF3IN#%]KH!0ET SRL;E]5G9VV8#INUP0%$QZ0B([I()6=L&4IQP
M<P9+ 6I3\B@NHZR!ED!^8:OKCA_\Z\5QO]O%<6\UCOO=+HY[]^*X=_^FW]KP
M'VJ_'\ZS'9N@:[EK^W,'IG3F0F7ZFX\(FSU;OXXF[@]P=Q0)4BT<VO^+&*R)
M&34TG26E 1M42GI%G85L-(KSX6U!,@,MLE1.-@-0/OFJ=NTK/(C4?ZII'V(0
M?UDQU7AO'J./-\LM=NQMGA @ 3B%\:_!%%VCJ>.H9M?E<7BT;U2$T,Y\[53X
M"NWU: /#=3L)VQ@;/YF09CMU5AGZK89Y7Q@R%EV#\8E!TAN37 TBGB98:3A
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MM"6LA4X9NY#[6F;R2F;'0GN8.QC3GP7=V\>NEPC&UE!](=FY+C83?!FLF<Q
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M*,E*)K/#[@"DG&SJ(T3FC&2!?*;1 E:M1)'/''<4S6#/1^HE0I 'LW-I+XX
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ME=B^IPQ>1<K1.8LIPZ*L60&Q8U+A+E:1)VB:P4@2#3)D<,Z#&?Q:7@W&#)A
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M-P61MDMH%:VH]"R-S^$NW<-QL;O$E-)X#>R_M$53^XQK)CX;&4U&W:;)=U2
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M-3+CZ&U2-;3%L;R/ONYO#;VM_\WY#+^:A6-UVP+_7W40'<E)\;: GH\_^R/
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MBG.Z_Q]#4<'C=_H,PKDLDUQ7N2DWX;+G9D7?>*'?\![MENOX!:);W^'_AS.
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MY/AA 0UZ=I9)7'5_;'<_LG@Q_./1A/2X5J3'HPGIL9,!\IN]F'<BV&_"8'_
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MG[F_*O?DE70GQ]]9,'L]YYB1.+7A7XZ>>"R0!,;2AQNQS"R_GA3[CP96F(7
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MDZB)\#78;,)2.]A74H$_MQG-)-;B@?+'.E-H95%P+&/>;2$ZWK2-;<\6U._
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MZ()0\A6[!''',%.M^*^4'VGTWWY,G@PX@\3C\!H8AIJ^6F428&4\9<\Y;XK
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M6&Y!,",E5*];^[B$E(]*'8]->5BJS4Z<FE/0F?3%H=]V?$<;G_"*B\(XA2\
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MX=W9TS3:HJ((L$:0P3@6V2=ALI*;QGIMCY(5%B!SKX<4K.PE,VDY%C@X)TC
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M=:DJA8M+J8+&UX1ZC?5K\+F6<,H$7\ F@;%6SV@HN>Z4OB/31.\I8$/9R/R
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M\8/O'GW_W>/;/I_;/?YIX%<8>(]\Y^$UL^_<WFUXYHHK+KT&UQD!_P)SN1X
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MN/B!%_!U/$!_J^BO^_&@V,.1X%I@U3(Q>48('J>_-/R"F-8K6K4PWTUYCI^
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MH+M";2O,=*JOM76F(8BJU31M[S19ZB^["KNA];,6XS(5<4215TMFXEPM4<"
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MS]W:FTAAQ\;SB]\_? 7VX_FGO[Y<_?H/4$L#!!0    ( 'U"_%I,F#M$E!(
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M^;%>LR3 J6\8>V T'O08V\YP(H97H_%5$PR8# 0!C%6M2?=]IPHKHPA0)O=
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MSHN.3G5>8514DHD.1P_CQY:)+P86\XD@G.7*E%;W?79LIC^.&UO/:TVUY<%
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M@3;F%@UJH\&E_ DFH\%0X[""J*U<"A@+"MRQ#%;&2"QW_H/T4-,R,U0&B I
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M;>$G.QDR6 !-=(-<Q#ME*$GNL%EN,WM"3<=RY"D(,J]([32'18D,@='Q<GR
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M5]Z5'(WUOFM.\,]A,+(;_P]02P,$%     @ ?4+\6K@A%)0J P  [@L  !$
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MZ%^#4]V>T 5%Y]M:H.ZG:FKY&U!+ P04    " !]0OQ:\/395OT*  !_A@
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M9_LNL2LH^@TK.&!E$)#TVM-A$0'CJ!&!RA!4Q/C%9IYE6\+?!(\EQ!-"H'D
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MH&F@29VI(JQ]<ET$(AGI,YM1,[D]O,1KB1ROC"T&M85Q0Q$$(Z M:%G<_*T
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M     &5X,3 M,2YH=&U02P$"% ,4    " !]0OQ:%"5#)1ZA  !<UP, "@
M            @ $TG0  97@Q,"TR+FAT;5!+ 0(4 Q0    ( 'U"_%I$WJ+=
M<&L  #>P @ *              "  7H^ 0!E>#$P+3,N:'1M4$L! A0#%
M  @ ?4+\6F)L4R3C9P  @K4"  H              ( !$JH! &5X,3 M-"YH
M=&U02P$"% ,4    " !]0OQ:\ D9'^A[  !35 , "@              @ $=
M$@( 97@Q,"TU+FAT;5!+ 0(4 Q0    ( 'U"_%I,F#M$E!(  !=P   *
M          "  2V. @!E>#$P+38N:'1M4$L! A0#%     @ ?4+\6HFM!H_3
M'@  $MP   L              ( !Z: " &9O<FTX+6LN:'1M4$L! A0#%
M  @ ?4+\6K@A%)0J P  [@L  !$              ( !Y;\" '!R<&@M,C R
M-3 W,C@N>'-D4$L! A0#%     @ ?4+\6O#TV5;]"@  ?X8  !4
M     ( !/L," '!R<&@M,C R-3 W,CA?;&%B+GAM;%!+ 0(4 Q0    ( 'U"
M_%JY5DG"7 <  -Q7   5              "  6[. @!P<G!H+3(P,C4P-S(X
>7W!R92YX;6Q02P4&      H "@!. @  _=4"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="prph-20250728.xsd" xlink:type="simple"/>
    <context id="AsOf2025-07-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2025-07-28</startDate>
            <endDate>2025-07-28</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-07-28" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-07-28" id="Fact000004">0000868278</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-07-28" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-07-28" id="Fact000010">2025-07-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-07-28" id="Fact000011">PROPHASE LABS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-07-28" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-07-28" id="Fact000013">000-21617</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-07-28" id="Fact000014">23-2577138</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-07-28" id="Fact000015">626                                             RXR Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-07-28" id="Fact000016">6th                                             Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-07-28" id="Fact000017">Uniondale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-07-28" id="Fact000018">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-07-28" id="Fact000019">11556</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-07-28" id="Fact000020">(215)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-07-28" id="Fact000021">345-0919</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-07-28" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-07-28" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-07-28" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-07-28" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-07-28" id="Fact000026">Common     Stock, par value $0.0005</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-07-28" id="Fact000027">PRPH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-07-28" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-07-28" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
